CN113512122A - 双特异性四价抗体及其制造和使用方法 - Google Patents

双特异性四价抗体及其制造和使用方法 Download PDF

Info

Publication number
CN113512122A
CN113512122A CN202110471082.8A CN202110471082A CN113512122A CN 113512122 A CN113512122 A CN 113512122A CN 202110471082 A CN202110471082 A CN 202110471082A CN 113512122 A CN113512122 A CN 113512122A
Authority
CN
China
Prior art keywords
ser
gly
thr
val
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110471082.8A
Other languages
English (en)
Inventor
高泽人
菲尔·谭
布莱恩·科瓦切维奇
布莱尔·伦肖
杰弗里·阿达莫
麦雅丝
卓识
陈澜
朱义
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chengdu Bailidote Biological Pharmaceutical Co Ltd
Seattle Immunization Co
Original Assignee
Sichuan Baili Pharmaceutical Co Ltd
Seattle Immunization Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan Baili Pharmaceutical Co Ltd, Seattle Immunization Co filed Critical Sichuan Baili Pharmaceutical Co Ltd
Publication of CN113512122A publication Critical patent/CN113512122A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6849—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6851—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6875—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody being a hybrid immunoglobulin
    • A61K47/6879—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody being a hybrid immunoglobulin the immunoglobulin having two or more different antigen-binding sites, e.g. bispecific or multispecific immunoglobulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/35—Valency
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/64—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a combination of variable region and constant region components
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance

Abstract

一种双特异性四价抗体，其包含具有一对重链和一对轻链的IgG，和连接到重链或轻链的C或N端的两个scFv组分。所述双特异性四价抗体可具有对EGFR家族中两个不同成员的结合特异性。

Description

双特异性四价抗体及其制造和使用方法
本申请是2015年12月19日提交的中国发明专利申请(申请号：201580036408.7；发明名称：双特异性四价抗体及其制造和使用方法)的分案申请。
相关专利申请的交叉参考
本申请要求2014年12月22号提交的美国临时申请第62095348号，名称为“双特异性抗体”的优先权，该文件全部内容在此引入作为参考。
序列表
与本申请相关联的序列表是以文本格式代替纸件副本的形式来提供，并且以引用方式并入本说明书中。包含所述序列表的文本文件名是序列表_ST25_0003PCT2.txt。所述文本文件大约227KB，在2015年12月18号创建，并经由EFS-Web进行电子提交。
技术领域
本公开总体涉及抗体治疗试剂技术领域，尤其涉及针对EGFR家族两个不同成员的双特异性四价抗体。
背景技术
ErbB/HER受体家族成员例如EGFR、HER2、HER3、HER4的过量表达和/或失调，已经表明在癌症的肿瘤发生中起重要作用。EGFR或者HER2的突变和扩增产生异常生长信号，其激活促成肿瘤发生的下游信号途径。针对EGFR和HER2的治疗性抗体和小分子抑制剂已被批准用于癌症的治疗(Arteaga等人,Nature Reviews Clinical Oncology 9 16-32,January2012)。针对EGFR家族成员，如EGFR和HER2的单克隆抗体已经在结肠癌(Price等人.,TheLancet Oncology 15(6),Pages 569-579,May 2014)、头颈部鳞状细胞瘤(Cohen,CancerTreatment Reviews 40(2014)567-577)、乳癌和胃癌(Arteaga等人,Nature ReviewsClinical Oncology 9 16-32,January 2012)中表现出良好的临床反应。几种治疗性抗EGFR抗体，包括西妥昔单抗、帕尼单抗和尼妥珠单抗是已获准用于几种癌症包括转移性结肠直肠癌、头颈部鳞状细胞癌和神经胶质瘤的疗法(Price和Cohen,Curr Treat OptionsOncol.2012Mar；13(l)：35-46；Bode等人,Expert Opin Biol Ther.2012Dec；12(12):1649-59)。令人遗憾的是最初对这些治疗剂反应的许多肿瘤由于对药剂的获得性抗性而最终发生进展(Jackman等人.J Clin Oncol 2010；8:357-60)。因此仍然存在着对更好的癌症治疗方法需求。
发明内容
本公开提供了双特异性四价抗体。双特异性四价抗体可以包括具有两条重链和两条轻链的免疫球蛋白G(IgG)部分，以及与重链或轻链的C或N末端共价连接的两个scFv部分。IgG部分可具有与EGFR家族第一成员结合的特异性。scFv部分可具有与EGFR家族第二成员结合的特异性。IgG部分和两个scFv部分共价连接以作为双特异性四价抗体起作用。为使本公开的目的和有益效果更加清楚，下面将结合相应的附图详细阐述优选实施例。
附图说明
现在参考附图详细描述本公开的优选实施例，其中类似的参考标号表示类似的元件。
图1是示出了实例二价单特异性免疫球蛋白G(IgG)抗体的结构域结构的图。
图2是示出了根据本发明的一个实施例，包含IgG部分和2个scFv部分的实例四价双特异性抗体的结构域的图。
图3示出了实例四价双特异性抗体1X1、1X2、1X3、1X4、1X4.2、1X5和1X6的结构域结构图。
图4示出了SI-1X4和SI-1X4.2之间的VH结构域序列比较，示出了5个氨基酸差异。
图5和6是示出了利用BLI的单体EGFR结合的图。
图7、8和9是示出了双特异性ELI结合的图。
图10是示出了二聚EGFR ELISA的图。
图11示出了SI-1C5.2和SI-1X4.2与单体EGFR通过Octet分析的结合动力学。
图12示出了SI-1X抗体与A431细胞结合的流式细胞仪分析。
图13示出了SI-1X抗体与BxPC3细胞结合的流式细胞仪分析。
图14示出了SI-1X4.2抗体与Fadu细胞结合的流式细胞仪分析。
图15示出了SI-1X4.2抗体与A431细胞结合的流式细胞仪分析。
图16示出了SI-1X抗体对A431细胞增殖的作用。
图17示出了SI-1X抗体对A431细胞增殖的作用。
图18示出了SI-1X抗体对BxPC3细胞增殖的作用。
图19示出了SI-1X抗体对BxPC3细胞增殖的作用。
图20示出了SI-1X4.2抗体对Fadu细胞增殖的作用。
图21示出了SI-1X4.2抗体对A431细胞增殖的作用。
图22示出了SI-1X抗体对Fadu细胞的ADCC活性。
图23示出了SI-1X抗体对NCI-H1975细胞的ADCC活性。
图24示出了SI-1X抗体的热熔性以展示其热稳定性。
图25示出SI-1X抗体在七天时间内的血浆稳定性。
图26是示出经EGFR包被的ELISA用于大鼠PK研究的结果图。
图27是示出经HER3包被的ELISA用于大鼠PK研究的结果图。
图28是示出夹心ELISA用于大鼠PK研究的结果图。
图29是示出小鼠异种移植研究中平均肿瘤体积对天数的曲线图
图30是示出小鼠异种移植研究中相对体重对周数的曲线图。
具体实施方式
本公开提供了较目前已知的抗EGFR抗体，具有更优异治疗特性或者疗效的双特异性四价抗体。在一个实施例中，抗体靶向EGFR家族的两个成员，包括但不限于EGFR和HER3。双特异性四价抗体可同时抑制EGFR和HER3介导的信号传导，因而克服EGFR抑制剂或单克隆抗体治疗中的耐药性。
必须注意，如本文和所附权利要求书中所用，贯穿本说明书和权利要求书的单数形式“一(a)”、“一个(an)”以及“所述(the)”、单词“包含(comprise)”或变形例如“包含(comprises)”或“包含(comprising)”应理解为意味着包括所叙述的整体或者整体的组合，但是并不排除任何其他的整体或者整体的组合，包括复数对象，除非上下文另外清楚地说明。
“抗体片段”包含完整抗体的部分,优选完整抗体的抗原结合区或可变区。抗体片段的实例包括Fv、Fab、Fab'、F(ab')2、Fab'-SH；diabodies；线性抗体(参考美国专利第5641870号实例2；Zapata等，Protein Eng.8(10):1057-1062(1995))；单链抗体分子(例如scFv)尽管在本描述中，并且在整个说明书中，提到了抗体和抗体的各种性质，但是相同的公开内容也适用于功能性抗体片段，例如，双效Fab片段。
在一方面，双特异性四价抗体可以包括具有两条重链和两条轻链的免疫球蛋白G(IgG)部分，以及与重链或轻链的C或N末端共价连接的两个scFv部分。IgG部分可具有与EGFR家族第一成员结合的特异性。scFv部分可具有与EGFR家族第二成员结合的特异性。IgG部分可以为scFv部分提供稳定性。双特异性四价抗体可阻断AKT和MAPK/ERK途径的信号传导，并且可以介导针对表达一种或两种抗原的细胞的抗体依赖性细胞介导的细胞毒性(ADCC)。在一个实施例中，双特异性四价抗体能够同时结合两种抗原。在一些实施例中，与单特异性抗体亲本对照或单特异性抗体亲本对照的组合相比，双特异性四价抗体在体外和体内增殖试验中提供更强的肿瘤抑制。
在一个实施例中，本公开提供具有两条IgGl重链、两条κ轻链和两条单链Fv(scFv)结构域的双特异性四价抗体。两条IgG1重链和κ轻链形成对EGFR家族的第一成员具有结合特异性的IgG部分。两个scFv结构域具有对EGFR家族第二成员的结合特异性，
并且每个scFv结构域通过具有氨基酸序列(gly-gly-gly-gly-ser)n(也称为(G4S)2)的连接体连接到IgG1重链的C末端，以提供IgG1-连接体连接，n是至少为1的整数。例如，n可以是2、3、4、5、6、7、8、9、10或17。每个scFv结构域具有“N末端-可变重链-连接体-可变轻链-C末端”的结构顺序。连接体可具有氨基酸序列(gly-gly-gly-gly-ser)m，也称为(G4S)m。m可以是至少2或至少3的整数。例如m可以是3、4、5、6、11或12。在一些实施例中，IgGl重链中至少一个或两个是人源化或人的。在一些实施例中，κ轻链中至少一个或两个是人源化或人的。
EGFR家族成员可包括EGFR、HER2、HER3、片断或其衍生物。在一些实施例中，EGFR家族的第一成员可以是EGFR、HER2、其片段或衍生物。在一些实施例中，EGFR家族的第二成员可以是HER3、其片段或衍生物。在一个实施例中，IgG部分可具有针对HER3的结合特异性。在一个实施例中，scFv结构域可以具有针对EGFR的结合特异性。在一个实施例中，IgG部分可具有针对HER3的结合特异性，且scFv结构域可以具有针对EGFR的结合特异性。在一个实施例中，IgG部分可以具有针对EGFR的结合特异性。在一个实施例中，scFv结构域可以具有针对HER3的结合特异性。在一个实施例中，IgG部分可以具有针对EGFR的结合特异性，且scFv结构域可以具有针对HER3的结合特异性。
在一些实施例中，IgGl重链中的一条或两条的C末端缺失一个氨基酸残基。例如在连接体被融合到C末端上之前，赖氨酸残基可从IgGl链的C末端缺失。赖氨酸残基的缺失导致IgGl-连接体连接对蛋白酶活性具有抗性。
在一些实施例中，IgGl重链中的一条或两条含有两个在CH3结构域中的突变。例如，两个突变可以回复成人CH3结构域中的通用残基。
在一些实施例中，IgG1重链可以具有与SEQ ID NO 7、15、23、31、39、47和127有至少95％、98％或99％相似性的氨基酸序列。在一些实施例中，IgG1重链、连接体和scFv结构域可以具有与SEQ ID NO 56、66、76、86、98、108、118和136有至少95％、98％或99％相似性的氨基酸序列。在一些实施例中，κ轻链可具有与SEQ ID NO 3、11、19、27、35、43、51、61、71、81、92、103、113、123和131有至少95％、98％或99％相似性的氨基酸序列。在一些实施例中，可变轻链可具有与SEQ ID NO 4、12、20、28、36、44、52、62、72、82、93、104、114、124和132有至少95％、98％或99％相似性的氨基酸序列。在一些实施例中，可变重链可具有与SEQ IDNO 8、16、24、32、40、48、57、67、77、87、99、109、119、128和137有至少95％、98％或99％相似性的氨基酸序列。
在一些实施例中，IgG部分可以具有针对HER3的结合特异性，且scFv结构域可以具有针对EGFR的结合特异性。在一个实施例中，IgGl重链、连接体和scFv结构域具有SEQ IDNO 56的氨基酸序列，并且κ轻链具有SEQ ID NO 51的氨基酸序列。在一个实施例中，IgGl重链、连接体和scFv结构域具有SEQ ID NO 76的氨基酸序列，并且κ轻链具有SEQ ID NO 71的氨基酸序列。在一个实施例中，IgGl重链、连接体和scFv结构域具有SEQ ID NO 108的氨基酸序列，并且κ轻链具有SEQ ID NO 103的氨基酸序列。
在一些实施例中，IgG部分具有针对EGFR的结合特异性，且scFv结构域具有针对HER3的结合特异性。在一个实施例中，IgGl重链、连接体和scFv结构域具有SEQ ID NO66的氨基酸序列，并且κ轻链具有SEQ ID NO 61的氨基酸序列。在一个实施例中，IgGl重链、连接体和scFv结构域具有SEQ ID NO 86的氨基酸序列，并且κ轻链具有SEQ ID NO 81的氨基酸序列。在一个实施例中，IgGl重链、连接体和scFv结构域具有SEQ ID NO98的氨基酸序列，并且κ轻链具有SEQ ID NO 92的氨基酸序列。在一个实施例中，IgGl重链、连接体和scFv结构域具有SEQ ID NO 118的氨基酸序列，并且κ轻链具有SEQ ID NO 113的氨基酸序列。在一个实施例中，IgGl重链、连接体和scFv结构域具有SEQ ID NO 136的氨基酸序列，并且κ轻链具有SEQ ID NO 131的氨基酸序列。
双特异性四价抗体具有抑制癌细胞生长的活性。在某些实施例中，本发明的抗体对其靶标EGRF或HER3具有解离常数(Kd)≤80nM、≤50nM、≤30nM、≤20nM、≤10nM、或≤0.1nM。抗体可同时结合两个靶标。在一些实施例中，抗体以低于50nM的Kd结合EGRF和HER3。在一些实施例中，抗体以低于40、30、25、20、19、18或者10nM的Kd结合EGRF和/或HER3。在一个实施例中，抗体以低于30nM的Kd结合EGRF并且以低于30nM的Kd结合HER3。在一个实施例中，抗体以低于50nM的Kd结合EGRF并且同时以低于50nM的Kd结合HER3。
在另一方面中，本公开提供了分离的核酸，其编码在此公开的双特异性四价抗体或其亚组分。亚组分可以是IgGl重链、κ轻链、可变轻链或可变重链。
在另一方面中，本公开提供了具有分离的核酸的表达载体，核酸编码在此公开的双特异性四价抗体或其亚组分。载体在宿主细胞内是可表达的。宿主细胞可以是原核细胞或真核细胞。
在另一方面中，本公开提供了宿主细胞，其具有分离的核酸或包括这些核酸序列的表达载体，核酸编码在此公开的双特异性四价抗体。
在另一方面中，本公开提供产生双特异性四价抗体的方法。在一个实施例中，该方法可包括培养上述宿主细胞使得产生抗体。
在另一方面中，本公开提供免疫偶联物，其包括本文所述的双特异性四价抗体以及细胞毒性剂。
在另一方面中，本公开提供了药物组成。该药物组成可包括本文所述的双特异性四价抗体或免疫偶联物和药学上可接受的载剂。在一些实施例中，组成可进一步包括放射性同位素、放射性核素、毒素、治疗剂、化学治疗剂或其组合物。
在另一方面，本公开提供治疗癌症受试者的方法。在一个实施例中，该方法包括给受试者施用有效量的本文所述的双特异性四价抗体的步骤。该癌症可以包括表达EGFR家族至少两个成员(包括例如EGFR、HER2、HER3、其片段或衍生物)的细胞。癌症可以是乳癌、结肠直肠癌、胰腺癌、头颈癌、黑素瘤、卵巢癌、前列腺癌和非小细胞肺癌、神经胶质瘤、食管癌、鼻咽癌、肛门癌、直肠癌、胃癌、膀胱癌、子宫颈癌和脑癌。
在一个实施例中，所述方法可进一步包括施用有效量的治疗剂。该治疗剂可以是例如抗体、化学治疗剂、细胞毒性剂、酶或其组合物。在一些实施例中，该治疗剂可以是抗雌激素剂、受体酪氨酸抑制剂或者其组合。在一些实施例中，该治疗剂可以是生物制剂。在一个实施例中，该治疗剂可以是检查点抑制剂。在一些实施例中，治疗剂可包括PD1、PDL1、CTLA4、4-1BB、OX40、GITR、TIM3、LAG 3、TIGIT、CD40、CD27、HVEM、BTLA、VISTA、B7H4、其衍生物、偶联物或片段。在一些实施例中，治疗剂可以是卡培他滨、顺铂、曲妥单抗、氟维司群、他莫昔芬、来曲唑、依西美坦、阿那曲唑、氨鲁米特、睾内酯、伏氯唑、福美司坦、法罗唑、来曲唑、埃罗替尼、拉法替尼、达沙替尼、吉非替尼、伊马替尼、帕唑帕尼、拉帕替尼、苏尼替尼、尼洛替尼、索拉非尼、纳米微粒白蛋白结合型紫杉醇或其衍生物。在一些实施例中，有此治疗需要的受试者是人。
在一个实施例中，本公开提供了通过给受试者施用有效量的双特异性四价抗体以抑制HER受体的生物活性来治疗受试者的方法。
在一实施例中，本公开提供具有有效浓度的双特异性四价抗体的溶液。在一个实施例中，该溶液是受试者的血浆。
IgG的一般结构图在图1中示出。
根据一些实施例的双特异性四价抗体典型结构图在图2中示出。在这个实例中，双特异四价抗体包括两条人IgGl重链、两条人κ轻链和两条单链Fv(scFv)结构域。两条人IgG1重链和人κ轻链形成对EGFR家族的一个成员具有结合特异性的IgG部分，并且两个scFv结构域中的每个通过具有氨基酸序列gly-gly-gly-gly-ser-gly-gly-gly-gly-ser((G4S)2)的连接体连接到人IgG1重链中的任一条的C末端残基。每个scFv结构域按如下顺序：N末端-可变重链-接头-可变轻链-C末端。接头由氨基酸序列为gly-gly-gly-gly-ser-gly-gly-gly-gly-ser-gly-gly-gly-gly-ser,也称为(G4S)3构成。对于双特异性四价抗体的一些实施例，CH1、CH2、CH3、CL、连接体和接头氨基酸序列是相同的。每个双特异性四价抗体在抗体的一个末端具有二价抗HER3结合的特异性和在另一个末端上具有二价抗EGFR结合特异性。一对抗HER3可变重链和可变轻链命名为1C1，且四对抗EGFR可变重链和可变轻链分别命名为1C3、1C5、1C5.2、1C6和1C6.4。双特异性四价抗体命名为1X1、1X2、1X3、1X4、1X4.2、1X5、1X5.2、1X6和1X6.4。
此外，参照物分子1C4(也命名为SI-1C4)在一些研究中使用。1C4是在由Schaefer等人2011(Schaefer等人,Cancer Cell.2011Oct 18；20(4):472-86)所述的2-in-1平台上针对EGFR和HER3构建的双特异性抗体。IC4具有类似于单克隆抗体的结构。所述分子在每个Fab臂上能结合EGFR或HER3，但是不能在每个Fab臂上同时接合两个靶标。
可变轻链、可变重链和单链Fv(scFv)DNA片段经由外部供应商通过基因合成生成。人γ-1重链和人κ轻链DNA片段经由外部供应商通过基因合成生成。使用限制性位点通过DNA连接将片段装配在一起，并克隆到设计用于在哺乳动物细胞中瞬时表达的载体中。载体含有强CMV衍生启动子以及瞬时表达所需的其他上游和下游元件。通过DNA测序验证所得IgG表达质粒含有预期的DNA序列。
如在别处所述，使用线性PEI转染悬浮适应的HEK293F细胞实现抗体构建体的瞬时表达(参见CSHProtocols；2008；doi:10.1101/pdb.prot4977)。如果有必要的话，从所得转染上清液中使用蛋白亲和层析和尺寸排阻层析纯化抗体。通过Superdex 200柱来分析蛋白质质量。用于所有试验的蛋白质都具有大于90％的纯度。
双特异性抗体可用于治疗具有EGFR和HER3共表达的癌症类型，包括但不限于结肠癌、头颈部鳞状细胞癌、肺癌、神经胶质瘤、胰腺癌、鼻咽癌和其他癌症类型。
双特异性抗体具有四价双重特异性。实例抗体可以包括一个IgG和两个scFv，相比于单特异性抗体IgG，其提供了两种不同的结合特异性。与仅使用scFv的其他双特异性抗体例如BiTE技术(Lutterbuese等人，Proceedings of the National Academy of Sciencesof the United States of America 107.28(2010)：12605-12610.PMC.Web.2Dec.2014)和其他(例如，US7332585B2)相比，IgG组分提供了稳定性和改善的血浆半衰期。其还能够介导ADCC，而不具有Fc组分的那些则不能(例如，US7332585B2)。四价双重特异性性质为双特异性抗体提供优于一些其他双特异性抗体的同时结合能力，后者仅可一次结合一种抗原(Schanzer等人，Antimicrob.Agents Chemother.2011,55(5):2369；EP272942A1)。
为了叙述方便，双特异性抗体序列或其相关序列概括在下表1中。
表1双特异性抗体的核苷酸和氨基酸序列或其相关的核苷酸和氨基酸序列的概括
Figure BDA0003045403970000071
Figure BDA0003045403970000081
Figure BDA0003045403970000091
Figure BDA0003045403970000101
Figure BDA0003045403970000111
实例
虽然以下实例仅提供作为举例说明而用，而非用于限制，但是本领域技术人员应该容易地识别各种各样的非关键参数，这些参数可被更改或修改以生成基本上相同或相似的结果。
实例1：SI-1X4和SI-1X4.2之间的序列差异
SI-1X4.2为SI-1X4分子的变型，含有如下5个氨基酸变化：使用Kabat编号系统的V71A、T75S、N76S、A93T和S107T。对于一些位点，特别是75、76和93位，虽然这些位点不位于CDR区，但是它们能与抗原发生相互作用，对于结合和活性是必要的。图4示出了SI-1X4.2和SI-1X4之间的5个氨基酸差异。
实例2：使用BLI表征抗表皮生长因子受体(EGFR)抗体
通过BLItz仪器(ForteBio公司)以生物膜层干涉法(BLI)结合试验测定抗体与EGFR胞外结构域单体的结合能力。将25μg/mL的SI-1C3、SI-1C4、SI-1C6、SI-1X1、SI-1X2、SI-1X5和SI-1X6稀释于PBS中并经120秒俘获在抗人lgG Fc BLItz生物传感器的尖端上。尖端于PBS中洗涤30秒，然后转移至588nM EGFR(ProSpecBio，PKA-344)样品中用于结合。在120秒的结合时间内，EGFR ECD与尖端的结合记录为生物膜层干涉法信号(Δnm)。尖端移至PBS中并观察解离240秒(观察*SI-1C6的解离时间仅为120秒)。图5和6记录了从EGFR与负载抗体的生物传感器的结合步骤开始的数据。各图都示出了与作为基准抗体的SI-1C4的对比。
由于SI-1C3和SI-1X2共用它们的以Fab示出的EGFR结合域，它们的结合谱相似并强于SI-1X1上示出的scFv形式(图6)。与SI-1C4相比，每个均对EGFR具有非常慢的解离速率，且不受它们的结合速率的影响。SI-1X1在与EGFR结合时可能示出较弱的结合速率，但会保持极强的结合。在图5中观察到相同的趋势，其中SI-1C6和SI-1X6上示出的EGFR结合域的Fab变体以比S1-1X5上示出的其典型的scFv高的速率结合。在双特异性抗体的Fab侧具有EGFR结合域似乎会以快于scFV变体的结合速率而结合，但表现出相似的解离速率。在这个试验(数据未示出)中，SI-1X3和SI-1X4没有表现出单体EGFR结合，在下面的ELISA中，进行二聚EGFR结合的研究。
实例3：使用BLI表征抗EGFR和Her3的抗体
与EGFR和Her3胞外域的双特异性结合在BLItz仪器(ForteBio公司)上以生物膜层干涉法(BLI)结合试验进行测量。将200nM的SI-1C1、SI-1C3、SI-1C4、SI-1C6、SI-1X1、SI-1X2、SI-1X3、SI-1X4、Sl-1X5和SI-1X6稀释于IX动力学缓冲液KB(ForteBio公司)中并经120秒俘获在抗人lgG Fc BLItz生物传感器的尖端上。尖端于KB中洗涤30秒，然后转移至200nMEGFR样品(ProSpecBio，PKA-344)中用于结合。在120秒的结合时间内，EGFR ECD与尖端的结合记录为生物膜层干涉法信号(Δnm)。尖端移至KB中并观察解离60秒。用Her3 ECD样品(Sino Biological，10201-H08H-10)在200nM下重复该过程120秒，以及在KB中进行相似的解离步骤60秒。图8-10、7-9记录了从EGFR与负载抗体的生物传感器的结合步骤开始的数据。抗体在通过Fc结合到传感器上时能够表现出同时特异性结合EGFR和Her3。如图7和图8中所观察到的，示出为Fab(SI-1X2、SI-1X6)的EGFR结合域比它们的scFv形式(分别为SI-1X1、SI-1X5)在结合时具有更强的结合速率。此时，EGFR和Her3两者都表现出相同的Fab>>scFv结合速率趋势。SI-1X3和SI-1X4没有表现出与单体EGFR结合，然而，正如所预期的那样，各自都具有结合Her3的能力，
这是由于每个分子使用相同的如SI-1X1、SI-1X2、SI-1X5和SI-1X6等aHer3结合域。在下面的ELISA中研究SI-1X3和SI-1X4的二聚EGFR结合。
实例4：二聚EGFR ELISA试验
正如早些时候所观察到的，在BLI试验中SI-1X3和SI-1X4不能结合单体形式的EGFR(图9)。为了使SI-1C5、SI-1X3和SI-1X4中使用的aEGFR结合域在体外与EGFR结合，有人建议需进行二价结合(Perez等人，临床肿瘤学杂志2014；3(1)：5)。为了对其进行观察，相对于其他使用EGFR二聚形式的EGFR结合抗体，我们将ELISA用于抗体结合。
使用与实验室自制的兔Fc融合的二聚EGFR ECD试剂SI-2C1来进行ELISA。将EGFR以3μg/mL在PBS中在4℃下包被在Maxisorp免疫板(Nunc)上过夜。免疫板在室温下用3％BSA和0.05％Tween20于PBS中封闭2小时。除了SI-1C5、SI-1X3和SI-1X4起始为50μg/mL(以nM记录)外，抗体起始以10ug/mL在室温下俘获1小时，所有都在PBST(1％BSA)中进行3倍稀释。使用山羊抗人IgG-HRP抗体(Jackson ImmunoResearch，109-035-098)在PBST(1％BSA)中以1:2000稀释度检测抗体的Fc部分，并在TMB(Thermo Scientific)中显色5分钟，用H2SO4作为终止溶液。在各个步骤之间用PBST(1％BSA)洗涤三次。所有的数据点都进行三次重复，并在450nm下收集(图10)。与其他分子相比，在该ELISA方式中SI-1C5、SI-1X3和SI-1X4都以高浓度与二聚EGFR ECD结合。
实施例5：使用Octet测定1C5.2和1X4.2的结合动力学
使用具有抗人Fc传感器的ForteBio Octet Red96仪器(ForteBio，AHC#18#-5060)测定动力学。结合实验在1000RPM的搅拌下于30℃下进行。EGFR蛋白质为人EGFR的胞外域(Met1-Ser645)，其具有C末端多组氨酸标签。所有样品都稀释于10X动力学缓冲液(ForteBio#18#-5032)中。1C5.2、1X6和1X4.2各自以10μg/ml加载到8个传感器上，计300秒，然后在10X动力学缓冲液中检测基线60秒。以单浓度的EGFR蛋白质(300、100、33.33、11.11、3.705、1.235、0.4116和0nM)用各个传感器进行EGFR蛋白质结合300秒。然后，在10X动力学缓冲液中解离900秒。图11中示出了1C5.2和1X4.2的典型结合和解离曲线。
使用ForteBio数据分析软件v9.0进行数据分析。进行软件曲线拟合，对于各1C5.2(表2)、1X4.2(表3)和1X6(表4)，使用四个最佳曲线拟合并取平均值以测定KD、k(结合)和k(解离)。SI-1C5.2和Sl-1X4.2的平均KD分别是19.2nM和18.4nM。SI-1C6的平均KD是3.04nM。如实例1中所述，与1C5和1X4相比，1C5.2和1X4.2含有5个氨基酸变化。当与图10中针对1C5和1X4产生的数据相比时，这些变化导致对EGFR ECD的结合改善。
表2 1C5.2的KD、KON和KDIS的概括
<u>EGFR(NM)</u> <u>KD(M)</u> <u>KON(1/MS)</u> <u>KDIS(1/S)</u>
SI-1C5.2 300 3.74E-08 4.61E+04 1.72E-03
SI-1C5.2 100 2.23E-08 7.89E+04 1.76E-03
SI-1C5.2 33.3 9.94E-09 1.60E+05 1.59E-03
SI-1C5.2 11.1 7.08E-09 2.12E+05 1.50E-03
平均值 1.92E-08 1.24E+05 1.64E-03
表3 1X4.2的KD、KON和KDIS的概括
Figure BDA0003045403970000131
Figure BDA0003045403970000141
表4 1X6的KD、KON和KDIS的概括
<u>EGFR(NM)</u> <u>KD(M)</u> <u>KON(1/MS)</u> <u>KDIS(1/S)</u>
SI-1C6 300 3.04E-09 4.11E+05 1.25E-03
SI-1C6 100 3.04E-09 4.11E+05 1.25E-03
SI-1C6 33.3 3.04E-09 4.11E+05 1.25E-03
SI-1C6 11.1 3.04E-09 4.11E+05 1.25E-03
平均值 3.04E-09 4.11E+05 1.25E-03
实例6：实例双特异性抗体对肿瘤细胞系的的结合测试
通过流式细胞术测试双特异性抗体SI-1X1、SI-1X2、SI-1X3、SI-1X4、SI-1X5和SI-1X6，以及同型对照抗体与肿瘤细胞系A431(表皮样癌，ATCCCRL-1555)和BxPC3(胰腺癌，ATCC CRL-1687)的结合。细胞生长于含有10％胎牛血清的RPMI-1640培养基中并在指数生长期时收集用于分析。5x106细胞的各等份在PBS中洗涤一次，然后重悬于250μl的PBS+1％胎牛血清(BSA)中并在4℃下培养15分钟以阻止细胞膜进行非特异性结合。将在PBS/1％BSA中稀释至10μg/ml的250μl的抗体加入各样品中以达到5μg/ml的抗体终浓度。细胞在混匀后于4℃下在一抗中培养1小时。然后，细胞用1ml的PBS/1％BSA洗涤两次，然后重悬于500μl的PE-偶联小鼠抗人IgG-Fc中并在混匀后于4℃下孵育45分钟。样品用1ml的PBS/1％BSA再次洗涤两次，重悬于300ml的PBS中并使用FACScalibur流式细胞仪分析。对于各样品，在FL-2通道中收集10000个数据采集点。使用FCS Express软件生成直方图，且SI-1X直方图与同型对照抗体染色得到的直方图叠加。所有六种双特异性抗体显示相对于指示细胞结合的对照染色的直方图位移。该数据在图12(A431细胞结合)和图13(BxPC3细胞结合)中示出。
实例7：通过细胞结合试验表征SI-1C5.2和SI-1X4.2
通过流式细胞术测试双特异性抗体SI-1X4.2、单特异性抗体SI-1C5.2和SI-1C1以及同型对照抗体与肿瘤细胞系A431(表皮样癌，ATCC CRL-1555)(图14)和FaDu(BxPC3(下咽鳞癌，ATCC HTB-43)(图15)的结合。细胞生长于含有10％胎牛血清的RPMI-1640培养基中并在指数生长期时收集用于分析。细胞在PBS中洗涤一次，然后以5x106个细胞/ml的浓度重悬于PBS+5％胎牛血清白蛋白(FBS)中并在4℃下培养15分钟以阻止细胞膜进行非特异性结合。100μl等份细胞加入96孔板中的100μl等份抗体(也在PBS+5％FBS中稀释)中。样品于冰上在一抗中孵育45分钟。然后，细胞用200μl的PBS+5％FBS洗涤两次，然后重悬于100μl的PE偶联小鼠抗人IgG-Fc中并于冰上孵育30分钟。样品用200μl的PBS+5％FBS再次洗涤两次，重悬于200μl的PBS中并使用FACScalibur流式细胞仪分析。对于各样品，在FL-2通道中收集10000个数据采集点。使用FCS Express软件生成直方图，并测定各数据集合的几何平均荧光强度(GMFI)。通过使用Graphpad Prism软件对GMFI相对抗体浓度绘图来测定EC50结合值。双特异性抗体SI-1X4.2示出了与单特异性抗EGFR抗体SI-1C5.2相似的结合谱，在两个细胞系中具有相似的EC50。其他单特异性抗Her3抗体SI-1C1与这两个细胞系结合较弱，这可能是由于Her3在细胞表面上的表达水平较低。如实例1中所述，与1C5和1X4相比，1C5.2和1X4.2含有5个氨基酸变化。与亲本分子1X4相比，这些变化可使得与靶细胞的结合改善。
实例8：SI-1X抗体对肿瘤细胞系的抗增殖作用
为了评价抗Her3/EGFR双特异性抗体的生长抑制潜能，测试对于A431细胞(ATCCCRL-1555，Manassas，Va.)的增殖的作用，A431细胞是表皮样癌肿瘤细胞系。还测试对于胰腺腺癌细胞系BxPC3(ATCC CRL-1687,Manassas,Va.)的增殖的作用。对于各个细胞系，细胞以6000个细胞/孔的密度接种到100μl的含1％胎牛血清的RPMI-1640培养基中的96孔组织培养板之中。4小时之后，加入0.0015nM至100nΜ之间范围内的各个浓度的测试抗体。细胞在测试抗体存在下培养72小时。向各个孔中加入20μl的MTS试剂(Promega，Madison，Wl)，且细胞在37℃下孵育2小时。MTS很容易地被活的增殖细胞摄入，还原成甲臜(其很容易地吸收490nM波长的光)，然后分泌到培养基中。在孵育之后，使用BioTek(Winooski，VT)ELx800吸光度读取仪测量OD490值。为建立基准代谢活动，也以这种方式加入抗体到细胞中，以此时的对照细胞OD490nM吸光值作为对照细胞吸光值。。增殖可通过从72小时OD490中减去对照基准OD490来计算。抗体滴定的数据根据以下公式以对照组的％来表示：对照组的％＝(测试增殖/对照增殖)*100。
各种双特异性抗Her3/抗EGFR抗体对于A431细胞增殖的作用在图16和图17中示出。SI-1X2展示出比对照抗体SI-1C1(抗Her3)、SI-1C3(抗EGFR)或SI-1C1和SI-1C3联用更有效的抗增殖作用。SI-1X1也表现出抗增殖作用，尽管未到可于SI-1C3和SI-1C1与SI-1C3的组合所见的程度。抑制曲线以及IC50值在图17中示出。对于SI-1X5和SI-1X6观察到相似结果，其中SI-1X6比SI-1X5和对照抗体S1-1C1(抗Her3)更有效，然而它却示出出与对照抗体S1-1C6(抗EGFR)和SI-1C1与SI-1C6的组合相似的抗增殖潜能。这可连同IC50值一起见于图17中。
还测试这些分子在BxPC3细胞系中的抗增殖作用(图18和图19)。SI-1X2再次显示出比对照抗体SI-1C1(抗Her3)、SI-1C3(抗EGFR)或SI-1C1和SI-1C3联用更有效的抗增殖作用。SI-1X1比SI-1C1更有效，但比SI-1C3和SI-1C1与SI-1C3的组合弱。抑制曲线和IC50值示出在图19中。与对照抗体SI-1C1(抗Her3)、SI-1C6(抗-EGFR)或SI-1C1和SI-ICS组合相比，BxPC3增殖被SI-1X5和SI-1X6两者更强地抑制。该数据连同IC50值一起见于图19中。
实例9：SI-1C5.2和SI-1X4.2对肿瘤细胞系的抗增殖作用
为了评价抗Her3/EGFR双特异性抗体的生长抑制潜能，测试对于FaDu(鼻咽部鳞状细胞癌系，ATCC HTB-43)和A431(表皮样癌ATCC CRL-1555)细胞的增殖的作用。细胞以6000个细胞/孔的密度接种到100μl的含1％胎牛血清的RPMI-1640培养基中的96孔组织培养板之中。4小时之后，加入0.0015nM至100nΜ之间范围内的各个浓度的测试抗体。细胞在测试抗体存在下培养72小时。在各个孔中加入11μl的阿尔玛蓝试剂(Thermo Scientific)，细胞在37℃下培养2小时。阿尔玛蓝很容易地被活的增殖细胞摄入，还原，然后分泌到培养基中。阿尔玛蓝的还原形式具有很强的荧光性。在培养之后，荧光使用分子仪器公司(Sunnyvale，CA)FilterMax F5多模式板读取仪进行测量，该读取仪使用535nm的激发波长和595nm的发射波长。为建立基准代谢活动，也以这种方式加入抗体到细胞后，以此时的荧光值作为对照细胞荧光值。增殖可通过从72小时荧光值中减去对照基准荧光来计算。抗体滴定的数据根据以下公式以对照组的％来表示：对照组的％＝(测试增殖/对照增殖)*100。
SI-1C5.2和SI-1X4.2对于Fadu和A431细胞增殖的作用分别在图20和图21中示出。在这两个细胞系中，SI-1X4.2展示出比对照抗体SI-1C5.2(抗EGFR Mab)、SI-1C1(抗Her3Mab))或SI-1C1和SI-1C7联用改善的有效的抗增殖作用。
实例10：SI-1X双特异性抗体的ADCC活性
测试SI-1X抗体介导针对多个肿瘤细胞系的细胞毒性的能力。获取正常、健康志愿者的全血。血液用等体积的磷酸缓冲盐水(PBS)稀释。将20ml等份的稀释血液小心地分装于15ml的Ficol Pacque PLUS(GE Life Sciences目录号17-1440-02；Pittsburgh，PA)上。试管在300g下不间断离心40分钟。在离心之后，小心地吸出大部分的血浆层，并用移液管以尽可能最小地体积小心地移除血沉棕黄色层(含有PBMC)。PBMC合并入50ml的试管内并加入PBS以使每个试管定容至50ml。试管在1300RPM下离心10分钟，并小心地吸出上清。细胞重悬于40ml的PBS中并再次离心。该过程共重复两次洗涤。在最后一次洗涤后，细胞重悬于30ml的RPMI-1630+10％FBS中并在37℃下在5％CO2中过夜培养。
测试的靶细胞是头颈部鳞状细胞癌细胞系FaDu(ATCC HTB-43,Manassus,VA)和非小细胞肺腺癌细胞系NCI-H1975(ATCC CRL-5908,Manassus,VA)。如下所述，利用钙黄绿素标记靶细胞。细胞以单层生长然后经细胞消化液孵育后去贴壁。在不含血清的RPMI中洗涤细胞两次。将1ml 4xl06个细胞/ml的细胞与1ml RPMI(不含血清)+20μΜ钙黄绿素AM(Sigma目录号C1359；St.Louis,MO)混合。将细胞在37℃下培养30分钟，每隔10分钟进行温和混合。标记后，利用14ml RPMI+10％FBS+2.5mM丙磺舒(试验培养基)洗涤细胞两次。丙磺舒(Sigma目录号P8761；St.Louis,MO)是一种阴离子转运蛋白抑制剂并被认为减少细胞内钙黄绿素的自发释放。将细胞重悬在20ml试验培养基中并允许在37℃，5％CO2下恢复2小时。然后，利用试验培养基洗涤细胞一次并稀释至200,000个细胞/ml。将50μl(10,000个细胞)钙黄绿素标记的细胞的等份试样等分量加到96孔圆底平板中。将50μl抗体(以3X最终浓度)加到细胞中并在冰上允许结合40分钟。使来自前一天的PBMC在300g下离心5分钟，重悬在20ml新鲜试验培养基中，计数并稀释至6x106个细胞/ml。将50μl PBMC(300,000)加入每个孔中并在37℃，5％CO2下，将平板培养4小时。将每个抗体通过10倍连续稀释一式三份滴定，从50nM开始并递减到0.00005nM。也建立在抗体和效应细胞不存在下含有标记靶细胞的对照孔以测定最大和自发钙黄绿素释放。
在4小时的培养结束时，将50μl含有8％IGEPALCA-630(Sigma目录号18896；St.Louis,MO)的试验培养基加入只含有标记靶细胞的对照孔中(以测定最大钙黄绿素释放)。将50μl试验培养基加入所有其他孔中以使每个孔的总体积到200μl。使平板在2000RPM下离心10分钟并将150μl上清液小心地转移到V型底96孔平板中。使这些平板在2000RPM下再离心10分钟并将100ml上清液小心地转移到黑色、透明底的96孔平板中。
通过利用485nM的激发波长和535nM的发射波长测定每个样品的荧光来定量上清液中的钙黄绿素。将特异性裂解的百分比如下计算：
％特异性裂解＝[(测试样品值-自发释放)/(最大释放-自发释放)]*100
数据示出在图22和图23中。对于两种细胞系，SI-1X6.4介导细胞毒性，但并不特别地比对照抗体SI-1C6.2、SI-1C7、或SI-1C6.2+SI-1C7的组合更有效。Sl-1X6.4以比我们的基准抗体SI-1C4更低的EC50介导细胞毒性。对于两种细胞系，SI-1X4.2以与对照抗体大致相同的程度介导细胞毒性。但是，其在介导细胞毒性方面，不像基准SI-1C4那么有效。这可能是因为SI-1X4.2的较低亲和性。
实例11：SI-1X双特异性抗体的热稳定性
进行蛋白热转移研究用于蛋白热稳定性分析。建立利用蛋白热转移缓冲液TM和蛋白热转移染料TM(Applied Biosystems)的蛋白熔解反应。简单地讲，20μl反应混合物含有5μg蛋白、5μl蛋白热转移缓冲液TM和2.5μl8X稀释的蛋白热转移TM染料。对于阴性对照，使用PBS来代替。将反应混合物加入MicroAmp光学反应平板中并利用MicroAmp光学粘合剂薄膜密封。每个样品由4个重复样组成。在Applied Biosystem实时PCR系统上从25到90℃以1％增量运行蛋白熔解反应，然后利用蛋白热转移软件TM分析。图24示出了SI-1X2、SI-1X4.2、SI-1X6.4、SI-1C3、SI-1C3、SI-1C6.2、SI-1C5.2和SI-1C7的熔解曲线。表5示出了这些分子的Tm。Tm被定义为去折叠50％蛋白所需的温度。双特异性分子1X2、1X4.2和1X6都具有约66℃的Tm，这与所有MAb(1C3、1C6.2、1C5.2)和Fc-scFv(1C7)分子相当。
表5
蛋白名称 Tm(℃)
SI-1X2 66.52
SI-1C3 70.06
SI-1X4.2 66.94
SI-1C5.2 70.26
SI-1X6.4 66.50
SI-1C6.2 70.12
SI-1C7 66.40
实例12：SI-1X双特异性抗体的血浆稳定性
在37℃下在95％人类血浆(Atlanta Biologies,S40110)中以100μg/mL培养0、3和7天时间点以及第7天的55℃的额外时间点以提供发生降解的已知条件后，通过ELISA比较分子SI-1C5.2、SI-1C6.2、SI-1X4.2和Sl-1X6.4与单体EGFR ECD的结合来测定这些分子的血浆稳定性。利用3μg/mL单体EGFR ECD(SI-2R4)的PBS在4℃下包被ELISA平板过夜。在25℃下利用3％BSA PBST封闭包被的ELISA平板2小时，然后利用PBST洗涤3次。利用1％BSA PBST以1:10稀释SI-1C6.2和SI-1X6.4并在整个平板上以4x稀释。利用1％BSA PBST以1:2稀释SI-1C5.2和SI-1X4.2并在整个平板上以4倍稀释，以及在25℃下培养1小时。利用PBST再洗涤3次，然后利用1μg/mL Her3 ECD兔IgGl(SI-1R1)在25℃下在1％BSA PBST中抗原俘获1小时。利用PBST再洗涤3次，然后在25℃下施加以1:5000稀释于1％BSA PBST中的山羊抗兔IgG-HRP(Bio-Rad 172-1019)二抗，保持1小时。利用PBST洗涤最后3次，然后利用100μlPierce 1-step Ultra TMB ELISA(Pierce,34028)显色10分钟，利用100μl2M H2SO4最终终止反应。在450nm下读取平板。将ELISA数据作图并利用GraphPad Prism 6产生曲线。
ELISA的结果由图25中的EC50记录且当保持在37℃时表现出少许降解的有利特征。当置于55℃时，因为分子经历降解条件，所以EC50移动约一个对数。在37℃下，SI-1C5.2的EC50值从第0天的589.7pM变成第7天的755.2pM(Δ165.5pM)且在55℃下变为第7天的6.522nM(Δ5932.3pM)。在37℃下，SI-1C6的EC50值从第0天的218.2pM变为第7天的226.6pM(Δ8.4pM)且在55℃下变为第7天的1.322nM(Δ1103pM)。在37℃下，SI-1X4.2的EC50值从第0天的429.3pM变为第7天的466.7pM(Δ37.4pM)且在55℃下变为第7天的4.248nM(Δ3818.7pM)。在37℃下，SI-1X6的EC50值从第0天的209.3pM变为第7天的237.3pM(Δ28pM)在55℃下偏移到第7天的4.112nM(Δ3902.7pM)。
实例13：SI-1X分子的PK半衰期
为了测试其体内半衰期，在SD大鼠中进行药物动力学试验。将双特异性Abs的单次静脉内尾静脉注射(1C6 lOmg/kg、1X6 lOmg/kg、1X2 lOmg/kg、1X4 32mg/kg)给予按体重随机化(190-212g范围)的4只雌性大鼠组。在每个时间点从眼眶血管丛抽取血液(～150μl)，制备成血浆，并储存在-80℃下直到分析。研究持续时间是28天。
利用三个ELISA试验测定抗体浓度。在试验1中(EGFR ECD包被的ELISA)，将重组EGFR-兔Fc包被到平板上，利用PBST(具有0.05％吐温的磷酸盐缓冲盐水)洗涤孔并利用1％BSA的PBST封闭。然后添加血清或血清稀释的标准物，随后PBST洗涤，添加HRP标记的兔抗人IgG(BOSTER)，并再次PBST洗涤。然后添加TMB并在暗处将平板孵育2.5分钟。通过添加2M硫酸终止颜色反应。在450nm波长下读取平板。对于试验2(Her3包被的ELISA)，利用类似ELISA检测血清，但是将重组HER3-His用作俘获试剂。对于试验3(夹心ELISA)，包被重组HER3-His，添加血清或血清稀释的标准物，然后PBST洗涤，添加含EGFR-兔Fc的PBST，再次PBST洗涤。然后添加HRP标记的山羊抗兔IgG(BOSTER)。利用非房室模型测定PK参数。
图26-28示出了分别利用三个不同试验得到的四个抗体的血清浓度数据。表6中提供体内PK研究的拟合PK参数。PK数据包括半衰期，其表示表征抗体从血清去除的β相以及Cmax，Cmax表示观察到的最大血清浓度，AUC，其表示浓度时间曲线下的面积。
表6
Figure BDA0003045403970000191
实例14：小鼠异种移植研究
实例测试Fadu的临床前模型(头颈鳞状细胞癌异种移植模型)中伴随阻断EGFR、HER3的SI-1X2、SI-1X4.2和SI-1X6的活性并对它们、西妥昔单抗、西妥昔单抗和抗-HER3抗体的组合的效力进行比较。
所有小鼠研究通过研究所动物照管(Institutional Animal care)进行并根据指导方针使用委员会批准的动物方案。六周大的雌性Balb/c裸鼠从北京Vital RiverLaboratories购买并关在空气过滤的层流柜中，进行12小时的白天循环并随意获取食物和水。计算动物组的尺寸以测量25％的安慰剂组与治疗组之间的平均差异，具有80％的功效和0.01的P值。携带异种移植物的宿主小鼠被随机地并同等地分配到对照或治疗组。以受控及非盲性方式进行动物试验。对于细胞系来源的异种移植物研究，对小鼠进行皮下注射含2x106Fadu的150μl的细胞悬液(每只小鼠)。
一旦肿瘤达到100-250mm3的平均体积，将小鼠随机化为9组，每组具有6只小鼠。媒剂对照，1C6(25mg/kg)、1C4(25mg/kg)、1C6+1C1(25mg/kg+50mg/kg)、SI-1X2(25mg/kg)、SI-1X6(10mg/kg)、SI-1X6(25mg/kg)和SI-1X4.2(10mg/kg)SI-1X4(25mg/kg)。通过静脉内注射每周一次施用所有试验制品。在整个治疗期每隔3天通过数字式卡尺测定肿瘤并利用下式测定体积：l/2x长度x宽度2。在第一次给药前记录小鼠的体重以及随后在治疗期和恢复期每隔一周记录。
与阳性对照(除了低剂量SI-1X4.210mg/kg组)相比，SI-1X2、SI-1X6以及SI-1X4.2和SI-1X6组合的所有测试组明显地产生肿瘤生长抑制(图29-30)。并且，在治疗停止后2周，没有观察到复发，除了低剂量SI-1X4.210mg/kg组外。
药物组合物
术语“有效量”是指有效实现所需效果(例如改善受试者的疾病)的药物的量。当疾病是癌症时，有效量的药物可抑制(例如，在一定程度上减缓、抑制或停止)以下实例特征的一个或多个，包括但不限于，癌细胞生长、癌细胞增殖、癌细胞运动、癌细胞渗入外周器官、肿瘤转移和肿瘤生长。其中疾病是癌症时，有效量的药物当施用于受试者时或者可进行以下中的一种或多种：减缓或停止肿瘤生长、减小肿瘤尺寸(例如，体积或质量)、在一定程度上缓解与癌症相关的一个或多个症状、延长无进展生存期、得到目标响应(包括，例如，部分响应或完全响应)、以及增加总存活时间。在一定程度上，药物可阻止生长和/或杀死现有癌细胞，其具有细胞抑制性和/或细胞毒性。
关于施用给受试者(例如需要治疗的人类患者)的适宜组合物的调配，可将文中所公开的抗体与该领域已知的药学上可接受的载剂混合或组合，这取决于所选择的施用途径。对文中公开的抗体的施用模式没有特定的限制，适宜的施用途径和适宜组合物的选择在该领域是已知的，而无需过多试验。
虽然许多施用形式是可能的，但是一个实例施用形式会是注射用溶液，特别是用于静脉内或动脉内注射。通常，用于注射的适宜药物组合物包括药学上的适宜载剂或赋形剂，例如但不限于缓冲液、表面活性剂或稳定剂。实例缓冲液可包括但不限于乙酸盐、磷酸盐或柠檬酸盐缓冲液。实例表面活性剂可包括，但不限于聚山梨醇酯。实例稳定剂可包括但不限于人白蛋白。
同样，技术人员具有确定有效治疗症状(例如癌症)的文中所公开抗体的有效量或浓度的能力。其他参数(例如药物组合物中多种组分的比例、施用剂量和频率)可由技术人员得到，而无需过多试验。例如，用于注射的适宜溶液可含有但不限于约1至约20、约1至约10mg抗体/ml。实例剂量可以是但不限于约0.1至约20、约1至约5mg/Kg体重。实例施用频率可以是但不限于每天一次或每周三次。
虽然本公开内容已参照特定实施例或实例加以描述，但是应了解，实施例是说明性的以及所公开内容范围不如此受限。本公开的其他实施例对本公开所属的该领域的技术人员是显而易见的。这些其他实施例被视为涵盖在本公开的范围内。因此，本公开的范围由所附的权利要求限定并由上述说明支持。
序列表
<110> 西雅图免疫公司
<120> 双特异性四价抗体及其制造和使用方法
<130> EM01.0003PCT1
<140> PCT/US15/66951
<141> 2015-12-19
<150> US 62095348
<151> 2014-12-22
<160> 138
<170> PatentIn version 3.5
<210> 1
<211> 654
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 1
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc 60
tcctgcactg gaaccagcag tgacgttggt ggttataact ttgtctcctg gtaccaacaa 120
cacccaggca aagcccccaa actcatgatc tatgatgtca gtgatcggcc ctcaggggtg 180
tctgatcgct tctccggctc caagtctggc aacacggcct ccctgatcat ctctggcctc 240
caggctgacg acgaggctga ttattactgc agctcatatg ggagcagcag cactcatgtg 300
attttcggcg gagggaccaa gctgaccgtc ctacgtacgg tggctgcacc atctgtcttc 360
atcttcccgc catctgatga gcagttgaaa tctggaactg cctctgttgt gtgcctgctg 420
aataacttct atcccagaga ggccaaagta cagtggaagg tggataacgc cctccaatcg 480
ggtaactccc aggagagtgt cacagagcag gacagcaagg acagcaccta cagcctcagc 540
agcaccctga cgctgagcaa agcagactac gagaaacaca aagtctacgc ctgcgaagtc 600
acccatcagg gcctgagctc gcccgtcaca aagagcttca acaggggaga gtgt 654
<210> 2
<211> 333
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 2
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc 60
tcctgcactg gaaccagcag tgacgttggt ggttataact ttgtctcctg gtaccaacaa 120
cacccaggca aagcccccaa actcatgatc tatgatgtca gtgatcggcc ctcaggggtg 180
tctgatcgct tctccggctc caagtctggc aacacggcct ccctgatcat ctctggcctc 240
caggctgacg acgaggctga ttattactgc agctcatatg ggagcagcag cactcatgtg 300
attttcggcg gagggaccaa gctgaccgtc cta 333
<210> 3
<211> 218
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 3
Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
1 5 10 15
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr
20 25 30
Asn Phe Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
35 40 45
Met Ile Tyr Asp Val Ser Asp Arg Pro Ser Gly Val Ser Asp Arg Phe
50 55 60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Ile Ile Ser Gly Leu
65 70 75 80
Gln Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Gly Ser Ser
85 90 95
Ser Thr His Val Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Arg
100 105 110
Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln
115 120 125
Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr
130 135 140
Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser
145 150 155 160
Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr
165 170 175
Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys
180 185 190
His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro
195 200 205
Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210> 4
<211> 110
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 4
Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
1 5 10 15
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr
20 25 30
Asn Phe Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
35 40 45
Met Ile Tyr Asp Val Ser Asp Arg Pro Ser Gly Val Ser Asp Arg Phe
50 55 60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Ile Ile Ser Gly Leu
65 70 75 80
Gln Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Gly Ser Ser
85 90 95
Ser Thr His Val Ile Phe Gly Gly Gly Thr Lys Leu Thr Val
100 105 110
<210> 5
<211> 1344
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 5
caggtgcagc tgcaggagtc ggggggaggc ctggtcaagc ctggagggtc cctgagactc 60
tcctgtgcag cctctggatt cacctttagt agttattgga tgagctgggt ccgccaggct 120
ccagggaagg ggctggagtg ggtggccaac ataaaccgcg atggaagtgc gagttactat 180
gtggactctg tgaagggccg attcaccatc tccagagacg acgccaagaa ctcactgtat 240
ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagatcgt 300
ggggtgggct acttcgatct ctggggccgt ggcaccctgg tcaccgtctc gagcgctagc 360
accaagggcc catcggtctt ccccctggca ccctcctcca agagcacctc tgggggcaca 420
gcggccctgg gctgcctggt caaggactac ttccccgaac cggtgacggt gtcgtggaac 480
tcaggcgccc tgaccagcgg cgtgcacacc ttcccggctg tcctacagtc ctcaggactc 540
tactccctca gcagcgtggt gaccgtgccc tccagcagct tgggcaccca gacctacatc 600
tgcaacgtga atcacaagcc cagcaacacc aaggtggaca agagagttga gcccaaatct 660
tgtgacaaaa ctcacacatg cccaccgtgc ccagcacctg aactcctggg gggaccgtca 720
gtcttcctct tccccccaaa acccaaggac accctcatga tctcccggac ccctgaggtc 780
acatgcgtgg tggtggacgt gagccacgaa gaccctgagg tcaagttcaa ctggtacgtg 840
gacggcgtgg aggtgcataa tgccaagaca aagccgcggg aggagcagta caacagcacg 900
taccgtgtgg tcagcgtcct caccgtcctg caccaggact ggctgaatgg caaggagtac 960
aagtgcaagg tctccaacaa agccctccca gcccccatcg agaaaaccat ctccaaagcc 1020
aaagggcagc cccgagaacc acaggtgtac accctgcccc catcccggga ggagatgacc 1080
aagaaccagg tcagcctgac ctgcctggtc aaaggcttct atcccagcga catcgccgtg 1140
gagtgggaga gcaatgggca gccggagaac aactacaaga ccacgcctcc cgtgctggac 1200
tccgacggct ccttcttcct ctatagcaag ctcaccgtgg acaagagcag gtggcagcag 1260
gggaacgtct tctcatgctc cgtgatgcat gaggctctgc acaaccacta cacgcagaag 1320
agcctctccc tgtctccggg taaa 1344
<210> 6
<211> 354
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 6
caggtgcagc tgcaggagtc ggggggaggc ctggtcaagc ctggagggtc cctgagactc 60
tcctgtgcag cctctggatt cacctttagt agttattgga tgagctgggt ccgccaggct 120
ccagggaagg ggctggagtg ggtggccaac ataaaccgcg atggaagtgc gagttactat 180
gtggactctg tgaagggccg attcaccatc tccagagacg acgccaagaa ctcactgtat 240
ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagatcgt 300
ggggtgggct acttcgatct ctggggccgt ggcaccctgg tcaccgtctc gagc 354
<210> 7
<211> 448
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 7
Gln Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Asn Ile Asn Arg Asp Gly Ser Ala Ser Tyr Tyr Val Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ala Lys Asn Ser Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Asp Arg Gly Val Gly Tyr Phe Asp Leu Trp Gly Arg Gly Thr
100 105 110
Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe Pro
115 120 125
Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly
130 135 140
Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp Asn
145 150 155 160
Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu Gln
165 170 175
Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser Ser
180 185 190
Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro Ser
195 200 205
Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp Lys Thr
210 215 220
His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser
225 230 235 240
Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg
245 250 255
Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro
260 265 270
Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala
275 280 285
Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val
290 295 300
Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr
305 310 315 320
Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr
325 330 335
Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu
340 345 350
Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys
355 360 365
Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser
370 375 380
Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp
385 390 395 400
Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser
405 410 415
Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala
420 425 430
Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
435 440 445
<210> 8
<211> 118
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 8
Gln Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Asn Ile Asn Arg Asp Gly Ser Ala Ser Tyr Tyr Val Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ala Lys Asn Ser Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Asp Arg Gly Val Gly Tyr Phe Asp Leu Trp Gly Arg Gly Thr
100 105 110
Leu Val Thr Val Ser Ser
115
<210> 9
<211> 642
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 9
Gly Ala Cys Ala Thr Cys Cys Ala Gly Ala Thr Gly Ala Cys Cys Cys
1 5 10 15
Ala Gly Thr Cys Thr Cys Cys Ala Thr Cys Cys Thr Cys Cys Cys Thr
20 25 30
Gly Thr Cys Thr Gly Cys Ala Thr Cys Thr Gly Thr Ala Gly Gly Ala
35 40 45
Gly Ala Cys Ala Gly Ala Gly Thr Cys Ala Cys Cys Ala Thr Cys Ala
50 55 60
Cys Thr Thr Gly Cys Cys Ala Gly Gly Cys Gly Ala Gly Thr Cys Ala
65 70 75 80
Gly Gly Ala Cys Ala Thr Cys Ala Gly Cys Ala Ala Cys Thr Ala Thr
85 90 95
Thr Thr Ala Ala Ala Thr Thr Gly Gly Thr Ala Thr Cys Ala Gly Cys
100 105 110
Ala Gly Ala Ala Ala Cys Cys Ala Gly Gly Gly Ala Ala Ala Gly Cys
115 120 125
Cys Cys Cys Thr Ala Ala Ala Cys Thr Cys Cys Thr Gly Ala Thr Cys
130 135 140
Thr Ala Cys Gly Ala Thr Gly Cys Ala Thr Cys Cys Ala Ala Thr Thr
145 150 155 160
Thr Gly Gly Ala Ala Ala Cys Ala Gly Gly Gly Gly Thr Cys Cys Cys
165 170 175
Ala Thr Cys Ala Ala Gly Gly Thr Thr Cys Ala Gly Thr Gly Gly Ala
180 185 190
Ala Gly Thr Gly Gly Ala Thr Cys Thr Gly Gly Gly Ala Cys Ala Gly
195 200 205
Ala Thr Thr Thr Thr Ala Cys Thr Thr Thr Cys Ala Cys Cys Ala Thr
210 215 220
Cys Ala Gly Cys Ala Gly Cys Cys Thr Gly Cys Ala Gly Cys Cys Thr
225 230 235 240
Gly Ala Ala Gly Ala Thr Ala Thr Thr Gly Cys Ala Ala Cys Ala Thr
245 250 255
Ala Thr Thr Thr Cys Thr Gly Thr Cys Ala Ala Cys Ala Cys Thr Thr
260 265 270
Thr Gly Ala Thr Cys Ala Thr Cys Thr Cys Cys Cys Gly Cys Thr Cys
275 280 285
Gly Cys Thr Thr Thr Cys Gly Gly Cys Gly Gly Ala Gly Gly Gly Ala
290 295 300
Cys Cys Ala Ala Gly Gly Thr Gly Gly Ala Ala Ala Thr Thr Ala Ala
305 310 315 320
Ala Cys Gly Thr Ala Cys Gly Gly Thr Gly Gly Cys Thr Gly Cys Ala
325 330 335
Cys Cys Ala Thr Cys Thr Gly Thr Cys Thr Thr Cys Ala Thr Cys Thr
340 345 350
Thr Cys Cys Cys Gly Cys Cys Ala Thr Cys Thr Gly Ala Thr Gly Ala
355 360 365
Gly Cys Ala Gly Thr Thr Gly Ala Ala Ala Thr Cys Thr Gly Gly Ala
370 375 380
Ala Cys Thr Gly Cys Cys Thr Cys Thr Gly Thr Thr Gly Thr Gly Thr
385 390 395 400
Gly Cys Cys Thr Gly Cys Thr Gly Ala Ala Thr Ala Ala Cys Thr Thr
405 410 415
Cys Thr Ala Thr Cys Cys Cys Ala Gly Ala Gly Ala Gly Gly Cys Cys
420 425 430
Ala Ala Ala Gly Thr Ala Cys Ala Gly Thr Gly Gly Ala Ala Gly Gly
435 440 445
Thr Gly Gly Ala Thr Ala Ala Cys Gly Cys Cys Cys Thr Cys Cys Ala
450 455 460
Ala Thr Cys Gly Gly Gly Thr Ala Ala Cys Thr Cys Cys Cys Ala Gly
465 470 475 480
Gly Ala Gly Ala Gly Thr Gly Thr Cys Ala Cys Ala Gly Ala Gly Cys
485 490 495
Ala Gly Gly Ala Cys Ala Gly Cys Ala Ala Gly Gly Ala Cys Ala Gly
500 505 510
Cys Ala Cys Cys Thr Ala Cys Ala Gly Cys Cys Thr Cys Ala Gly Cys
515 520 525
Ala Gly Cys Ala Cys Cys Cys Thr Gly Ala Cys Gly Cys Thr Gly Ala
530 535 540
Gly Cys Ala Ala Ala Gly Cys Ala Gly Ala Cys Thr Ala Cys Gly Ala
545 550 555 560
Gly Ala Ala Ala Cys Ala Cys Ala Ala Ala Gly Thr Cys Thr Ala Cys
565 570 575
Gly Cys Cys Thr Gly Cys Gly Ala Ala Gly Thr Cys Ala Cys Cys Cys
580 585 590
Ala Thr Cys Ala Gly Gly Gly Cys Cys Thr Gly Ala Gly Cys Thr Cys
595 600 605
Gly Cys Cys Cys Gly Thr Cys Ala Cys Ala Ala Ala Gly Ala Gly Cys
610 615 620
Thr Thr Cys Ala Ala Cys Ala Gly Gly Gly Gly Ala Gly Ala Gly Thr
625 630 635 640
Gly Thr
<210> 10
<211> 321
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 10
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc 60
atcacttgcc aggcgagtca ggacatcagc aactatttaa attggtatca gcagaaacca 120
gggaaagccc ctaaactcct gatctacgat gcatccaatt tggaaacagg ggtcccatca 180
aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct 240
gaagatattg caacatattt ctgtcaacac tttgatcatc tcccgctcgc tttcggcgga 300
gggaccaagg tggaaattaa a 321
<210> 11
<211> 214
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 11
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Asn Tyr
20 25 30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Ile Ala Thr Tyr Phe Cys Gln His Phe Asp His Leu Pro Leu
85 90 95
Ala Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210> 12
<211> 107
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 12
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Asn Tyr
20 25 30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Ile Ala Thr Tyr Phe Cys Gln His Phe Asp His Leu Pro Leu
85 90 95
Ala Phe Gly Gly Gly Thr Lys Val Glu Ile Lys
100 105
<210> 13
<211> 1347
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 13
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc 60
acctgcactg tctctggtgg ctccgtcagc agtggtgatt actactggac ctggatccgg 120
cagtccccag ggaagggact ggagtggatt ggacacatct attacagtgg gaacaccaat 180
tataacccct ccctcaagag ccgactcacc atatcaattg acacgtccaa gactcagttc 240
tccctgaagc tgagttctgt gaccgctgcg gacacggcca tttattactg tgtgcgagat 300
cgagtgactg gtgcttttga tatctggggc caagggacaa tggtcaccgt ctcgagcgct 360
agcaccaagg gcccatcggt cttccccctg gcaccctcct ccaagagcac ctctgggggc 420
acagcggccc tgggctgcct ggtcaaggac tacttccccg aaccggtgac ggtgtcgtgg 480
aactcaggcg ccctgaccag cggcgtgcac accttcccgg ctgtcctaca gtcctcagga 540
ctctactccc tcagcagcgt ggtgaccgtg ccctccagca gcttgggcac ccagacctac 600
atctgcaacg tgaatcacaa gcccagcaac accaaggtgg acaagagagt tgagcccaaa 660
tcttgtgaca aaactcacac atgcccaccg tgcccagcac ctgaactcct ggggggaccg 720
tcagtcttcc tcttcccccc aaaacccaag gacaccctca tgatctcccg gacccctgag 780
gtcacatgcg tggtggtgga cgtgagccac gaagaccctg aggtcaagtt caactggtac 840
gtggacggcg tggaggtgca taatgccaag acaaagccgc gggaggagca gtacaacagc 900
acgtaccgtg tggtcagcgt cctcaccgtc ctgcaccagg actggctgaa tggcaaggag 960
tacaagtgca aggtctccaa caaagccctc ccagccccca tcgagaaaac catctccaaa 1020
gccaaagggc agccccgaga accacaggtg tacaccctgc ccccatcccg ggaggagatg 1080
accaagaacc aggtcagcct gacctgcctg gtcaaaggct tctatcccag cgacatcgcc 1140
gtggagtggg agagcaatgg gcagccggag aacaactaca agaccacgcc tcccgtgctg 1200
gactccgacg gctccttctt cctctatagc aagctcaccg tggacaagag caggtggcag 1260
caggggaacg tcttctcatg ctccgtgatg catgaggctc tgcacaacca ctacacgcag 1320
aagagcctct ccctgtctcc gggtaaa 1347
<210> 14
<211> 357
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 14
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc 60
acctgcactg tctctggtgg ctccgtcagc agtggtgatt actactggac ctggatccgg 120
cagtccccag ggaagggact ggagtggatt ggacacatct attacagtgg gaacaccaat 180
tataacccct ccctcaagag ccgactcacc atatcaattg acacgtccaa gactcagttc 240
tccctgaagc tgagttctgt gaccgctgcg gacacggcca tttattactg tgtgcgagat 300
cgagtgactg gtgcttttga tatctggggc caagggacaa tggtcaccgt ctcgagc 357
<210> 15
<211> 449
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 15
Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu
1 5 10 15
Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Val Ser Ser Gly
20 25 30
Asp Tyr Tyr Trp Thr Trp Ile Arg Gln Ser Pro Gly Lys Gly Leu Glu
35 40 45
Trp Ile Gly His Ile Tyr Tyr Ser Gly Asn Thr Asn Tyr Asn Pro Ser
50 55 60
Leu Lys Ser Arg Leu Thr Ile Ser Ile Asp Thr Ser Lys Thr Gln Phe
65 70 75 80
Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Ile Tyr Tyr
85 90 95
Cys Val Arg Asp Arg Val Thr Gly Ala Phe Asp Ile Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp Lys
210 215 220
Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro
225 230 235 240
Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser
245 250 255
Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp
260 265 270
Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn
275 280 285
Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val
290 295 300
Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu
305 310 315 320
Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys
325 330 335
Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr
340 345 350
Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr
355 360 365
Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu
370 375 380
Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu
385 390 395 400
Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys
405 410 415
Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu
420 425 430
Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly
435 440 445
Lys
<210> 16
<211> 119
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 16
Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu
1 5 10 15
Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Val Ser Ser Gly
20 25 30
Asp Tyr Tyr Trp Thr Trp Ile Arg Gln Ser Pro Gly Lys Gly Leu Glu
35 40 45
Trp Ile Gly His Ile Tyr Tyr Ser Gly Asn Thr Asn Tyr Asn Pro Ser
50 55 60
Leu Lys Ser Arg Leu Thr Ile Ser Ile Asp Thr Ser Lys Thr Gln Phe
65 70 75 80
Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Ile Tyr Tyr
85 90 95
Cys Val Arg Asp Arg Val Thr Gly Ala Phe Asp Ile Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser
115
<210> 17
<211> 642
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 17
gatatccaga tgacccagtc cccgagctcc ctgtccgcct ctgtgggcga tagggtcacc 60
atcacctgcc gtgccagtca gaatattgct actgatgtag cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatttactcg gcatccttcc tctactctgg agtcccttct 180
cgcttctctg gtagcggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgtcagcaa agtgagccgg agccgtacac gttcggacag 300
ggtaccaagg tggagatcaa acgtacggtg gctgcaccat ctgtcttcat cttcccgcca 360
tctgatgagc agttgaaatc tggaactgcc tctgttgtgt gcctgctgaa taacttctat 420
cccagagagg ccaaagtaca gtggaaggtg gataacgccc tccaatcggg taactcccag 480
gagagtgtca cagagcagga cagcaaggac agcacctaca gcctcagcag caccctgacg 540
ctgagcaaag cagactacga gaaacacaaa gtctacgcct gcgaagtcac ccatcagggc 600
ctgagctcgc ccgtcacaaa gagcttcaac aggggagagt gt 642
<210> 18
<211> 321
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 18
gatatccaga tgacccagtc cccgagctcc ctgtccgcct ctgtgggcga tagggtcacc 60
atcacctgcc gtgccagtca gaatattgct actgatgtag cctggtatca acagaaacca 120
ggaaaagctc cgaagcttct gatttactcg gcatccttcc tctactctgg agtcccttct 180
cgcttctctg gtagcggttc cgggacggat ttcactctga ccatcagcag tctgcagccg 240
gaagacttcg caacttatta ctgtcagcaa agtgagccgg agccgtacac gttcggacag 300
ggtaccaagg tggagatcaa a 321
<210> 19
<211> 214
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 19
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asn Ile Ala Thr Asp
20 25 30
Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Ser Ala Ser Phe Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Glu Pro Glu Pro Tyr
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210> 20
<211> 107
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 20
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asn Ile Ala Thr Asp
20 25 30
Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Ser Ala Ser Phe Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Glu Pro Glu Pro Tyr
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys
100 105
<210> 21
<211> 1353
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 21
gaggtgcagc tggtcgagtc tggcggcgga ctggtgcagc ccggtggctc tctgcgactg 60
tcttgtgccg cctctggctt caccctcagt ggcgattgga tccactgggt gcgacaggct 120
cccggaaagg gcctggagtg ggtgggtgag atctctgctg ccggtggcta caccgattac 180
gccgactctg tgaagggccg attcaccatc tctgccgaca cctctaagaa caccgcctac 240
ctgcagatga actctctgcg agccgaggac accgctgtgt actactgtgc acgagaaagt 300
agagtttcct tcgaagccgc catggactac tggggccagg gcaccctggt gaccgtgtcc 360
tctgctagca ccaagggccc atcggtcttc cccctggcac cctcctccaa gagcacctct 420
gggggcacag cggccctggg ctgcctggtc aaggactact tccccgaacc ggtgacggtg 480
tcgtggaact caggcgccct gaccagcggc gtgcacacct tcccggctgt cctacagtcc 540
tcaggactct actccctcag cagcgtggtg accgtgccct ccagcagctt gggcacccag 600
acctacatct gcaacgtgaa tcacaagccc agcaacacca aggtggacaa gagagttgag 660
cccaaatctt gtgacaaaac tcacacatgc ccaccgtgcc cagcacctga actcctgggg 720
ggaccgtcag tcttcctctt ccccccaaaa cccaaggaca ccctcatgat ctcccggacc 780
cctgaggtca catgcgtggt ggtggacgtg agccacgaag accctgaggt caagttcaac 840
tggtacgtgg acggcgtgga ggtgcataat gccaagacaa agccgcggga ggagcagtac 900
aacagcacgt accgtgtggt cagcgtcctc accgtcctgc accaggactg gctgaatggc 960
aaggagtaca agtgcaaggt ctccaacaaa gccctcccag cccccatcga gaaaaccatc 1020
tccaaagcca aagggcagcc ccgagaacca caggtgtaca ccctgccccc atcccgggag 1080
gagatgacca agaaccaggt cagcctgacc tgcctggtca aaggcttcta tcccagcgac 1140
atcgccgtgg agtgggagag caatgggcag ccggagaaca actacaagac cacgcctccc 1200
gtgctggact ccgacggctc cttcttcctc tatagcaagc tcaccgtgga caagagcagg 1260
tggcagcagg ggaacgtctt ctcatgctcc gtgatgcatg aggctctgca caaccactac 1320
acgcagaaga gcctctccct gtctccgggt aaa 1353
<210> 22
<211> 363
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 22
Gly Ala Gly Gly Thr Gly Cys Ala Gly Cys Thr Gly Gly Thr Cys Gly
1 5 10 15
Ala Gly Thr Cys Thr Gly Gly Cys Gly Gly Cys Gly Gly Ala Cys Thr
20 25 30
Gly Gly Thr Gly Cys Ala Gly Cys Cys Cys Gly Gly Thr Gly Gly Cys
35 40 45
Thr Cys Thr Cys Thr Gly Cys Gly Ala Cys Thr Gly Thr Cys Thr Thr
50 55 60
Gly Thr Gly Cys Cys Gly Cys Cys Thr Cys Thr Gly Gly Cys Thr Thr
65 70 75 80
Cys Ala Cys Cys Cys Thr Cys Ala Gly Thr Gly Gly Cys Gly Ala Thr
85 90 95
Thr Gly Gly Ala Thr Cys Cys Ala Cys Thr Gly Gly Gly Thr Gly Cys
100 105 110
Gly Ala Cys Ala Gly Gly Cys Thr Cys Cys Cys Gly Gly Ala Ala Ala
115 120 125
Gly Gly Gly Cys Cys Thr Gly Gly Ala Gly Thr Gly Gly Gly Thr Gly
130 135 140
Gly Gly Thr Gly Ala Gly Ala Thr Cys Thr Cys Thr Gly Cys Thr Gly
145 150 155 160
Cys Cys Gly Gly Thr Gly Gly Cys Thr Ala Cys Ala Cys Cys Gly Ala
165 170 175
Thr Thr Ala Cys Gly Cys Cys Gly Ala Cys Thr Cys Thr Gly Thr Gly
180 185 190
Ala Ala Gly Gly Gly Cys Cys Gly Ala Thr Thr Cys Ala Cys Cys Ala
195 200 205
Thr Cys Thr Cys Thr Gly Cys Cys Gly Ala Cys Ala Cys Cys Thr Cys
210 215 220
Thr Ala Ala Gly Ala Ala Cys Ala Cys Cys Gly Cys Cys Thr Ala Cys
225 230 235 240
Cys Thr Gly Cys Ala Gly Ala Thr Gly Ala Ala Cys Thr Cys Thr Cys
245 250 255
Thr Gly Cys Gly Ala Gly Cys Cys Gly Ala Gly Gly Ala Cys Ala Cys
260 265 270
Cys Gly Cys Thr Gly Thr Gly Thr Ala Cys Thr Ala Cys Thr Gly Thr
275 280 285
Gly Cys Ala Cys Gly Ala Gly Ala Ala Ala Gly Thr Ala Gly Ala Gly
290 295 300
Thr Thr Thr Cys Cys Thr Thr Cys Gly Ala Ala Gly Cys Cys Gly Cys
305 310 315 320
Cys Ala Thr Gly Gly Ala Cys Thr Ala Cys Thr Gly Gly Gly Gly Cys
325 330 335
Cys Ala Gly Gly Gly Cys Ala Cys Cys Cys Thr Gly Gly Thr Gly Ala
340 345 350
Cys Cys Gly Thr Gly Thr Cys Cys Thr Cys Thr
355 360
<210> 23
<211> 451
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 23
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Leu Ser Gly Asp
20 25 30
Trp Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Gly Glu Ile Ser Ala Ala Gly Gly Tyr Thr Asp Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Glu Ser Arg Val Ser Phe Glu Ala Ala Met Asp Tyr Trp Gly
100 105 110
Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala
130 135 140
Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala
165 170 175
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His
195 200 205
Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys
210 215 220
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly
225 230 235 240
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
260 265 270
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val
275 280 285
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
290 295 300
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile
325 330 335
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser
355 360 365
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
370 375 380
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
405 410 415
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met
420 425 430
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser
435 440 445
Pro Gly Lys
450
<210> 24
<211> 121
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 24
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Leu Ser Gly Asp
20 25 30
Trp Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Gly Glu Ile Ser Ala Ala Gly Gly Tyr Thr Asp Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Glu Ser Arg Val Ser Phe Glu Ala Ala Met Asp Tyr Trp Gly
100 105 110
Gln Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 25
<211> 657
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 25
gatattcaaa tgactcaatc tccttcttct ctttctgctt ctgttggtga tcgtgttact 60
attacttgtc gttcttctca aaatattgtt cattctaatg gtaatactta tcttgattgg 120
tatcaacaaa ctcctggtaa agctcctaaa cttcttattt ataaagtttc taatcgtttt 180
tctggtgttc cttctcgttt ttctggttct ggttctggta ctgattttac ttttactatt 240
tcttctcttc aacctgaaga tattgctact tattattgtt ttcaatattc tcatgttcct 300
tggacttttg gtcaaggtac taaacttcaa attactcgta cggtggctgc accatctgtc 360
ttcatcttcc cgccatctga tgagcagttg aaatctggaa ctgcctctgt tgtgtgcctg 420
ctgaataact tctatcccag agaggccaaa gtacagtgga aggtggataa cgccctccaa 480
tcgggtaact cccaggagag tgtcacagag caggacagca aggacagcac ctacagcctc 540
agcagcaccc tgacgctgag caaagcagac tacgagaaac acaaagtcta cgcctgcgaa 600
gtcacccatc agggcctgag ctcgcccgtc acaaagagct tcaacagggg agagtgt 657
<210> 26
<211> 336
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 26
gatattcaaa tgactcaatc tccttcttct ctttctgctt ctgttggtga tcgtgttact 60
attacttgtc gttcttctca aaatattgtt cattctaatg gtaatactta tcttgattgg 120
tatcaacaaa ctcctggtaa agctcctaaa cttcttattt ataaagtttc taatcgtttt 180
tctggtgttc cttctcgttt ttctggttct ggttctggta ctgattttac ttttactatt 240
tcttctcttc aacctgaaga tattgctact tattattgtt ttcaatattc tcatgttcct 300
tggacttttg gtcaaggtac taaacttcaa attact 336
<210> 27
<211> 219
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 27
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ser Ser Gln Asn Ile Val His Ser
20 25 30
Asn Gly Asn Thr Tyr Leu Asp Trp Tyr Gln Gln Thr Pro Gly Lys Ala
35 40 45
Pro Lys Leu Leu Ile Tyr Lys Val Ser Asn Arg Phe Ser Gly Val Pro
50 55 60
Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile
65 70 75 80
Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Phe Gln Tyr
85 90 95
Ser His Val Pro Trp Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr
100 105 110
Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu
115 120 125
Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe
130 135 140
Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln
145 150 155 160
Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser
165 170 175
Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu
180 185 190
Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser
195 200 205
Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210> 28
<211> 112
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 28
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ser Ser Gln Asn Ile Val His Ser
20 25 30
Asn Gly Asn Thr Tyr Leu Asp Trp Tyr Gln Gln Thr Pro Gly Lys Ala
35 40 45
Pro Lys Leu Leu Ile Tyr Lys Val Ser Asn Arg Phe Ser Gly Val Pro
50 55 60
Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile
65 70 75 80
Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Phe Gln Tyr
85 90 95
Ser His Val Pro Trp Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr
100 105 110
<210> 29
<211> 1359
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 29
caagttcaac ttcaacaatc tggtgctgaa gttaaaaaac ctggttcttc tgttaaagtt 60
tcttgtaaag cctctggtta tacttttact aattattata tttattgggt tcgtcaagct 120
cctggtcaag gtcttgaatg gattggtggt attaatccta cttctggtgg ttctaatttt 180
aatgaaaaat ttaaaactcg tgttactatt actgttgatg aatctacgaa cactgcttat 240
atggaacttt cttctcttcg ttctgaagat actgcttttt atttttgtgc gcgtcaaggt 300
ctttggtttg attctgatgg tcgtggtttt gatttttggg gtcaaggttc cactgttact 360
gtctcgagcg ctagcaccaa gggcccatcg gtcttccccc tggcaccctc ctccaagagc 420
acctctgggg gcacagcggc cctgggctgc ctggtcaagg actacttccc cgaaccggtg 480
acggtgtcgt ggaactcagg cgccctgacc agcggcgtgc acaccttccc ggctgtccta 540
cagtcctcag gactctactc cctcagcagc gtggtgaccg tgccctccag cagcttgggc 600
acccagacct acatctgcaa cgtgaatcac aagcccagca acaccaaggt ggacaagaga 660
gttgagccca aatcttgtga caaaactcac acatgcccac cgtgcccagc acctgaactc 720
ctggggggac cgtcagtctt cctcttcccc ccaaaaccca aggacaccct catgatctcc 780
cggacccctg aggtcacatg cgtggtggtg gacgtgagcc acgaagaccc tgaggtcaag 840
ttcaactggt acgtggacgg cgtggaggtg cataatgcca agacaaagcc gcgggaggag 900
cagtacaaca gcacgtaccg tgtggtcagc gtcctcaccg tcctgcacca ggactggctg 960
aatggcaagg agtacaagtg caaggtctcc aacaaagccc tcccagcccc catcgagaaa 1020
accatctcca aagccaaagg gcagccccga gaaccacagg tgtacaccct gcccccatcc 1080
cgggaggaga tgaccaagaa ccaggtcagc ctgacctgcc tggtcaaagg cttctatccc 1140
agcgacatcg ccgtggagtg ggagagcaat gggcagccgg agaacaacta caagaccacg 1200
cctcccgtgc tggactccga cggctccttc ttcctctata gcaagctcac cgtggacaag 1260
agcaggtggc agcaggggaa cgtcttctca tgctccgtga tgcatgaggc tctgcacaac 1320
cactacacgc agaagagcct ctccctgtct ccgggtaaa 1359
<210> 30
<211> 369
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 30
caagttcaac ttcaacaatc tggtgctgaa gttaaaaaac ctggttcttc tgttaaagtt 60
tcttgtaaag cctctggtta tacttttact aattattata tttattgggt tcgtcaagct 120
cctggtcaag gtcttgaatg gattggtggt attaatccta cttctggtgg ttctaatttt 180
aatgaaaaat ttaaaactcg tgttactatt actgttgatg aatctacgaa cactgcttat 240
atggaacttt cttctcttcg ttctgaagat actgcttttt atttttgtgc gcgtcaaggt 300
ctttggtttg attctgatgg tcgtggtttt gatttttggg gtcaaggttc cactgttact 360
gtctcgagc 369
<210> 31
<211> 453
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 31
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr
20 25 30
Tyr Ile Tyr Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Gly Ile Asn Pro Thr Ser Gly Gly Ser Asn Phe Asn Glu Lys Phe
50 55 60
Lys Thr Arg Val Thr Ile Thr Val Asp Glu Ser Thr Asn Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Phe Tyr Phe Cys
85 90 95
Ala Arg Gln Gly Leu Trp Phe Asp Ser Asp Gly Arg Gly Phe Asp Phe
100 105 110
Trp Gly Gln Gly Ser Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly
115 120 125
Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly
130 135 140
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145 150 155 160
Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
165 170 175
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
180 185 190
Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val
195 200 205
Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys
210 215 220
Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu
225 230 235 240
Leu Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr
245 250 255
Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val
260 265 270
Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val
275 280 285
Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser
290 295 300
Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu
305 310 315 320
Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala
325 330 335
Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro
340 345 350
Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln
355 360 365
Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala
370 375 380
Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr
385 390 395 400
Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu
405 410 415
Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser
420 425 430
Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser
435 440 445
Leu Ser Pro Gly Lys
450
<210> 32
<211> 123
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 32
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr
20 25 30
Tyr Ile Tyr Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Gly Ile Asn Pro Thr Ser Gly Gly Ser Asn Phe Asn Glu Lys Phe
50 55 60
Lys Thr Arg Val Thr Ile Thr Val Asp Glu Ser Thr Asn Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Phe Tyr Phe Cys
85 90 95
Ala Arg Gln Gly Leu Trp Phe Asp Ser Asp Gly Arg Gly Phe Asp Phe
100 105 110
Trp Gly Gln Gly Ser Thr Val Thr Val Ser Ser
115 120
<210> 33
<211> 657
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 33
gatattcaaa tgactcaatc tccttcttct ctttctgctt ctgttggtga tcgtgttact 60
attacttgtc gttcttctca aaatattgtt cattctaatg gtaatactta tcttgattgg 120
tatcaacaaa ctcctggtaa agctcctaaa cttcttattt ataaagtttc taatcgtttt 180
tctggtgttc cttctcgttt ttctggttct ggttctggta ctgattttac ttttactatt 240
tcttctcttc aacctgaaga tattgctact tattattgtt ttcaatattc tcatgttcct 300
tggacttttg gtcaaggtac taaacttcaa attactcgta cggtggctgc accatctgtc 360
ttcatcttcc cgccatctga tgagcagttg aaatctggaa ctgcctctgt tgtgtgcctg 420
ctgaataact tctatcccag agaggccaaa gtacagtgga aggtggataa cgccctccaa 480
tcgggtaact cccaggagag tgtcacagag caggacagca aggacagcac ctacagcctc 540
agcagcaccc tgacgctgag caaagcagac tacgagaaac acaaagtcta cgcctgcgaa 600
gtcacccatc agggcctgag ctcgcccgtc acaaagagct tcaacagggg agagtgt 657
<210> 34
<211> 336
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 34
gatattcaaa tgactcaatc tccttcttct ctttctgctt ctgttggtga tcgtgttact 60
attacttgtc gttcttctca aaatattgtt cattctaatg gtaatactta tcttgattgg 120
tatcaacaaa ctcctggtaa agctcctaaa cttcttattt ataaagtttc taatcgtttt 180
tctggtgttc cttctcgttt ttctggttct ggttctggta ctgattttac ttttactatt 240
tcttctcttc aacctgaaga tattgctact tattattgtt ttcaatattc tcatgttcct 300
tggacttttg gtcaaggtac taaacttcaa attact 336
<210> 35
<211> 218
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 35
Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
1 5 10 15
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr
20 25 30
Asn Phe Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
35 40 45
Met Ile Tyr Asp Val Ser Asp Arg Pro Ser Gly Val Ser Asp Arg Phe
50 55 60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Ile Ile Ser Gly Leu
65 70 75 80
Gln Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Gly Ser Ser
85 90 95
Ser Thr His Val Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Arg
100 105 110
Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln
115 120 125
Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr
130 135 140
Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser
145 150 155 160
Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr
165 170 175
Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys
180 185 190
His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro
195 200 205
Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210> 36
<211> 111
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 36
Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
1 5 10 15
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr
20 25 30
Asn Phe Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
35 40 45
Met Ile Tyr Asp Val Ser Asp Arg Pro Ser Gly Val Ser Asp Arg Phe
50 55 60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Ile Ile Ser Gly Leu
65 70 75 80
Gln Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Gly Ser Ser
85 90 95
Ser Thr His Val Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
100 105 110
<210> 37
<211> 1356
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 37
caggtgcagc tgcagcagag cggcgccgag gtgaagaagc ccggcagcag cgtgaaggtg 60
agctgcaagg ccagcggcta caccttcacc aactactaca tctactgggt gcggcaggcc 120
cccggccagg gcctggagtg gatcggcggc atcaacccca ccagcggcgg cagcaacttc 180
aacgagaagt tcaagacccg ggtgaccatc accgccgacg agagcagcac caccgcctac 240
atggagctga gcagcctgcg gagcgaggac accgccttct acttctgcac ccggcagggc 300
ctgtggttcg acagcgacgg ccggggcttc gacttctggg gccagggcac caccgtgacc 360
gtgagcagcg ctagcaccaa gggcccatcg gtcttccccc tggcaccctc ctccaagagc 420
acctctgggg gcacagcggc cctgggctgc ctggtcaagg actacttccc cgaaccggtg 480
acggtgtcgt ggaactcagg cgccctgacc agcggcgtgc acaccttccc ggctgtccta 540
cagtcctcag gactctactc cctcagcagc gtggtgaccg tgccctccag cagcttgggc 600
acccagacct acatctgcaa cgtgaatcac aagcccagca acaccaaggt ggacaagaga 660
gttgagccca aatcttgtga caaaactcac acatgcccac cgtgcccagc acctgaactc 720
ctggggggac cgtcagtctt cctcttcccc ccaaaaccca aggacaccct catgatctcc 780
cggacccctg aggtcacatg cgtggtggtg gacgtgagcc acgaagaccc tgaggtcaag 840
ttcaactggt acgtggacgg cgtggaggtg cataatgcca agacaaagcc gcgggaggag 900
cagtacaaca gcacgtaccg tgtggtcagc gtcctcaccg tcctgcacca ggactggctg 960
aatggcaagg agtacaagtg caaggtctcc aacaaagccc tcccagcccc catcgagaaa 1020
accatctcca aagccaaagg gcagccccga gaaccacagg tgtacaccct gcccccatcc 1080
cgggatgagc tgaccaagaa ccaggtcagc ctgacctgcc tggtcaaagg cttctatccc 1140
agcgacatcg ccgtggagtg ggagagcaat gggcagccgg agaacaacta caagaccacg 1200
cctcccgtgc tggactccga cggctccttc ttcctctata gcaagctcac cgtggacaag 1260
agcaggtggc agcaggggaa cgtcttctca tgctccgtga tgcatgaggc tctgcacaac 1320
cactacacgc agaagagcct ctccctgtct ccgggt 1356
<210> 38
<211> 369
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 38
caggtgcagc tgcagcagag cggcgccgag gtgaagaagc ccggcagcag cgtgaaggtg 60
agctgcaagg ccagcggcta caccttcacc aactactaca tctactgggt gcggcaggcc 120
cccggccagg gcctggagtg gatcggcggc atcaacccca ccagcggcgg cagcaacttc 180
aacgagaagt tcaagacccg ggtgaccatc accgccgacg agagcagcac caccgcctac 240
atggagctga gcagcctgcg gagcgaggac accgccttct acttctgcac ccggcagggc 300
ctgtggttcg acagcgacgg ccggggcttc gacttctggg gccagggcac caccgtgacc 360
gtgagcagc 369
<210> 39
<211> 452
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 39
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr
20 25 30
Tyr Ile Tyr Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Gly Ile Asn Pro Thr Ser Gly Gly Ser Asn Phe Asn Glu Lys Phe
50 55 60
Lys Thr Arg Val Thr Ile Thr Ala Asp Glu Ser Ser Thr Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Phe Tyr Phe Cys
85 90 95
Thr Arg Gln Gly Leu Trp Phe Asp Ser Asp Gly Arg Gly Phe Asp Phe
100 105 110
Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly
115 120 125
Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly
130 135 140
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145 150 155 160
Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
165 170 175
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
180 185 190
Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val
195 200 205
Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys
210 215 220
Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu
225 230 235 240
Leu Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr
245 250 255
Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val
260 265 270
Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val
275 280 285
Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser
290 295 300
Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu
305 310 315 320
Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala
325 330 335
Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro
340 345 350
Gln Val Tyr Thr Leu Pro Pro Ser Arg Asp Glu Leu Thr Lys Asn Gln
355 360 365
Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala
370 375 380
Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr
385 390 395 400
Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu
405 410 415
Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser
420 425 430
Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser
435 440 445
Leu Ser Pro Gly
450
<210> 40
<211> 123
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 40
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr
20 25 30
Tyr Ile Tyr Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Gly Ile Asn Pro Thr Ser Gly Gly Ser Asn Phe Asn Glu Lys Phe
50 55 60
Lys Thr Arg Val Thr Ile Thr Ala Asp Glu Ser Ser Thr Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Phe Tyr Phe Cys
85 90 95
Thr Arg Gln Gly Leu Trp Phe Asp Ser Asp Gly Arg Gly Phe Asp Phe
100 105 110
Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser
115 120
<210> 41
<211> 642
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 41
gacatcttgc tgactcagtc tccagtcatc ctgtctgtga gtccaggaga aagagtcagt 60
ttctcctgca gggccagtca gagtattggc acaaacatac actggtatca gcaaagaaca 120
aatggttctc caaggcttct cataaagtat gcttctgagt ctatctctgg gattccttcc 180
aggtttagtg gcagtggatc agggacagat tttactctta gcatcaacag tgtggagtct 240
gaagatattg cagattatta ctgtcaacaa aataataact ggccaaccac gttcggtgct 300
gggaccaagc tggagctgaa acgtacggtg gctgcaccat ctgtcttcat cttcccgcca 360
tctgatgagc agttgaaatc tggaactgcc tctgttgtgt gcctgctgaa taacttctat 420
cccagagagg ccaaagtaca gtggaaggtg gataacgccc tccaatcggg taactcccag 480
gagagtgtca cagagcagga cagcaaggac agcacctaca gcctcagcag caccctgacg 540
ctgagcaaag cagactacga gaaacacaaa gtctacgcct gcgaagtcac ccatcagggc 600
ctgagctcgc ccgtcacaaa gagcttcaac aggggagagt gt 642
<210> 42
<211> 321
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 42
gacatcttgc tgactcagtc tccagtcatc ctgtctgtga gtccaggaga aagagtcagt 60
ttctcctgca gggccagtca gagtattggc acaaacatac actggtatca gcaaagaaca 120
aatggttctc caaggcttct cataaagtat gcttctgagt ctatctctgg gattccttcc 180
aggtttagtg gcagtggatc agggacagat tttactctta gcatcaacag tgtggagtct 240
gaagatattg cagattatta ctgtcaacaa aataataact ggccaaccac gttcggtgct 300
gggaccaagc tggagctgaa a 321
<210> 43
<211> 214
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 43
Asp Ile Leu Leu Thr Gln Ser Pro Val Ile Leu Ser Val Ser Pro Gly
1 5 10 15
Glu Arg Val Ser Phe Ser Cys Arg Ala Ser Gln Ser Ile Gly Thr Asn
20 25 30
Ile His Trp Tyr Gln Gln Arg Thr Asn Gly Ser Pro Arg Leu Leu Ile
35 40 45
Lys Tyr Ala Ser Glu Ser Ile Ser Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Ser Ile Asn Ser Val Glu Ser
65 70 75 80
Glu Asp Ile Ala Asp Tyr Tyr Cys Gln Gln Asn Asn Asn Trp Pro Thr
85 90 95
Thr Phe Gly Ala Gly Thr Lys Leu Glu Leu Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210> 44
<211> 107
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 44
Asp Ile Leu Leu Thr Gln Ser Pro Val Ile Leu Ser Val Ser Pro Gly
1 5 10 15
Glu Arg Val Ser Phe Ser Cys Arg Ala Ser Gln Ser Ile Gly Thr Asn
20 25 30
Ile His Trp Tyr Gln Gln Arg Thr Asn Gly Ser Pro Arg Leu Leu Ile
35 40 45
Lys Tyr Ala Ser Glu Ser Ile Ser Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Ser Ile Asn Ser Val Glu Ser
65 70 75 80
Glu Asp Ile Ala Asp Tyr Tyr Cys Gln Gln Asn Asn Asn Trp Pro Thr
85 90 95
Thr Phe Gly Ala Gly Thr Lys Leu Glu Leu Lys
100 105
<210> 45
<211> 1347
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 45
caggtgcagc tgaagcagtc aggacctggc ctagtgcagc cctcacagag cctgtccatc 60
acctgcacag tctctggttt ctcattaact aactatggtg tacactgggt tcgccagtct 120
ccaggaaagg gtctggagtg gctgggagtg atatggagtg gtggaaacac agactataat 180
acacctttca catccagact gagcatcaac aaggacaatt ccaagagcca agttttcttt 240
aaaatgaaca gtctgcaatc taatgacaca gccatatatt actgtgccag agccctcacc 300
tactatgatt acgagtttgc ttactggggc caagggactc tggtcactgt ctctagcgct 360
agcaccaagg gcccatcggt cttccccctg gcaccctcct ccaagagcac ctctgggggc 420
acagcggccc tgggctgcct ggtcaaggac tacttccccg aaccggtgac ggtgtcgtgg 480
aactcaggcg ccctgaccag cggcgtgcac accttcccgg ctgtcctaca gtcctcagga 540
ctctactccc tcagcagcgt ggtgaccgtg ccctccagca gcttgggcac ccagacctac 600
atctgcaacg tgaatcacaa gcccagcaac accaaggtgg acaagagagt tgagcccaaa 660
tcttgtgaca aaactcacac atgcccaccg tgcccagcac ctgaactcct ggggggaccg 720
tcagtcttcc tcttcccccc aaaacccaag gacaccctca tgatctcccg gacccctgag 780
gtcacatgcg tggtggtgga cgtgagccac gaagaccctg aggtcaagtt caactggtac 840
gtggacggcg tggaggtgca taatgccaag acaaagccgc gggaggagca gtacaacagc 900
acgtaccgtg tggtcagcgt cctcaccgtc ctgcaccagg actggctgaa tggcaaggag 960
tacaagtgca aggtctccaa caaagccctc ccagccccca tcgagaaaac catctccaaa 1020
gccaaagggc agccccgaga accacaggtg tacaccctgc ccccatcccg ggaggagatg 1080
accaagaacc aggtcagcct gacctgcctg gtcaaaggct tctatcccag cgacatcgcc 1140
gtggagtggg agagcaatgg gcagccggag aacaactaca agaccacgcc tcccgtgctg 1200
gactccgacg gctccttctt cctctatagc aagctcaccg tggacaagag caggtggcag 1260
caggggaacg tcttctcatg ctccgtgatg catgaggctc tgcacaacca ctacacgcag 1320
aagagcctct ccctgtctcc gggtaaa 1347
<210> 46
<211> 357
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 46
caggtgcagc tgaagcagtc aggacctggc ctagtgcagc cctcacagag cctgtccatc 60
acctgcacag tctctggttt ctcattaact aactatggtg tacactgggt tcgccagtct 120
ccaggaaagg gtctggagtg gctgggagtg atatggagtg gtggaaacac agactataat 180
acacctttca catccagact gagcatcaac aaggacaatt ccaagagcca agttttcttt 240
aaaatgaaca gtctgcaatc taatgacaca gccatatatt actgtgccag agccctcacc 300
tactatgatt acgagtttgc ttactggggc caagggactc tggtcactgt ctctagc 357
<210> 47
<211> 449
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 47
Gln Val Gln Leu Lys Gln Ser Gly Pro Gly Leu Val Gln Pro Ser Gln
1 5 10 15
Ser Leu Ser Ile Thr Cys Thr Val Ser Gly Phe Ser Leu Thr Asn Tyr
20 25 30
Gly Val His Trp Val Arg Gln Ser Pro Gly Lys Gly Leu Glu Trp Leu
35 40 45
Gly Val Ile Trp Ser Gly Gly Asn Thr Asp Tyr Asn Thr Pro Phe Thr
50 55 60
Ser Arg Leu Ser Ile Asn Lys Asp Asn Ser Lys Ser Gln Val Phe Phe
65 70 75 80
Lys Met Asn Ser Leu Gln Ser Asn Asp Thr Ala Ile Tyr Tyr Cys Ala
85 90 95
Arg Ala Leu Thr Tyr Tyr Asp Tyr Glu Phe Ala Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp Lys
210 215 220
Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro
225 230 235 240
Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser
245 250 255
Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp
260 265 270
Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn
275 280 285
Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val
290 295 300
Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu
305 310 315 320
Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys
325 330 335
Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr
340 345 350
Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr
355 360 365
Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu
370 375 380
Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu
385 390 395 400
Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys
405 410 415
Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu
420 425 430
Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly
435 440 445
Lys
<210> 48
<211> 119
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 48
Gln Val Gln Leu Lys Gln Ser Gly Pro Gly Leu Val Gln Pro Ser Gln
1 5 10 15
Ser Leu Ser Ile Thr Cys Thr Val Ser Gly Phe Ser Leu Thr Asn Tyr
20 25 30
Gly Val His Trp Val Arg Gln Ser Pro Gly Lys Gly Leu Glu Trp Leu
35 40 45
Gly Val Ile Trp Ser Gly Gly Asn Thr Asp Tyr Asn Thr Pro Phe Thr
50 55 60
Ser Arg Leu Ser Ile Asn Lys Asp Asn Ser Lys Ser Gln Val Phe Phe
65 70 75 80
Lys Met Asn Ser Leu Gln Ser Asn Asp Thr Ala Ile Tyr Tyr Cys Ala
85 90 95
Arg Ala Leu Thr Tyr Tyr Asp Tyr Glu Phe Ala Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser
115
<210> 49
<211> 654
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 49
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc 60
tcctgcactg gaaccagcag tgacgttggt ggttataact ttgtctcctg gtaccaacaa 120
cacccaggca aagcccccaa actcatgatc tatgatgtca gtgatcggcc ctcaggggtg 180
tctgatcgct tctccggctc caagtctggc aacacggcct ccctgatcat ctctggcctc 240
caggctgacg acgaggctga ttattactgc agctcatatg ggagcagcag cactcatgtg 300
attttcggcg gagggaccaa gctgaccgtc ctacgtacgg tggctgcacc atctgtcttc 360
atcttcccgc catctgatga gcagttgaaa tctggaactg cctctgttgt gtgcctgctg 420
aataacttct atcccagaga ggccaaagta cagtggaagg tggataacgc cctccaatcg 480
ggtaactccc aggagagtgt cacagagcag gacagcaagg acagcaccta cagcctcagc 540
agcaccctga cgctgagcaa agcagactac gagaaacaca aagtctacgc ctgcgaagtc 600
acccatcagg gcctgagctc gcccgtcaca aagagcttca acaggggaga gtgt 654
<210> 50
<211> 333
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 50
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc 60
tcctgcactg gaaccagcag tgacgttggt ggttataact ttgtctcctg gtaccaacaa 120
cacccaggca aagcccccaa actcatgatc tatgatgtca gtgatcggcc ctcaggggtg 180
tctgatcgct tctccggctc caagtctggc aacacggcct ccctgatcat ctctggcctc 240
caggctgacg acgaggctga ttattactgc agctcatatg ggagcagcag cactcatgtg 300
attttcggcg gagggaccaa gctgaccgtc cta 333
<210> 51
<211> 218
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 51
Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
1 5 10 15
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr
20 25 30
Asn Phe Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
35 40 45
Met Ile Tyr Asp Val Ser Asp Arg Pro Ser Gly Val Ser Asp Arg Phe
50 55 60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Ile Ile Ser Gly Leu
65 70 75 80
Gln Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Gly Ser Ser
85 90 95
Ser Thr His Val Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Arg
100 105 110
Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln
115 120 125
Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr
130 135 140
Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser
145 150 155 160
Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr
165 170 175
Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys
180 185 190
His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro
195 200 205
Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210> 52
<211> 111
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 52
Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
1 5 10 15
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr
20 25 30
Asn Phe Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
35 40 45
Met Ile Tyr Asp Val Ser Asp Arg Pro Ser Gly Val Ser Asp Arg Phe
50 55 60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Ile Ile Ser Gly Leu
65 70 75 80
Gln Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Gly Ser Ser
85 90 95
Ser Thr His Val Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
100 105 110
<210> 53
<211> 2100
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 53
caggtgcagc tgcaggagtc ggggggaggc ctggtcaagc ctggagggtc cctgagactc 60
tcctgtgcag cctctggatt cacctttagt agttattgga tgagctgggt ccgccaggct 120
ccagggaagg ggctggagtg ggtggccaac ataaaccgcg atggaagtgc gagttactat 180
gtggactctg tgaagggccg attcaccatc tccagagacg acgccaagaa ctcactgtat 240
ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagatcgt 300
ggggtgggct acttcgatct ctggggccgt ggcaccctgg tcaccgtctc gagcgctagc 360
accaagggcc catcggtctt ccccctggca ccctcctcca agagcacctc tgggggcaca 420
gcggccctgg gctgcctggt caaggactac ttccccgaac cggtgacggt gtcgtggaac 480
tcaggcgccc tgaccagcgg cgtgcacacc ttcccggctg tcctacagtc ctcaggactc 540
tactccctca gcagcgtggt gaccgtgccc tccagcagct tgggcaccca gacctacatc 600
tgcaacgtga atcacaagcc cagcaacacc aaggtggaca agagagttga gcccaaatct 660
tgtgacaaaa ctcacacatg cccaccgtgc ccagcacctg aactcctggg gggaccgtca 720
gtcttcctct tccccccaaa acccaaggac accctcatga tctcccggac ccctgaggtc 780
acatgcgtgg tggtggacgt gagccacgaa gaccctgagg tcaagttcaa ctggtacgtg 840
gacggcgtgg aggtgcataa tgccaagaca aagccgcggg aggagcagta caacagcacg 900
taccgtgtgg tcagcgtcct caccgtcctg caccaggact ggctgaatgg caaggagtac 960
aagtgcaagg tctccaacaa agccctccca gcccccatcg agaaaaccat ctccaaagcc 1020
aaagggcagc cccgagaacc acaggtgtac accctgcccc catcccggga ggagatgacc 1080
aagaaccagg tcagcctgac ctgcctggtc aaaggcttct atcccagcga catcgccgtg 1140
gagtgggaga gcaatgggca gccggagaac aactacaaga ccacgcctcc cgtgctggac 1200
tccgacggct ccttcttcct ctatagcaag ctcaccgtgg acaagagcag gtggcagcag 1260
gggaacgtct tctcatgctc cgtgatgcat gaggctctgc acaaccacta cacgcagaag 1320
agcctctccc tgtctccggg taaaggcggt ggaggatccg gcggtggtgg atcacaggtg 1380
cagctgcagg agtcgggccc aggactggtg aagccttcgg agaccctgtc cctcacctgc 1440
actgtctctg gtggctccgt cagcagtggt gattactact ggacctggat acggcagtcc 1500
ccagggaagg gactggagtg gattggacac atctattaca gtgggaacac caattataac 1560
ccctccctca agagccgact caccatatca attgacacgt ccaagactca gttctccctg 1620
aagctgagtt ctgtgaccgc tgcggacacg gccatttatt actgtgtgcg agatcgagtg 1680
actggtgctt ttgatatctg gggccaaggg acaatggtca ccgtctcgag cggtggaggc 1740
ggttcaggcg gaggtggttc cggcggtggc ggctccgaca tccagatgac ccagtctcca 1800
tcctccctgt ctgcatctgt aggagacaga gtcaccatca cttgccaggc gagtcaggac 1860
atcagcaact atttaaattg gtatcagcag aaaccaggga aagcccctaa actcctgatc 1920
tacgatgcat ccaatttgga aacaggggtc ccatcaaggt tcagtggaag tggatctggg 1980
acagatttta ctttcaccat cagcagcctg cagcctgaag atattgcaac atatttctgt 2040
caacactttg atcatctccc gctcgctttc ggcggaggga ccaaggtgga aattaaacgt 2100
<210> 54
<211> 354
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 54
caggtgcagc tgcaggagtc ggggggaggc ctggtcaagc ctggagggtc cctgagactc 60
tcctgtgcag cctctggatt cacctttagt agttattgga tgagctgggt ccgccaggct 120
ccagggaagg ggctggagtg ggtggccaac ataaaccgcg atggaagtgc gagttactat 180
gtggactctg tgaagggccg attcaccatc tccagagacg acgccaagaa ctcactgtat 240
ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagatcgt 300
ggggtgggct acttcgatct ctggggccgt ggcaccctgg tcaccgtctc gagc 354
<210> 55
<211> 726
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 55
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc 60
acctgcactg tctctggtgg ctccgtcagc agtggtgatt actactggac ctggatacgg 120
cagtccccag ggaagggact ggagtggatt ggacacatct attacagtgg gaacaccaat 180
tataacccct ccctcaagag ccgactcacc atatcaattg acacgtccaa gactcagttc 240
tccctgaagc tgagttctgt gaccgctgcg gacacggcca tttattactg tgtgcgagat 300
cgagtgactg gtgcttttga tatctggggc caagggacaa tggtcaccgt ctcgagcggt 360
ggaggcggtt caggcggagg tggttccggc ggtggcggct ccgacatcca gatgacccag 420
tctccatcct ccctgtctgc atctgtagga gacagagtca ccatcacttg ccaggcgagt 480
caggacatca gcaactattt aaattggtat cagcagaaac cagggaaagc ccctaaactc 540
ctgatctacg atgcatccaa tttggaaaca ggggtcccat caaggttcag tggaagtgga 600
tctgggacag attttacttt caccatcagc agcctgcagc ctgaagatat tgcaacatat 660
ttctgtcaac actttgatca tctcccgctc gctttcggcg gagggaccaa ggtggaaatt 720
aaacgt 726
<210> 56
<211> 700
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 56
Gln Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Asn Ile Asn Arg Asp Gly Ser Ala Ser Tyr Tyr Val Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ala Lys Asn Ser Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Asp Arg Gly Val Gly Tyr Phe Asp Leu Trp Gly Arg Gly Thr
100 105 110
Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe Pro
115 120 125
Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly
130 135 140
Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp Asn
145 150 155 160
Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu Gln
165 170 175
Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser Ser
180 185 190
Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro Ser
195 200 205
Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp Lys Thr
210 215 220
His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser
225 230 235 240
Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg
245 250 255
Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro
260 265 270
Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala
275 280 285
Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val
290 295 300
Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr
305 310 315 320
Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr
325 330 335
Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu
340 345 350
Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys
355 360 365
Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser
370 375 380
Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp
385 390 395 400
Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser
405 410 415
Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala
420 425 430
Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
435 440 445
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val Gln Leu Gln Glu
450 455 460
Ser Gly Pro Gly Leu Val Lys Pro Ser Glu Thr Leu Ser Leu Thr Cys
465 470 475 480
Thr Val Ser Gly Gly Ser Val Ser Ser Gly Asp Tyr Tyr Trp Thr Trp
485 490 495
Ile Arg Gln Ser Pro Gly Lys Gly Leu Glu Trp Ile Gly His Ile Tyr
500 505 510
Tyr Ser Gly Asn Thr Asn Tyr Asn Pro Ser Leu Lys Ser Arg Leu Thr
515 520 525
Ile Ser Ile Asp Thr Ser Lys Thr Gln Phe Ser Leu Lys Leu Ser Ser
530 535 540
Val Thr Ala Ala Asp Thr Ala Ile Tyr Tyr Cys Val Arg Asp Arg Val
545 550 555 560
Thr Gly Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser
565 570 575
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
580 585 590
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
595 600 605
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Asn Tyr
610 615 620
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
625 630 635 640
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
645 650 655
Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro
660 665 670
Glu Asp Ile Ala Thr Tyr Phe Cys Gln His Phe Asp His Leu Pro Leu
675 680 685
Ala Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg
690 695 700
<210> 57
<211> 118
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 57
Gln Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Asn Ile Asn Arg Asp Gly Ser Ala Ser Tyr Tyr Val Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ala Lys Asn Ser Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Asp Arg Gly Val Gly Tyr Phe Asp Leu Trp Gly Arg Gly Thr
100 105 110
Leu Val Thr Val Ser Ser
115
<210> 58
<211> 242
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 58
Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu
1 5 10 15
Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Val Ser Ser Gly
20 25 30
Asp Tyr Tyr Trp Thr Trp Ile Arg Gln Ser Pro Gly Lys Gly Leu Glu
35 40 45
Trp Ile Gly His Ile Tyr Tyr Ser Gly Asn Thr Asn Tyr Asn Pro Ser
50 55 60
Leu Lys Ser Arg Leu Thr Ile Ser Ile Asp Thr Ser Lys Thr Gln Phe
65 70 75 80
Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Ile Tyr Tyr
85 90 95
Cys Val Arg Asp Arg Val Thr Gly Ala Phe Asp Ile Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
115 120 125
Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser
130 135 140
Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Gln Ala Ser
145 150 155 160
Gln Asp Ile Ser Asn Tyr Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys
165 170 175
Ala Pro Lys Leu Leu Ile Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val
180 185 190
Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr
195 200 205
Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Phe Cys Gln His
210 215 220
Phe Asp His Leu Pro Leu Ala Phe Gly Gly Gly Thr Lys Val Glu Ile
225 230 235 240
Lys Arg
<210> 59
<211> 642
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 59
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc 60
atcacttgcc aggcgagtca ggacatcagc aactatttaa attggtatca gcagaaacca 120
gggaaagccc ctaaactcct gatctacgat gcatccaatt tggaaacagg ggtcccatca 180
aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct 240
gaagatattg caacatattt ctgtcaacac tttgatcatc tcccgctcgc tttcggcgga 300
gggaccaagg tggaaattaa acgtacggtg gctgcaccat ctgtcttcat cttcccgcca 360
tctgatgagc agttgaaatc tggaactgcc tctgttgtgt gcctgctgaa taacttctat 420
cccagagagg ccaaagtaca gtggaaggtg gataacgccc tccaatcggg taactcccag 480
gagagtgtca cagagcagga cagcaaggac agcacctaca gcctcagcag caccctgacg 540
ctgagcaaag cagactacga gaaacacaaa gtctacgcct gcgaagtcac ccatcagggc 600
ctgagctcgc ccgtcacaaa gagcttcaac aggggagagt gt 642
<210> 60
<211> 321
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 60
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc 60
atcacttgcc aggcgagtca ggacatcagc aactatttaa attggtatca gcagaaacca 120
gggaaagccc ctaaactcct gatctacgat gcatccaatt tggaaacagg ggtcccatca 180
aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct 240
gaagatattg caacatattt ctgtcaacac tttgatcatc tcccgctcgc tttcggcgga 300
gggaccaagg tggaaattaa a 321
<210> 61
<211> 214
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 61
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Asn Tyr
20 25 30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Ile Ala Thr Tyr Phe Cys Gln His Phe Asp His Leu Pro Leu
85 90 95
Ala Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210> 62
<211> 107
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 62
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Asn Tyr
20 25 30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Ile Ala Thr Tyr Phe Cys Gln His Phe Asp His Leu Pro Leu
85 90 95
Ala Phe Gly Gly Gly Thr Lys Val Glu Ile Lys
100 105
<210> 63
<211> 2109
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 63
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc 60
acctgcactg tctctggtgg ctccgtcagc agtggtgatt actactggac ctggatccgg 120
cagtccccag ggaagggact ggagtggatt ggacacatct attacagtgg gaacaccaat 180
tataacccct ccctcaagag ccgactcacc atatcaattg acacgtccaa gactcagttc 240
tccctgaagc tgagttctgt gaccgctgcg gacacggcca tttattactg tgtgcgagat 300
cgagtgactg gtgcttttga tatctggggc caagggacaa tggtcaccgt ctcgagcgct 360
agcaccaagg gcccatcggt cttccccctg gcaccctcct ccaagagcac ctctgggggc 420
acagcggccc tgggctgcct ggtcaaggac tacttccccg aaccggtgac ggtgtcgtgg 480
aactcaggcg ccctgaccag cggcgtgcac accttcccgg ctgtcctaca gtcctcagga 540
ctctactccc tcagcagcgt ggtgaccgtg ccctccagca gcttgggcac ccagacctac 600
atctgcaacg tgaatcacaa gcccagcaac accaaggtgg acaagagagt tgagcccaaa 660
tcttgtgaca aaactcacac atgcccaccg tgcccagcac ctgaactcct ggggggaccg 720
tcagtcttcc tcttcccccc aaaacccaag gacaccctca tgatctcccg gacccctgag 780
gtcacatgcg tggtggtgga cgtgagccac gaagaccctg aggtcaagtt caactggtac 840
gtggacggcg tggaggtgca taatgccaag acaaagccgc gggaggagca gtacaacagc 900
acgtaccgtg tggtcagcgt cctcaccgtc ctgcaccagg actggctgaa tggcaaggag 960
tacaagtgca aggtctccaa caaagccctc ccagccccca tcgagaaaac catctccaaa 1020
gccaaagggc agccccgaga accacaggtg tacaccctgc ccccatcccg ggaggagatg 1080
accaagaacc aggtcagcct gacctgcctg gtcaaaggct tctatcccag cgacatcgcc 1140
gtggagtggg agagcaatgg gcagccggag aacaactaca agaccacgcc tcccgtgctg 1200
gactccgacg gctccttctt cctctatagc aagctcaccg tggacaagag caggtggcag 1260
caggggaacg tcttctcatg ctccgtgatg catgaggctc tgcacaacca ctacacgcag 1320
aagagcctct ccctgtctcc gggtaaaggc ggtggaggat ccggcggtgg tggatcacag 1380
gtgcagctgc aggagtcggg gggaggcctg gtcaagcctg gagggtccct gagactctcc 1440
tgtgcagcct ctggattcac ctttagtagt tattggatga gctgggtccg ccaggctcca 1500
gggaaggggc tggagtgggt ggccaacata aaccgcgatg gaagtgcgag ttactatgtg 1560
gactctgtga agggccgatt caccatctcc agagacgacg ccaagaactc actgtatctg 1620
caaatgaaca gcctgagagc tgaggacacg gctgtgtatt actgtgcgag agatcgtggg 1680
gtgggctact tcgatctctg gggccgtggc accctggtca ccgtctcgag cggtggaggc 1740
ggttcaggcg gaggtggttc cggcggtggc ggctcccagt ctgccctgac tcagcctgcc 1800
tccgtgtctg ggtctcctgg acagtcgatc accatctcct gcactggaac cagcagtgac 1860
gttggtggtt ataactttgt ctcctggtac caacaacacc caggcaaagc ccccaaactc 1920
atgatctatg atgtcagtga tcggccctca ggggtgtctg atcgcttctc cggctccaag 1980
tctggcaaca cggcctccct gatcatctct ggcctccagg ctgacgacga ggctgattat 2040
tactgcagct catatgggag cagcagcact catgtgattt tcggcggagg gaccaaggtg 2100
accgtccta 2109
<210> 64
<211> 357
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 64
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc 60
acctgcactg tctctggtgg ctccgtcagc agtggtgatt actactggac ctggatccgg 120
cagtccccag ggaagggact ggagtggatt ggacacatct attacagtgg gaacaccaat 180
tataacccct ccctcaagag ccgactcacc atatcaattg acacgtccaa gactcagttc 240
tccctgaagc tgagttctgt gaccgctgcg gacacggcca tttattactg tgtgcgagat 300
cgagtgactg gtgcttttga tatctggggc caagggacaa tggtcaccgt ctcgagc 357
<210> 65
<211> 732
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 65
caggtgcagc tgcaggagtc ggggggaggc ctggtcaagc ctggagggtc cctgagactc 60
tcctgtgcag cctctggatt cacctttagt agttattgga tgagctgggt ccgccaggct 120
ccagggaagg ggctggagtg ggtggccaac ataaaccgcg atggaagtgc gagttactat 180
gtggactctg tgaagggccg attcaccatc tccagagacg acgccaagaa ctcactgtat 240
ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagatcgt 300
ggggtgggct acttcgatct ctggggccgt ggcaccctgg tcaccgtctc gagcggtgga 360
ggcggttcag gcggaggtgg ttccggcggt ggcggctccc agtctgccct gactcagcct 420
gcctccgtgt ctgggtctcc tggacagtcg atcaccatct cctgcactgg aaccagcagt 480
gacgttggtg gttataactt tgtctcctgg taccaacaac acccaggcaa agcccccaaa 540
ctcatgatct atgatgtcag tgatcggccc tcaggggtgt ctgatcgctt ctccggctcc 600
aagtctggca acacggcctc cctgatcatc tctggcctcc aggctgacga cgaggctgat 660
tattactgca gctcatatgg gagcagcagc actcatgtga ttttcggcgg agggaccaag 720
gtgaccgtcc ta 732
<210> 66
<211> 703
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 66
Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu
1 5 10 15
Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Val Ser Ser Gly
20 25 30
Asp Tyr Tyr Trp Thr Trp Ile Arg Gln Ser Pro Gly Lys Gly Leu Glu
35 40 45
Trp Ile Gly His Ile Tyr Tyr Ser Gly Asn Thr Asn Tyr Asn Pro Ser
50 55 60
Leu Lys Ser Arg Leu Thr Ile Ser Ile Asp Thr Ser Lys Thr Gln Phe
65 70 75 80
Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Ile Tyr Tyr
85 90 95
Cys Val Arg Asp Arg Val Thr Gly Ala Phe Asp Ile Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp Lys
210 215 220
Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro
225 230 235 240
Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser
245 250 255
Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp
260 265 270
Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn
275 280 285
Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val
290 295 300
Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu
305 310 315 320
Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys
325 330 335
Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr
340 345 350
Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr
355 360 365
Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu
370 375 380
Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu
385 390 395 400
Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys
405 410 415
Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu
420 425 430
Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly
435 440 445
Lys Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val Gln Leu Gln
450 455 460
Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly Ser Leu Arg Leu Ser
465 470 475 480
Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr Trp Met Ser Trp Val
485 490 495
Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ala Asn Ile Asn Arg
500 505 510
Asp Gly Ser Ala Ser Tyr Tyr Val Asp Ser Val Lys Gly Arg Phe Thr
515 520 525
Ile Ser Arg Asp Asp Ala Lys Asn Ser Leu Tyr Leu Gln Met Asn Ser
530 535 540
Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Asp Arg Gly
545 550 555 560
Val Gly Tyr Phe Asp Leu Trp Gly Arg Gly Thr Leu Val Thr Val Ser
565 570 575
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
580 585 590
Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
595 600 605
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr
610 615 620
Asn Phe Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
625 630 635 640
Met Ile Tyr Asp Val Ser Asp Arg Pro Ser Gly Val Ser Asp Arg Phe
645 650 655
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Ile Ile Ser Gly Leu
660 665 670
Gln Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Gly Ser Ser
675 680 685
Ser Thr His Val Ile Phe Gly Gly Gly Thr Lys Val Thr Val Leu
690 695 700
<210> 67
<211> 119
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 67
Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu
1 5 10 15
Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Val Ser Ser Gly
20 25 30
Asp Tyr Tyr Trp Thr Trp Ile Arg Gln Ser Pro Gly Lys Gly Leu Glu
35 40 45
Trp Ile Gly His Ile Tyr Tyr Ser Gly Asn Thr Asn Tyr Asn Pro Ser
50 55 60
Leu Lys Ser Arg Leu Thr Ile Ser Ile Asp Thr Ser Lys Thr Gln Phe
65 70 75 80
Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Ile Tyr Tyr
85 90 95
Cys Val Arg Asp Arg Val Thr Gly Ala Phe Asp Ile Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser
115
<210> 68
<211> 243
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 68
Gln Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Asn Ile Asn Arg Asp Gly Ser Ala Ser Tyr Tyr Val Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ala Lys Asn Ser Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Asp Arg Gly Val Gly Tyr Phe Asp Leu Trp Gly Arg Gly Thr
100 105 110
Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
115 120 125
Gly Gly Gly Gly Ser Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser
130 135 140
Gly Ser Pro Gly Gln Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser
145 150 155 160
Asp Val Gly Gly Tyr Asn Phe Val Ser Trp Tyr Gln Gln His Pro Gly
165 170 175
Lys Ala Pro Lys Leu Met Ile Tyr Asp Val Ser Asp Arg Pro Ser Gly
180 185 190
Val Ser Asp Arg Phe Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu
195 200 205
Ile Ile Ser Gly Leu Gln Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Ser
210 215 220
Ser Tyr Gly Ser Ser Ser Thr His Val Ile Phe Gly Gly Gly Thr Lys
225 230 235 240
Val Thr Val
<210> 69
<211> 654
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 69
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc 60
tcctgcactg gaaccagcag tgacgttggt ggttataact ttgtctcctg gtaccaacaa 120
cacccaggca aagcccccaa actcatgatc tatgatgtca gtgatcggcc ctcaggggtg 180
tctgatcgct tctccggctc caagtctggc aacacggcct ccctgatcat ctctggcctc 240
caggctgacg acgaggctga ttattactgc agctcatatg ggagcagcag cactcatgtg 300
attttcggcg gagggaccaa gctgaccgtc ctacgtacgg tggctgcacc atctgtcttc 360
atcttcccgc catctgatga gcagttgaaa tctggaactg cctctgttgt gtgcctgctg 420
aataacttct atcccagaga ggccaaagta cagtggaagg tggataacgc cctccaatcg 480
ggtaactccc aggagagtgt cacagagcag gacagcaagg acagcaccta cagcctcagc 540
agcaccctga cgctgagcaa agcagactac gagaaacaca aagtctacgc ctgcgaagtc 600
acccatcagg gcctgagctc gcccgtcaca aagagcttca acaggggaga gtgt 654
<210> 70
<211> 333
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 70
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc 60
tcctgcactg gaaccagcag tgacgttggt ggttataact ttgtctcctg gtaccaacaa 120
cacccaggca aagcccccaa actcatgatc tatgatgtca gtgatcggcc ctcaggggtg 180
tctgatcgct tctccggctc caagtctggc aacacggcct ccctgatcat ctctggcctc 240
caggctgacg acgaggctga ttattactgc agctcatatg ggagcagcag cactcatgtg 300
attttcggcg gagggaccaa gctgaccgtc cta 333
<210> 71
<211> 218
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 71
Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
1 5 10 15
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr
20 25 30
Asn Phe Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
35 40 45
Met Ile Tyr Asp Val Ser Asp Arg Pro Ser Gly Val Ser Asp Arg Phe
50 55 60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Ile Ile Ser Gly Leu
65 70 75 80
Gln Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Gly Ser Ser
85 90 95
Ser Thr His Val Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Arg
100 105 110
Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln
115 120 125
Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr
130 135 140
Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser
145 150 155 160
Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr
165 170 175
Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys
180 185 190
His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro
195 200 205
Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210> 72
<211> 111
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 72
Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
1 5 10 15
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr
20 25 30
Asn Phe Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
35 40 45
Met Ile Tyr Asp Val Ser Asp Arg Pro Ser Gly Val Ser Asp Arg Phe
50 55 60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Ile Ile Ser Gly Leu
65 70 75 80
Gln Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Gly Ser Ser
85 90 95
Ser Thr His Val Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
100 105 110
<210> 73
<211> 2127
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 73
caggtgcagc tgcaggagtc ggggggaggc ctggtcaagc ctggagggtc cctgagactc 60
tcctgtgcag cctctggatt cacctttagt agttattgga tgagctgggt ccgccaggct 120
ccagggaagg ggctggagtg ggtggccaac ataaaccgcg atggaagtgc gagttactat 180
gtggactctg tgaagggccg attcaccatc tccagagacg acgccaagaa ctcactgtat 240
ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagatcgt 300
ggggtgggct acttcgatct ctggggccgt ggcaccctgg tcaccgtctc gagcgctagc 360
accaagggcc catcggtctt ccccctggca ccctcctcca agagcacctc tgggggcaca 420
gcggccctgg gctgcctggt caaggactac ttccccgaac cggtgacggt gtcgtggaac 480
tcaggcgccc tgaccagcgg cgtgcacacc ttcccggctg tcctacagtc ctcaggactc 540
tactccctca gcagcgtggt gaccgtgccc tccagcagct tgggcaccca gacctacatc 600
tgcaacgtga atcacaagcc cagcaacacc aaggtggaca agagagttga gcccaaatct 660
tgtgacaaaa ctcacacatg cccaccgtgc ccagcacctg aactcctggg gggaccgtca 720
gtcttcctct tccccccaaa acccaaggac accctcatga tctcccggac ccctgaggtc 780
acatgcgtgg tggtggacgt gagccacgaa gaccctgagg tcaagttcaa ctggtacgtg 840
gacggcgtgg aggtgcataa tgccaagaca aagccgcggg aggagcagta caacagcacg 900
taccgtgtgg tcagcgtcct caccgtcctg caccaggact ggctgaatgg caaggagtac 960
aagtgcaagg tctccaacaa agccctccca gcccccatcg agaaaaccat ctccaaagcc 1020
aaagggcagc cccgagaacc acaggtgtac accctgcccc catcccggga ggagatgacc 1080
aagaaccagg tcagcctgac ctgcctggtc aaaggcttct atcccagcga catcgccgtg 1140
gagtgggaga gcaatgggca gccggagaac aactacaaga ccacgcctcc cgtgctggac 1200
tccgacggct ccttcttcct ctatagcaag ctcaccgtgg acaagagcag gtggcagcag 1260
gggaacgtct tctcatgctc cgtgatgcat gaggctctgc acaaccacta cacgcagaag 1320
agcctctccc tgtctccggg taaaggcggt ggaggatccg gcggtggtgg atcacaagtt 1380
caacttcaac aatctggtgc tgaagttaaa aaacctggtt cttctgttaa agtttcttgt 1440
aaagcctctg gttatacttt tactaattat tatatttatt gggttcgtca agctcctggt 1500
caaggtcttg aatggattgg tggtattaat cctacttctg gtggttctaa ttttaatgaa 1560
aaatttaaaa ctcgtgttac tattactgtt gatgaatcta cgaacactgc ttatatggaa 1620
ctttcttctc ttcgttctga agatactgct ttttattttt gtgcgcgtca aggtctttgg 1680
tttgattctg atggtcgtgg ttttgatttt tggggtcaag gttccactgt tactgtctcg 1740
agcggtggag gcggttcagg cggaggtggt tccggcggtg gcggctccga tattcaaatg 1800
actcaatctc cttcttctct ttctgcttct gttggtgatc gtgttactat tacttgtcgt 1860
tcttctcaaa atattgttca ttctaatggt aatacttatc ttgattggta tcaacaaact 1920
cctggtaaag ctcctaaact tcttatttat aaagtttcta atcgtttttc tggtgttcct 1980
tctcgttttt ctggttctgg ttctggtact gattttactt ttactatttc ttctcttcaa 2040
cctgaagata ttgctactta ttattgtttt caatattctc atgttccttg gacttttggt 2100
caaggtacta aacttcaaat tactcgt 2127
<210> 74
<211> 354
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 74
caggtgcagc tgcaggagtc ggggggaggc ctggtcaagc ctggagggtc cctgagactc 60
tcctgtgcag cctctggatt cacctttagt agttattgga tgagctgggt ccgccaggct 120
ccagggaagg ggctggagtg ggtggccaac ataaaccgcg atggaagtgc gagttactat 180
gtggactctg tgaagggccg attcaccatc tccagagacg acgccaagaa ctcactgtat 240
ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagatcgt 300
ggggtgggct acttcgatct ctggggccgt ggcaccctgg tcaccgtctc gagc 354
<210> 75
<211> 753
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 75
caagttcaac ttcaacaatc tggtgctgaa gttaaaaaac ctggttcttc tgttaaagtt 60
tcttgtaaag cctctggtta tacttttact aattattata tttattgggt tcgtcaagct 120
cctggtcaag gtcttgaatg gattggtggt attaatccta cttctggtgg ttctaatttt 180
aatgaaaaat ttaaaactcg tgttactatt actgttgatg aatctacgaa cactgcttat 240
atggaacttt cttctcttcg ttctgaagat actgcttttt atttttgtgc gcgtcaaggt 300
ctttggtttg attctgatgg tcgtggtttt gatttttggg gtcaaggttc cactgttact 360
gtctcgagcg gtggaggcgg ttcaggcgga ggtggttccg gcggtggcgg ctccgatatt 420
caaatgactc aatctccttc ttctctttct gcttctgttg gtgatcgtgt tactattact 480
tgtcgttctt ctcaaaatat tgttcattct aatggtaata cttatcttga ttggtatcaa 540
caaactcctg gtaaagctcc taaacttctt atttataaag tttctaatcg tttttctggt 600
gttccttctc gtttttctgg ttctggttct ggtactgatt ttacttttac tatttcttct 660
cttcaacctg aagatattgc tacttattat tgttttcaat attctcatgt tccttggact 720
tttggtcaag gtactaaact tcaaattact cgt 753
<210> 76
<211> 709
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 76
Gln Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Asn Ile Asn Arg Asp Gly Ser Ala Ser Tyr Tyr Val Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ala Lys Asn Ser Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Asp Arg Gly Val Gly Tyr Phe Asp Leu Trp Gly Arg Gly Thr
100 105 110
Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe Pro
115 120 125
Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly
130 135 140
Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp Asn
145 150 155 160
Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu Gln
165 170 175
Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser Ser
180 185 190
Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro Ser
195 200 205
Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp Lys Thr
210 215 220
His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser
225 230 235 240
Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg
245 250 255
Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro
260 265 270
Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala
275 280 285
Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val
290 295 300
Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr
305 310 315 320
Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr
325 330 335
Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu
340 345 350
Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys
355 360 365
Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser
370 375 380
Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp
385 390 395 400
Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser
405 410 415
Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala
420 425 430
Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
435 440 445
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val Gln Leu Gln Gln
450 455 460
Ser Gly Ala Glu Val Lys Lys Pro Gly Ser Ser Val Lys Val Ser Cys
465 470 475 480
Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr Tyr Ile Tyr Trp Val Arg
485 490 495
Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile Gly Gly Ile Asn Pro Thr
500 505 510
Ser Gly Gly Ser Asn Phe Asn Glu Lys Phe Lys Thr Arg Val Thr Ile
515 520 525
Thr Val Asp Glu Ser Thr Asn Thr Ala Tyr Met Glu Leu Ser Ser Leu
530 535 540
Arg Ser Glu Asp Thr Ala Phe Tyr Phe Cys Ala Arg Gln Gly Leu Trp
545 550 555 560
Phe Asp Ser Asp Gly Arg Gly Phe Asp Phe Trp Gly Gln Gly Ser Thr
565 570 575
Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
580 585 590
Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser
595 600 605
Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ser Ser Gln Asn
610 615 620
Ile Val His Ser Asn Gly Asn Thr Tyr Leu Asp Trp Tyr Gln Gln Thr
625 630 635 640
Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Lys Val Ser Asn Arg Phe
645 650 655
Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe
660 665 670
Thr Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr
675 680 685
Cys Phe Gln Tyr Ser His Val Pro Trp Thr Phe Gly Gln Gly Thr Lys
690 695 700
Leu Gln Ile Thr Arg
705
<210> 77
<211> 118
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 77
Gln Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Asn Ile Asn Arg Asp Gly Ser Ala Ser Tyr Tyr Val Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ala Lys Asn Ser Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Asp Arg Gly Val Gly Tyr Phe Asp Leu Trp Gly Arg Gly Thr
100 105 110
Leu Val Thr Val Ser Ser
115
<210> 78
<211> 251
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 78
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr
20 25 30
Tyr Ile Tyr Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Gly Ile Asn Pro Thr Ser Gly Gly Ser Asn Phe Asn Glu Lys Phe
50 55 60
Lys Thr Arg Val Thr Ile Thr Val Asp Glu Ser Thr Asn Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Phe Tyr Phe Cys
85 90 95
Ala Arg Gln Gly Leu Trp Phe Asp Ser Asp Gly Arg Gly Phe Asp Phe
100 105 110
Trp Gly Gln Gly Ser Thr Val Thr Val Ser Ser Gly Gly Gly Gly Ser
115 120 125
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln
130 135 140
Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr
145 150 155 160
Cys Arg Ser Ser Gln Asn Ile Val His Ser Asn Gly Asn Thr Tyr Leu
165 170 175
Asp Trp Tyr Gln Gln Thr Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr
180 185 190
Lys Val Ser Asn Arg Phe Ser Gly Val Pro Ser Arg Phe Ser Gly Ser
195 200 205
Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro Glu
210 215 220
Asp Ile Ala Thr Tyr Tyr Cys Phe Gln Tyr Ser His Val Pro Trp Thr
225 230 235 240
Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr Arg
245 250
<210> 79
<211> 657
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 79
gatattcaaa tgactcaatc tccttcttct ctttctgctt ctgttggtga tcgtgttact 60
attacttgtc gttcttctca aaatattgtt cattctaatg gtaatactta tcttgattgg 120
tatcaacaaa ctcctggtaa agctcctaaa cttcttattt ataaagtttc taatcgtttt 180
tctggtgttc cttctcgttt ttctggttct ggttctggta ctgattttac ttttactatt 240
tcttctcttc aacctgaaga tattgctact tattattgtt ttcaatattc tcatgttcct 300
tggacttttg gtcaaggtac taaacttcaa attactcgta cggtggctgc accatctgtc 360
ttcatcttcc cgccatctga tgagcagttg aaatctggaa ctgcctctgt tgtgtgcctg 420
ctgaataact tctatcccag agaggccaaa gtacagtgga aggtggataa cgccctccaa 480
tcgggtaact cccaggagag tgtcacagag caggacagca aggacagcac ctacagcctc 540
agcagcaccc tgacgctgag caaagcagac tacgagaaac acaaagtcta cgcctgcgaa 600
gtcacccatc agggcctgag ctcgcccgtc acaaagagct tcaacagggg agagtgt 657
<210> 80
<211> 336
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 80
gatattcaaa tgactcaatc tccttcttct ctttctgctt ctgttggtga tcgtgttact 60
attacttgtc gttcttctca aaatattgtt cattctaatg gtaatactta tcttgattgg 120
tatcaacaaa ctcctggtaa agctcctaaa cttcttattt ataaagtttc taatcgtttt 180
tctggtgttc cttctcgttt ttctggttct ggttctggta ctgattttac ttttactatt 240
tcttctcttc aacctgaaga tattgctact tattattgtt ttcaatattc tcatgttcct 300
tggacttttg gtcaaggtac taaacttcaa attact 336
<210> 81
<211> 219
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 81
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ser Ser Gln Asn Ile Val His Ser
20 25 30
Asn Gly Asn Thr Tyr Leu Asp Trp Tyr Gln Gln Thr Pro Gly Lys Ala
35 40 45
Pro Lys Leu Leu Ile Tyr Lys Val Ser Asn Arg Phe Ser Gly Val Pro
50 55 60
Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile
65 70 75 80
Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Phe Gln Tyr
85 90 95
Ser His Val Pro Trp Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr
100 105 110
Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu
115 120 125
Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe
130 135 140
Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln
145 150 155 160
Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser
165 170 175
Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu
180 185 190
Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser
195 200 205
Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210> 82
<211> 112
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 82
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ser Ser Gln Asn Ile Val His Ser
20 25 30
Asn Gly Asn Thr Tyr Leu Asp Trp Tyr Gln Gln Thr Pro Gly Lys Ala
35 40 45
Pro Lys Leu Leu Ile Tyr Lys Val Ser Asn Arg Phe Ser Gly Val Pro
50 55 60
Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile
65 70 75 80
Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Phe Gln Tyr
85 90 95
Ser His Val Pro Trp Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr
100 105 110
<210> 83
<211> 2121
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 83
caagttcaac ttcaacaatc tggtgctgaa gttaaaaaac ctggttcttc tgttaaagtt 60
tcttgtaaag cctctggtta tacttttact aattattata tttattgggt tcgtcaagct 120
cctggtcaag gtcttgaatg gattggtggt attaatccta cttctggtgg ttctaatttt 180
aatgaaaaat ttaaaactcg tgttactatt actgttgatg aatctacgaa cactgcttat 240
atggaacttt cttctcttcg ttctgaagat actgcttttt atttttgtgc gcgtcaaggt 300
ctttggtttg attctgatgg tcgtggtttt gatttttggg gtcaaggttc cactgttact 360
gtctcgagcg ctagcaccaa gggcccatcg gtcttccccc tggcaccctc ctccaagagc 420
acctctgggg gcacagcggc cctgggctgc ctggtcaagg actacttccc cgaaccggtg 480
acggtgtcgt ggaactcagg cgccctgacc agcggcgtgc acaccttccc ggctgtccta 540
cagtcctcag gactctactc cctcagcagc gtggtgaccg tgccctccag cagcttgggc 600
acccagacct acatctgcaa cgtgaatcac aagcccagca acaccaaggt ggacaagaga 660
gttgagccca aatcttgtga caaaactcac acatgcccac cgtgcccagc acctgaactc 720
ctggggggac cgtcagtctt cctcttcccc ccaaaaccca aggacaccct catgatctcc 780
cggacccctg aggtcacatg cgtggtggtg gacgtgagcc acgaagaccc tgaggtcaag 840
ttcaactggt acgtggacgg cgtggaggtg cataatgcca agacaaagcc gcgggaggag 900
cagtacaaca gcacgtaccg tgtggtcagc gtcctcaccg tcctgcacca ggactggctg 960
aatggcaagg agtacaagtg caaggtctcc aacaaagccc tcccagcccc catcgagaaa 1020
accatctcca aagccaaagg gcagccccga gaaccacagg tgtacaccct gcccccatcc 1080
cgggaggaga tgaccaagaa ccaggtcagc ctgacctgcc tggtcaaagg cttctatccc 1140
agcgacatcg ccgtggagtg ggagagcaat gggcagccgg agaacaacta caagaccacg 1200
cctcccgtgc tggactccga cggctccttc ttcctctata gcaagctcac cgtggacaag 1260
agcaggtggc agcaggggaa cgtcttctca tgctccgtga tgcatgaggc tctgcacaac 1320
cactacacgc agaagagcct ctccctgtct ccgggtaaag gcggtggagg atccggcggt 1380
ggtggatcac aggtgcagct gcaggagtcg gggggaggcc tggtcaagcc tggagggtcc 1440
ctgagactct cctgtgcagc ctctggattc acctttagta gttattggat gagctgggtc 1500
cgccaggctc cagggaaggg gctggagtgg gtggccaaca taaaccgcga tggaagtgcg 1560
agttactatg tggactctgt gaagggccga ttcaccatct ccagagacga cgccaagaac 1620
tcactgtatc tgcaaatgaa cagcctgaga gctgaggaca cggctgtgta ttactgtgcg 1680
agagatcgtg gggtgggcta cttcgatctc tggggccgtg gcaccctggt caccgtctcg 1740
agcggtggag gcggttcagg cggaggtggt tccggcggtg gcggctccca gtctgccctg 1800
actcagcctg cctccgtgtc tgggtctcct ggacagtcga tcaccatctc ctgcactgga 1860
accagcagtg acgttggtgg ttataacttt gtctcctggt accaacaaca cccaggcaaa 1920
gcccccaaac tcatgatcta tgatgtcagt gatcggccct caggggtgtc tgatcgcttc 1980
tccggctcca agtctggcaa cacggcctcc ctgatcatct ctggcctcca ggctgacgac 2040
gaggctgatt attactgcag ctcatatggg agcagcagca ctcatgtgat tttcggcgga 2100
gggaccaagg tgaccgtcct a 2121
<210> 84
<211> 369
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 84
caagttcaac ttcaacaatc tggtgctgaa gttaaaaaac ctggttcttc tgttaaagtt 60
tcttgtaaag cctctggtta tacttttact aattattata tttattgggt tcgtcaagct 120
cctggtcaag gtcttgaatg gattggtggt attaatccta cttctggtgg ttctaatttt 180
aatgaaaaat ttaaaactcg tgttactatt actgttgatg aatctacgaa cactgcttat 240
atggaacttt cttctcttcg ttctgaagat actgcttttt atttttgtgc gcgtcaaggt 300
ctttggtttg attctgatgg tcgtggtttt gatttttggg gtcaaggttc cactgttact 360
gtctcgagc 369
<210> 85
<211> 732
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 85
caggtgcagc tgcaggagtc ggggggaggc ctggtcaagc ctggagggtc cctgagactc 60
tcctgtgcag cctctggatt cacctttagt agttattgga tgagctgggt ccgccaggct 120
ccagggaagg ggctggagtg ggtggccaac ataaaccgcg atggaagtgc gagttactat 180
gtggactctg tgaagggccg attcaccatc tccagagacg acgccaagaa ctcactgtat 240
ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagatcgt 300
ggggtgggct acttcgatct ctggggccgt ggcaccctgg tcaccgtctc gagcggtgga 360
ggcggttcag gcggaggtgg ttccggcggt ggcggctccc agtctgccct gactcagcct 420
gcctccgtgt ctgggtctcc tggacagtcg atcaccatct cctgcactgg aaccagcagt 480
gacgttggtg gttataactt tgtctcctgg taccaacaac acccaggcaa agcccccaaa 540
ctcatgatct atgatgtcag tgatcggccc tcaggggtgt ctgatcgctt ctccggctcc 600
aagtctggca acacggcctc cctgatcatc tctggcctcc aggctgacga cgaggctgat 660
tattactgca gctcatatgg gagcagcagc actcatgtga ttttcggcgg agggaccaag 720
gtgaccgtcc ta 732
<210> 86
<211> 707
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 86
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr
20 25 30
Tyr Ile Tyr Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Gly Ile Asn Pro Thr Ser Gly Gly Ser Asn Phe Asn Glu Lys Phe
50 55 60
Lys Thr Arg Val Thr Ile Thr Val Asp Glu Ser Thr Asn Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Phe Tyr Phe Cys
85 90 95
Ala Arg Gln Gly Leu Trp Phe Asp Ser Asp Gly Arg Gly Phe Asp Phe
100 105 110
Trp Gly Gln Gly Ser Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly
115 120 125
Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly
130 135 140
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145 150 155 160
Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
165 170 175
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
180 185 190
Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val
195 200 205
Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys
210 215 220
Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu
225 230 235 240
Leu Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr
245 250 255
Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val
260 265 270
Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val
275 280 285
Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser
290 295 300
Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu
305 310 315 320
Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala
325 330 335
Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro
340 345 350
Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln
355 360 365
Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala
370 375 380
Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr
385 390 395 400
Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu
405 410 415
Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser
420 425 430
Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser
435 440 445
Leu Ser Pro Gly Lys Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln
450 455 460
Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly Ser
465 470 475 480
Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr Trp
485 490 495
Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ala
500 505 510
Asn Ile Asn Arg Asp Gly Ser Ala Ser Tyr Tyr Val Asp Ser Val Lys
515 520 525
Gly Arg Phe Thr Ile Ser Arg Asp Asp Ala Lys Asn Ser Leu Tyr Leu
530 535 540
Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala
545 550 555 560
Arg Asp Arg Gly Val Gly Tyr Phe Asp Leu Trp Gly Arg Gly Thr Leu
565 570 575
Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
580 585 590
Gly Gly Gly Ser Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly
595 600 605
Ser Pro Gly Gln Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp
610 615 620
Val Gly Gly Tyr Asn Phe Val Ser Trp Tyr Gln Gln His Pro Gly Lys
625 630 635 640
Ala Pro Lys Leu Met Ile Tyr Asp Val Ser Asp Arg Pro Ser Gly Val
645 650 655
Ser Asp Arg Phe Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Ile
660 665 670
Ile Ser Gly Leu Gln Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Ser Ser
675 680 685
Tyr Gly Ser Ser Ser Thr His Val Ile Phe Gly Gly Gly Thr Lys Val
690 695 700
Thr Val Leu
705
<210> 87
<211> 123
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 87
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr
20 25 30
Tyr Ile Tyr Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Gly Ile Asn Pro Thr Ser Gly Gly Ser Asn Phe Asn Glu Lys Phe
50 55 60
Lys Thr Arg Val Thr Ile Thr Val Asp Glu Ser Thr Asn Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Phe Tyr Phe Cys
85 90 95
Ala Arg Gln Gly Leu Trp Phe Asp Ser Asp Gly Arg Gly Phe Asp Phe
100 105 110
Trp Gly Gln Gly Ser Thr Val Thr Val Ser Ser
115 120
<210> 88
<211> 244
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 88
Gln Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Asn Ile Asn Arg Asp Gly Ser Ala Ser Tyr Tyr Val Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ala Lys Asn Ser Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Asp Arg Gly Val Gly Tyr Phe Asp Leu Trp Gly Arg Gly Thr
100 105 110
Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
115 120 125
Gly Gly Gly Gly Ser Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser
130 135 140
Gly Ser Pro Gly Gln Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser
145 150 155 160
Asp Val Gly Gly Tyr Asn Phe Val Ser Trp Tyr Gln Gln His Pro Gly
165 170 175
Lys Ala Pro Lys Leu Met Ile Tyr Asp Val Ser Asp Arg Pro Ser Gly
180 185 190
Val Ser Asp Arg Phe Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu
195 200 205
Ile Ile Ser Gly Leu Gln Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Ser
210 215 220
Ser Tyr Gly Ser Ser Ser Thr His Val Ile Phe Gly Gly Gly Thr Lys
225 230 235 240
Val Thr Val Leu
<210> 89
<211> 657
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 89
gatattcaaa tgactcaatc tccttcttct ctttctgctt ctgttggtga tcgtgttact 60
attacttgtc gttcttctca aaatattgtt cattctaatg gtaatactta tcttgattgg 120
tatcaacaaa ctcctggtaa agctcctaaa cttcttattt ataaagtttc taatcgtttt 180
tctggtgttc cttctcgttt ttctggttct ggttctggta ctgattttac ttttactatt 240
tcttctcttc aacctgaaga tattgctact tattattgtt ttcaatattc tcatgttcct 300
tggacttttg gtcaaggtac taaacttcaa attactcgta cggtggctgc accatctgtc 360
ttcatcttcc cgccatctga tgagcagttg aaatctggaa ctgcctctgt tgtgtgcctg 420
ctgaataact tctatcccag agaggccaaa gtacagtgga aggtggataa cgccctccaa 480
tcgggtaact cccaggagag tgtcacagag caggacagca aggacagcac ctacagcctc 540
agcagcaccc tgacgctgag caaagcagac tacgagaaac acaaagtcta cgcctgcgaa 600
gtcacccatc agggcctgag ctcgcccgtc acaaagagct tcaacagggg agagtgt 657
<210> 90
<211> 336
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 90
gatattcaaa tgactcaatc tccttcttct ctttctgctt ctgttggtga tcgtgttact 60
attacttgtc gttcttctca aaatattgtt cattctaatg gtaatactta tcttgattgg 120
tatcaacaaa ctcctggtaa agctcctaaa cttcttattt ataaagtttc taatcgtttt 180
tctggtgttc cttctcgttt ttctggttct ggttctggta ctgattttac ttttactatt 240
tcttctcttc aacctgaaga tattgctact tattattgtt ttcaatattc tcatgttcct 300
tggacttttg gtcaaggtac taaacttcaa attact 336
<210> 91
<211> 336
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 91
gacatccaga tgacccagtc cccttccagc ctgtccgctt ccgtgggcga cagggtgacc 60
atcacctgca ggtcctccca gaacatcgtg cactccaacg gcaataccta cctggactgg 120
taccagcaga cccccggcaa ggcccctaag ctgctgatct acaaggtgag caaccggttc 180
agcggcgtgc cttcccggtt ttccggatcc ggctccggca cagacttcac cttcaccatc 240
tcctccctgc aacccgagga catcgccacc tactactgct tccagtactc ccatgtgccc 300
tggaccttcg gccagggcac caagctgcag atcacc 336
<210> 92
<211> 218
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 92
Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
1 5 10 15
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr
20 25 30
Asn Phe Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
35 40 45
Met Ile Tyr Asp Val Ser Asp Arg Pro Ser Gly Val Ser Asp Arg Phe
50 55 60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Ile Ile Ser Gly Leu
65 70 75 80
Gln Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Gly Ser Ser
85 90 95
Ser Thr His Val Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Arg
100 105 110
Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln
115 120 125
Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr
130 135 140
Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser
145 150 155 160
Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr
165 170 175
Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys
180 185 190
His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro
195 200 205
Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210> 93
<211> 111
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 93
Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
1 5 10 15
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr
20 25 30
Asn Phe Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
35 40 45
Met Ile Tyr Asp Val Ser Asp Arg Pro Ser Gly Val Ser Asp Arg Phe
50 55 60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Ile Ile Ser Gly Leu
65 70 75 80
Gln Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Gly Ser Ser
85 90 95
Ser Thr His Val Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
100 105 110
<210> 94
<211> 2118
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 94
caggtgcagc tgcagcagag cggcgccgag gtgaagaagc ccggcagcag cgtgaaggtg 60
agctgcaagg ccagcggcta caccttcacc aactactaca tctactgggt gcggcaggcc 120
cccggccagg gcctggagtg gatcggcggc atcaacccca ccagcggcgg cagcaacttc 180
aacgagaagt tcaagacccg ggtgaccatc accgccgacg agagcagcac caccgcctac 240
atggagctga gcagcctgcg gagcgaggac accgccttct acttctgcac ccggcagggc 300
ctgtggttcg acagcgacgg ccggggcttc gacttctggg gccagggcac caccgtgacc 360
gtgagcagcg ctagcaccaa gggcccatcg gtcttccccc tggcaccctc ctccaagagc 420
acctctgggg gcacagcggc cctgggctgc ctggtcaagg actacttccc cgaaccggtg 480
acggtgtcgt ggaactcagg cgccctgacc agcggcgtgc acaccttccc ggctgtccta 540
cagtcctcag gactctactc cctcagcagc gtggtgaccg tgccctccag cagcttgggc 600
acccagacct acatctgcaa cgtgaatcac aagcccagca acaccaaggt ggacaagaga 660
gttgagccca aatcttgtga caaaactcac acatgcccac cgtgcccagc acctgaactc 720
ctggggggac cgtcagtctt cctcttcccc ccaaaaccca aggacaccct catgatctcc 780
cggacccctg aggtcacatg cgtggtggtg gacgtgagcc acgaagaccc tgaggtcaag 840
ttcaactggt acgtggacgg cgtggaggtg cataatgcca agacaaagcc gcgggaggag 900
cagtacaaca gcacgtaccg tgtggtcagc gtcctcaccg tcctgcacca ggactggctg 960
aatggcaagg agtacaagtg caaggtctcc aacaaagccc tcccagcccc catcgagaaa 1020
accatctcca aagccaaagg gcagccccga gaaccacagg tgtacaccct gcccccatcc 1080
cgggatgagc tgaccaagaa ccaggtcagc ctgacctgcc tggtcaaagg cttctatccc 1140
agcgacatcg ccgtggagtg ggagagcaat gggcagccgg agaacaacta caagaccacg 1200
cctcccgtgc tggactccga cggctccttc ttcctctata gcaagctcac cgtggacaag 1260
agcaggtggc agcaggggaa cgtcttctca tgctccgtga tgcatgaggc tctgcacaac 1320
cactacacgc agaagagcct ctccctgtct ccgggtggcg gtggagggtc cggcggtggt 1380
ggatcacagg tgcaattgca ggagtcgggg ggaggcctgg tcaagcctgg agggtccctg 1440
agactctcct gtgcagcctc tggattcacc tttagtagtt attggatgag ctgggtccgc 1500
caggctccag ggaaggggct ggagtgggtg gccaacataa accgcgatgg aagtgcgagt 1560
tactatgtgg actctgtgaa gggccgattc accatctcca gagacgacgc caagaactca 1620
ctgtatctgc aaatgaacag cctgagagct gaggacacgg ctgtgtatta ctgtgcgaga 1680
gatcgtgggg tgggctactt cgatctctgg ggccgtggca ccctggtcac cgtctcgagc 1740
ggtggaggcg gttcaggcgg aggtggttcc ggcggtggcg gctcccagtc tgccctgact 1800
cagcctgcct ccgtgtctgg gtctcctgga cagtcgatca ccatctcctg cactggaacc 1860
agcagtgacg ttggtggtta taactttgtc tcctggtacc aacaacaccc aggcaaagcc 1920
cccaaactca tgatctatga tgtcagtgat cggccctcag gggtgtctga tcgcttctcc 1980
ggctccaagt ctggcaacac ggcctccctg atcatctctg gcctccaggc tgacgacgag 2040
gctgattatt actgcagctc atatgggagc agcagcactc atgtgatttt cggcggaggg 2100
accaaggtga ccgtccta 2118
<210> 95
<211> 369
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 95
caggtgcagc tgcagcagag cggcgccgag gtgaagaagc ccggcagcag cgtgaaggtg 60
agctgcaagg ccagcggcta caccttcacc aactactaca tctactgggt gcggcaggcc 120
cccggccagg gcctggagtg gatcggcggc atcaacccca ccagcggcgg cagcaacttc 180
aacgagaagt tcaagacccg ggtgaccatc accgccgacg agagcagcac caccgcctac 240
atggagctga gcagcctgcg gagcgaggac accgccttct acttctgcac ccggcagggc 300
ctgtggttcg acagcgacgg ccggggcttc gacttctggg gccagggcac caccgtgacc 360
gtgagcagc 369
<210> 96
<211> 369
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 96
caggtgcagc tgcagcaatc cggcgccgag gtgaagaagc ctggctccag cgtgaaggtg 60
tcctgcaagg cctccggcta caccttcacc aactactaca tctactgggt gaggcaggct 120
cctggccagg gactggagtg gatcggcggc atcaacccta cctccggcgg ctccaacttc 180
aacgagaagt tcaagacccg ggtgaccatc accgccgatg agagctccac caccgcctac 240
atggagctgt cctccctgag gtccgaggac accgcctttt acttctgcac caggcaggga 300
ctgtggttcg actccgacgg ccggggcttc gatttttggg gccagggcac cacagtgacc 360
gtgtcctcc 369
<210> 97
<211> 732
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 97
caggtgcaat tgcaggagtc ggggggaggc ctggtcaagc ctggagggtc cctgagactc 60
tcctgtgcag cctctggatt cacctttagt agttattgga tgagctgggt ccgccaggct 120
ccagggaagg ggctggagtg ggtggccaac ataaaccgcg atggaagtgc gagttactat 180
gtggactctg tgaagggccg attcaccatc tccagagacg acgccaagaa ctcactgtat 240
ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagatcgt 300
ggggtgggct acttcgatct ctggggccgt ggcaccctgg tcaccgtctc gagcggtgga 360
ggcggttcag gcggaggtgg ttccggcggt ggcggctccc agtctgccct gactcagcct 420
gcctccgtgt ctgggtctcc tggacagtcg atcaccatct cctgcactgg aaccagcagt 480
gacgttggtg gttataactt tgtctcctgg taccaacaac acccaggcaa agcccccaaa 540
ctcatgatct atgatgtcag tgatcggccc tcaggggtgt ctgatcgctt ctccggctcc 600
aagtctggca acacggcctc cctgatcatc tctggcctcc aggctgacga cgaggctgat 660
tattactgca gctcatatgg gagcagcagc actcatgtga ttttcggcgg agggaccaag 720
gtgaccgtcc ta 732
<210> 98
<211> 706
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 98
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr
20 25 30
Tyr Ile Tyr Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Gly Ile Asn Pro Thr Ser Gly Gly Ser Asn Phe Asn Glu Lys Phe
50 55 60
Lys Thr Arg Val Thr Ile Thr Ala Asp Glu Ser Ser Thr Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Phe Tyr Phe Cys
85 90 95
Thr Arg Gln Gly Leu Trp Phe Asp Ser Asp Gly Arg Gly Phe Asp Phe
100 105 110
Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly
115 120 125
Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly
130 135 140
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145 150 155 160
Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
165 170 175
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
180 185 190
Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val
195 200 205
Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys
210 215 220
Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu
225 230 235 240
Leu Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr
245 250 255
Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val
260 265 270
Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val
275 280 285
Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser
290 295 300
Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu
305 310 315 320
Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala
325 330 335
Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro
340 345 350
Gln Val Tyr Thr Leu Pro Pro Ser Arg Asp Glu Leu Thr Lys Asn Gln
355 360 365
Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala
370 375 380
Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr
385 390 395 400
Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu
405 410 415
Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser
420 425 430
Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser
435 440 445
Leu Ser Pro Gly Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val
450 455 460
Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly Ser Leu
465 470 475 480
Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr Trp Met
485 490 495
Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ala Asn
500 505 510
Ile Asn Arg Asp Gly Ser Ala Ser Tyr Tyr Val Asp Ser Val Lys Gly
515 520 525
Arg Phe Thr Ile Ser Arg Asp Asp Ala Lys Asn Ser Leu Tyr Leu Gln
530 535 540
Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg
545 550 555 560
Asp Arg Gly Val Gly Tyr Phe Asp Leu Trp Gly Arg Gly Thr Leu Val
565 570 575
Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
580 585 590
Gly Gly Ser Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser
595 600 605
Pro Gly Gln Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val
610 615 620
Gly Gly Tyr Asn Phe Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala
625 630 635 640
Pro Lys Leu Met Ile Tyr Asp Val Ser Asp Arg Pro Ser Gly Val Ser
645 650 655
Asp Arg Phe Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Ile Ile
660 665 670
Ser Gly Leu Gln Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr
675 680 685
Gly Ser Ser Ser Thr His Val Ile Phe Gly Gly Gly Thr Lys Val Thr
690 695 700
Val Leu
705
<210> 99
<211> 123
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 99
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr
20 25 30
Tyr Ile Tyr Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Gly Ile Asn Pro Thr Ser Gly Gly Ser Asn Phe Asn Glu Lys Phe
50 55 60
Lys Thr Arg Val Thr Ile Thr Ala Asp Glu Ser Ser Thr Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Phe Tyr Phe Cys
85 90 95
Thr Arg Gln Gly Leu Trp Phe Asp Ser Asp Gly Arg Gly Phe Asp Phe
100 105 110
Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser
115 120
<210> 100
<211> 244
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 100
Gln Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Asn Ile Asn Arg Asp Gly Ser Ala Ser Tyr Tyr Val Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ala Lys Asn Ser Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Asp Arg Gly Val Gly Tyr Phe Asp Leu Trp Gly Arg Gly Thr
100 105 110
Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
115 120 125
Gly Gly Gly Gly Ser Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser
130 135 140
Gly Ser Pro Gly Gln Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser
145 150 155 160
Asp Val Gly Gly Tyr Asn Phe Val Ser Trp Tyr Gln Gln His Pro Gly
165 170 175
Lys Ala Pro Lys Leu Met Ile Tyr Asp Val Ser Asp Arg Pro Ser Gly
180 185 190
Val Ser Asp Arg Phe Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu
195 200 205
Ile Ile Ser Gly Leu Gln Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Ser
210 215 220
Ser Tyr Gly Ser Ser Ser Thr His Val Ile Phe Gly Gly Gly Thr Lys
225 230 235 240
Val Thr Val Leu
<210> 101
<211> 654
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 101
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc 60
tcctgcactg gaaccagcag tgacgttggt ggttataact ttgtctcctg gtaccaacaa 120
cacccaggca aagcccccaa actcatgatc tatgatgtca gtgatcggcc ctcaggggtg 180
tctgatcgct tctccggctc caagtctggc aacacggcct ccctgatcat ctctggcctc 240
caggctgacg acgaggctga ttattactgc agctcatatg ggagcagcag cactcatgtg 300
attttcggcg gagggaccaa gctgaccgtc ctacgtacgg tggctgcacc atctgtcttc 360
atcttcccgc catctgatga gcagttgaaa tctggaactg cctctgttgt gtgcctgctg 420
aataacttct atcccagaga ggccaaagta cagtggaagg tggataacgc cctccaatcg 480
ggtaactccc aggagagtgt cacagagcag gacagcaagg acagcaccta cagcctcagc 540
agcaccctga cgctgagcaa agcagactac gagaaacaca aagtctacgc ctgcgaagtc 600
acccatcagg gcctgagctc gcccgtcaca aagagcttca acaggggaga gtgt 654
<210> 102
<211> 333
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 102
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc 60
tcctgcactg gaaccagcag tgacgttggt ggttataact ttgtctcctg gtaccaacaa 120
cacccaggca aagcccccaa actcatgatc tatgatgtca gtgatcggcc ctcaggggtg 180
tctgatcgct tctccggctc caagtctggc aacacggcct ccctgatcat ctctggcctc 240
caggctgacg acgaggctga ttattactgc agctcatatg ggagcagcag cactcatgtg 300
attttcggcg gagggaccaa gctgaccgtc cta 333
<210> 103
<211> 218
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 103
Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
1 5 10 15
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr
20 25 30
Asn Phe Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
35 40 45
Met Ile Tyr Asp Val Ser Asp Arg Pro Ser Gly Val Ser Asp Arg Phe
50 55 60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Ile Ile Ser Gly Leu
65 70 75 80
Gln Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Gly Ser Ser
85 90 95
Ser Thr His Val Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Arg
100 105 110
Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln
115 120 125
Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr
130 135 140
Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser
145 150 155 160
Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr
165 170 175
Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys
180 185 190
His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro
195 200 205
Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210> 104
<211> 111
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 104
Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
1 5 10 15
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr
20 25 30
Asn Phe Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
35 40 45
Met Ile Tyr Asp Val Ser Asp Arg Pro Ser Gly Val Ser Asp Arg Phe
50 55 60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Ile Ile Ser Gly Leu
65 70 75 80
Gln Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Gly Ser Ser
85 90 95
Ser Thr His Val Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
100 105 110
<210> 105
<211> 2100
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 105
caggtgcagc tgcaggagtc ggggggaggc ctggtcaagc ctggagggtc cctgagactc 60
tcctgtgcag cctctggatt cacctttagt agttattgga tgagctgggt ccgccaggct 120
ccagggaagg ggctggagtg ggtggccaac ataaaccgcg atggaagtgc gagttactat 180
gtggactctg tgaagggccg attcaccatc tccagagacg acgccaagaa ctcactgtat 240
ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagatcgt 300
ggggtgggct acttcgatct ctggggccgt ggcaccctgg tcaccgtctc gagcgctagc 360
accaagggcc catcggtctt ccccctggca ccctcctcca agagcacctc tgggggcaca 420
gcggccctgg gctgcctggt caaggactac ttccccgaac cggtgacggt gtcgtggaac 480
tcaggcgccc tgaccagcgg cgtgcacacc ttcccggctg tcctacagtc ctcaggactc 540
tactccctca gcagcgtggt gaccgtgccc tccagcagct tgggcaccca gacctacatc 600
tgcaacgtga atcacaagcc cagcaacacc aaggtggaca agagagttga gcccaaatct 660
tgtgacaaaa ctcacacatg cccaccgtgc ccagcacctg aactcctggg gggaccgtca 720
gtcttcctct tccccccaaa acccaaggac accctcatga tctcccggac ccctgaggtc 780
acatgcgtgg tggtggacgt gagccacgaa gaccctgagg tcaagttcaa ctggtacgtg 840
gacggcgtgg aggtgcataa tgccaagaca aagccgcggg aggagcagta caacagcacg 900
taccgtgtgg tcagcgtcct caccgtcctg caccaggact ggctgaatgg caaggagtac 960
aagtgcaagg tctccaacaa agccctccca gcccccatcg agaaaaccat ctccaaagcc 1020
aaagggcagc cccgagaacc acaggtgtac accctgcccc catcccggga ggagatgacc 1080
aagaaccagg tcagcctgac ctgcctggtc aaaggcttct atcccagcga catcgccgtg 1140
gagtgggaga gcaatgggca gccggagaac aactacaaga ccacgcctcc cgtgctggac 1200
tccgacggct ccttcttcct ctatagcaag ctcaccgtgg acaagagcag gtggcagcag 1260
gggaacgtct tctcatgctc cgtgatgcat gaggctctgc acaaccacta cacgcagaag 1320
agcctctccc tgtctccggg taaaggcggt ggaggatccg gcggtggtgg atcacaggtg 1380
cagctgaagc agtcaggacc tggcctagtg cagccctcac agagcctgtc catcacctgc 1440
acagtctctg gtttctcatt aactaactat ggtgtacact gggttcgcca gtctccagga 1500
aagggtctgg agtggctggg agtgatatgg agtggtggaa acacagacta taatacacct 1560
ttcacatcca gactgagcat caacaaggac aattccaaga gccaagtttt ctttaaaatg 1620
aacagtctgc aatctaatga cacagccata tattactgtg ccagagccct cacctactat 1680
gattacgagt ttgcttactg gggccaaggg actctggtca ctgtctctag cggtggaggc 1740
ggttcaggcg gaggtggttc cggcggtggc ggctccgaca tcttgctgac tcagtctcca 1800
gtcatcctgt ctgtgagtcc aggagaaaga gtcagtttct cctgcagggc cagtcagagt 1860
attggcacaa acatacactg gtatcagcaa agaacaaatg gttctccaag gcttctcata 1920
aagtatgctt ctgagtctat ctctgggatt ccttccaggt ttagtggcag tggatcaggg 1980
acagatttta ctcttagcat caacagtgtg gagtctgaag atattgcaga ttattactgt 2040
caacaaaata ataactggcc aaccacgttc ggtgctggga ccaagctgga gctgaaacgt 2100
<210> 106
<211> 354
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 106
caggtgcagc tgcaggagtc ggggggaggc ctggtcaagc ctggagggtc cctgagactc 60
tcctgtgcag cctctggatt cacctttagt agttattgga tgagctgggt ccgccaggct 120
ccagggaagg ggctggagtg ggtggccaac ataaaccgcg atggaagtgc gagttactat 180
gtggactctg tgaagggccg attcaccatc tccagagacg acgccaagaa ctcactgtat 240
ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagatcgt 300
ggggtgggct acttcgatct ctggggccgt ggcaccctgg tcaccgtctc gagc 354
<210> 107
<211> 726
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 107
caggtgcagc tgaagcagtc aggacctggc ctagtgcagc cctcacagag cctgtccatc 60
acctgcacag tctctggttt ctcattaact aactatggtg tacactgggt tcgccagtct 120
ccaggaaagg gtctggagtg gctgggagtg atatggagtg gtggaaacac agactataat 180
acacctttca catccagact gagcatcaac aaggacaatt ccaagagcca agttttcttt 240
aaaatgaaca gtctgcaatc taatgacaca gccatatatt actgtgccag agccctcacc 300
tactatgatt acgagtttgc ttactggggc caagggactc tggtcactgt ctctagcggt 360
ggaggcggtt caggcggagg tggttccggc ggtggcggct ccgacatctt gctgactcag 420
tctccagtca tcctgtctgt gagtccagga gaaagagtca gtttctcctg cagggccagt 480
cagagtattg gcacaaacat acactggtat cagcaaagaa caaatggttc tccaaggctt 540
ctcataaagt atgcttctga gtctatctct gggattcctt ccaggtttag tggcagtgga 600
tcagggacag attttactct tagcatcaac agtgtggagt ctgaagatat tgcagattat 660
tactgtcaac aaaataataa ctggccaacc acgttcggtg ctgggaccaa gctggagctg 720
aaacgt 726
<210> 108
<211> 700
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 108
Gln Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Asn Ile Asn Arg Asp Gly Ser Ala Ser Tyr Tyr Val Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ala Lys Asn Ser Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Asp Arg Gly Val Gly Tyr Phe Asp Leu Trp Gly Arg Gly Thr
100 105 110
Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe Pro
115 120 125
Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly
130 135 140
Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp Asn
145 150 155 160
Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu Gln
165 170 175
Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser Ser
180 185 190
Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro Ser
195 200 205
Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp Lys Thr
210 215 220
His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser
225 230 235 240
Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg
245 250 255
Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro
260 265 270
Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala
275 280 285
Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val
290 295 300
Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr
305 310 315 320
Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr
325 330 335
Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu
340 345 350
Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys
355 360 365
Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser
370 375 380
Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp
385 390 395 400
Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser
405 410 415
Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala
420 425 430
Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
435 440 445
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val Gln Leu Lys Gln
450 455 460
Ser Gly Pro Gly Leu Val Gln Pro Ser Gln Ser Leu Ser Ile Thr Cys
465 470 475 480
Thr Val Ser Gly Phe Ser Leu Thr Asn Tyr Gly Val His Trp Val Arg
485 490 495
Gln Ser Pro Gly Lys Gly Leu Glu Trp Leu Gly Val Ile Trp Ser Gly
500 505 510
Gly Asn Thr Asp Tyr Asn Thr Pro Phe Thr Ser Arg Leu Ser Ile Asn
515 520 525
Lys Asp Asn Ser Lys Ser Gln Val Phe Phe Lys Met Asn Ser Leu Gln
530 535 540
Ser Asn Asp Thr Ala Ile Tyr Tyr Cys Ala Arg Ala Leu Thr Tyr Tyr
545 550 555 560
Asp Tyr Glu Phe Ala Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser
565 570 575
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
580 585 590
Asp Ile Leu Leu Thr Gln Ser Pro Val Ile Leu Ser Val Ser Pro Gly
595 600 605
Glu Arg Val Ser Phe Ser Cys Arg Ala Ser Gln Ser Ile Gly Thr Asn
610 615 620
Ile His Trp Tyr Gln Gln Arg Thr Asn Gly Ser Pro Arg Leu Leu Ile
625 630 635 640
Lys Tyr Ala Ser Glu Ser Ile Ser Gly Ile Pro Ser Arg Phe Ser Gly
645 650 655
Ser Gly Ser Gly Thr Asp Phe Thr Leu Ser Ile Asn Ser Val Glu Ser
660 665 670
Glu Asp Ile Ala Asp Tyr Tyr Cys Gln Gln Asn Asn Asn Trp Pro Thr
675 680 685
Thr Phe Gly Ala Gly Thr Lys Leu Glu Leu Lys Arg
690 695 700
<210> 109
<211> 118
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 109
Gln Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Asn Ile Asn Arg Asp Gly Ser Ala Ser Tyr Tyr Val Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ala Lys Asn Ser Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Asp Arg Gly Val Gly Tyr Phe Asp Leu Trp Gly Arg Gly Thr
100 105 110
Leu Val Thr Val Ser Ser
115
<210> 110
<211> 242
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 110
Gln Val Gln Leu Lys Gln Ser Gly Pro Gly Leu Val Gln Pro Ser Gln
1 5 10 15
Ser Leu Ser Ile Thr Cys Thr Val Ser Gly Phe Ser Leu Thr Asn Tyr
20 25 30
Gly Val His Trp Val Arg Gln Ser Pro Gly Lys Gly Leu Glu Trp Leu
35 40 45
Gly Val Ile Trp Ser Gly Gly Asn Thr Asp Tyr Asn Thr Pro Phe Thr
50 55 60
Ser Arg Leu Ser Ile Asn Lys Asp Asn Ser Lys Ser Gln Val Phe Phe
65 70 75 80
Lys Met Asn Ser Leu Gln Ser Asn Asp Thr Ala Ile Tyr Tyr Cys Ala
85 90 95
Arg Ala Leu Thr Tyr Tyr Asp Tyr Glu Phe Ala Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
115 120 125
Ser Gly Gly Gly Gly Ser Asp Ile Leu Leu Thr Gln Ser Pro Val Ile
130 135 140
Leu Ser Val Ser Pro Gly Glu Arg Val Ser Phe Ser Cys Arg Ala Ser
145 150 155 160
Gln Ser Ile Gly Thr Asn Ile His Trp Tyr Gln Gln Arg Thr Asn Gly
165 170 175
Ser Pro Arg Leu Leu Ile Lys Tyr Ala Ser Glu Ser Ile Ser Gly Ile
180 185 190
Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Ser
195 200 205
Ile Asn Ser Val Glu Ser Glu Asp Ile Ala Asp Tyr Tyr Cys Gln Gln
210 215 220
Asn Asn Asn Trp Pro Thr Thr Phe Gly Ala Gly Thr Lys Leu Glu Leu
225 230 235 240
Lys Arg
<210> 111
<211> 642
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 111
gacatcttgc tgactcagtc tccagtcatc ctgtctgtga gtccaggaga aagagtcagt 60
ttctcctgca gggccagtca gagtattggc acaaacatac actggtatca gcaaagaaca 120
aatggttctc caaggcttct cataaagtat gcttctgagt ctatctctgg gattccttcc 180
aggtttagtg gcagtggatc agggacagat tttactctta gcatcaacag tgtggagtct 240
gaagatattg cagattatta ctgtcaacaa aataataact ggccaaccac gttcggtgct 300
gggaccaagc tggagctgaa acgtacggtg gctgcaccat ctgtcttcat cttcccgcca 360
tctgatgagc agttgaaatc tggaactgcc tctgttgtgt gcctgctgaa taacttctat 420
cccagagagg ccaaagtaca gtggaaggtg gataacgccc tccaatcggg taactcccag 480
gagagtgtca cagagcagga cagcaaggac agcacctaca gcctcagcag caccctgacg 540
ctgagcaaag cagactacga gaaacacaaa gtctacgcct gcgaagtcac ccatcagggc 600
ctgagctcgc ccgtcacaaa gagcttcaac aggggagagt gt 642
<210> 112
<211> 321
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 112
gacatcttgc tgactcagtc tccagtcatc ctgtctgtga gtccaggaga aagagtcagt 60
ttctcctgca gggccagtca gagtattggc acaaacatac actggtatca gcaaagaaca 120
aatggttctc caaggcttct cataaagtat gcttctgagt ctatctctgg gattccttcc 180
aggtttagtg gcagtggatc agggacagat tttactctta gcatcaacag tgtggagtct 240
gaagatattg cagattatta ctgtcaacaa aataataact ggccaaccac gttcggtgct 300
gggaccaagc tggagctgaa a 321
<210> 113
<211> 214
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 113
Asp Ile Leu Leu Thr Gln Ser Pro Val Ile Leu Ser Val Ser Pro Gly
1 5 10 15
Glu Arg Val Ser Phe Ser Cys Arg Ala Ser Gln Ser Ile Gly Thr Asn
20 25 30
Ile His Trp Tyr Gln Gln Arg Thr Asn Gly Ser Pro Arg Leu Leu Ile
35 40 45
Lys Tyr Ala Ser Glu Ser Ile Ser Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Ser Ile Asn Ser Val Glu Ser
65 70 75 80
Glu Asp Ile Ala Asp Tyr Tyr Cys Gln Gln Asn Asn Asn Trp Pro Thr
85 90 95
Thr Phe Gly Ala Gly Thr Lys Leu Glu Leu Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210> 114
<211> 107
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 114
Asp Ile Leu Leu Thr Gln Ser Pro Val Ile Leu Ser Val Ser Pro Gly
1 5 10 15
Glu Arg Val Ser Phe Ser Cys Arg Ala Ser Gln Ser Ile Gly Thr Asn
20 25 30
Ile His Trp Tyr Gln Gln Arg Thr Asn Gly Ser Pro Arg Leu Leu Ile
35 40 45
Lys Tyr Ala Ser Glu Ser Ile Ser Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Ser Ile Asn Ser Val Glu Ser
65 70 75 80
Glu Asp Ile Ala Asp Tyr Tyr Cys Gln Gln Asn Asn Asn Trp Pro Thr
85 90 95
Thr Phe Gly Ala Gly Thr Lys Leu Glu Leu Lys
100 105
<210> 115
<211> 2109
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 115
caggtgcagc tgaagcagtc aggacctggc ctagtgcagc cctcacagag cctgtccatc 60
acctgcacag tctctggttt ctcattaact aactatggtg tacactgggt tcgccagtct 120
ccaggaaagg gtctggagtg gctgggagtg atatggagtg gtggaaacac agactataat 180
acacctttca catccagact gagcatcaac aaggacaatt ccaagagcca agttttcttt 240
aaaatgaaca gtctgcaatc taatgacaca gccatatatt actgtgccag agccctcacc 300
tactatgatt acgagtttgc ttactggggc caagggactc tggtcactgt ctctagcgct 360
agcaccaagg gcccatcggt cttccccctg gcaccctcct ccaagagcac ctctgggggc 420
acagcggccc tgggctgcct ggtcaaggac tacttccccg aaccggtgac ggtgtcgtgg 480
aactcaggcg ccctgaccag cggcgtgcac accttcccgg ctgtcctaca gtcctcagga 540
ctctactccc tcagcagcgt ggtgaccgtg ccctccagca gcttgggcac ccagacctac 600
atctgcaacg tgaatcacaa gcccagcaac accaaggtgg acaagagagt tgagcccaaa 660
tcttgtgaca aaactcacac atgcccaccg tgcccagcac ctgaactcct ggggggaccg 720
tcagtcttcc tcttcccccc aaaacccaag gacaccctca tgatctcccg gacccctgag 780
gtcacatgcg tggtggtgga cgtgagccac gaagaccctg aggtcaagtt caactggtac 840
gtggacggcg tggaggtgca taatgccaag acaaagccgc gggaggagca gtacaacagc 900
acgtaccgtg tggtcagcgt cctcaccgtc ctgcaccagg actggctgaa tggcaaggag 960
tacaagtgca aggtctccaa caaagccctc ccagccccca tcgagaaaac catctccaaa 1020
gccaaagggc agccccgaga accacaggtg tacaccctgc ccccatcccg ggaggagatg 1080
accaagaacc aggtcagcct gacctgcctg gtcaaaggct tctatcccag cgacatcgcc 1140
gtggagtggg agagcaatgg gcagccggag aacaactaca agaccacgcc tcccgtgctg 1200
gactccgacg gctccttctt cctctatagc aagctcaccg tggacaagag caggtggcag 1260
caggggaacg tcttctcatg ctccgtgatg catgaggctc tgcacaacca ctacacgcag 1320
aagagcctct ccctgtctcc gggtaaaggc ggtggaggat ccggcggtgg tggatcacag 1380
gtgcagctgc aggagtcggg gggaggcctg gtcaagcctg gagggtccct gagactctcc 1440
tgtgcagcct ctggattcac ctttagtagt tattggatga gctgggtccg ccaggctcca 1500
gggaaggggc tggagtgggt ggccaacata aaccgcgatg gaagtgcgag ttactatgtg 1560
gactctgtga agggccgatt caccatctcc agagacgacg ccaagaactc actgtatctg 1620
caaatgaaca gcctgagagc tgaggacacg gctgtgtatt actgtgcgag agatcgtggg 1680
gtgggctact tcgatctctg gggccgtggc accctggtca ccgtctcgag cggtggaggc 1740
ggttcaggcg gaggtggttc cggcggtggc ggctcccagt ctgccctgac tcagcctgcc 1800
tccgtgtctg ggtctcctgg acagtcgatc accatctcct gcactggaac cagcagtgac 1860
gttggtggtt ataactttgt ctcctggtac caacaacacc caggcaaagc ccccaaactc 1920
atgatctatg atgtcagtga tcggccctca ggggtgtctg atcgcttctc cggctccaag 1980
tctggcaaca cggcctccct gatcatctct ggcctccagg ctgacgacga ggctgattat 2040
tactgcagct catatgggag cagcagcact catgtgattt tcggcggagg gaccaaggtg 2100
accgtccta 2109
<210> 116
<211> 357
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 116
caggtgcagc tgaagcagtc aggacctggc ctagtgcagc cctcacagag cctgtccatc 60
acctgcacag tctctggttt ctcattaact aactatggtg tacactgggt tcgccagtct 120
ccaggaaagg gtctggagtg gctgggagtg atatggagtg gtggaaacac agactataat 180
acacctttca catccagact gagcatcaac aaggacaatt ccaagagcca agttttcttt 240
aaaatgaaca gtctgcaatc taatgacaca gccatatatt actgtgccag agccctcacc 300
tactatgatt acgagtttgc ttactggggc caagggactc tggtcactgt ctctagc 357
<210> 117
<211> 732
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 117
caggtgcagc tgcaggagtc ggggggaggc ctggtcaagc ctggagggtc cctgagactc 60
tcctgtgcag cctctggatt cacctttagt agttattgga tgagctgggt ccgccaggct 120
ccagggaagg ggctggagtg ggtggccaac ataaaccgcg atggaagtgc gagttactat 180
gtggactctg tgaagggccg attcaccatc tccagagacg acgccaagaa ctcactgtat 240
ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagatcgt 300
ggggtgggct acttcgatct ctggggccgt ggcaccctgg tcaccgtctc gagcggtgga 360
ggcggttcag gcggaggtgg ttccggcggt ggcggctccc agtctgccct gactcagcct 420
gcctccgtgt ctgggtctcc tggacagtcg atcaccatct cctgcactgg aaccagcagt 480
gacgttggtg gttataactt tgtctcctgg taccaacaac acccaggcaa agcccccaaa 540
ctcatgatct atgatgtcag tgatcggccc tcaggggtgt ctgatcgctt ctccggctcc 600
aagtctggca acacggcctc cctgatcatc tctggcctcc aggctgacga cgaggctgat 660
tattactgca gctcatatgg gagcagcagc actcatgtga ttttcggcgg agggaccaag 720
gtgaccgtcc ta 732
<210> 118
<211> 703
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 118
Gln Val Gln Leu Lys Gln Ser Gly Pro Gly Leu Val Gln Pro Ser Gln
1 5 10 15
Ser Leu Ser Ile Thr Cys Thr Val Ser Gly Phe Ser Leu Thr Asn Tyr
20 25 30
Gly Val His Trp Val Arg Gln Ser Pro Gly Lys Gly Leu Glu Trp Leu
35 40 45
Gly Val Ile Trp Ser Gly Gly Asn Thr Asp Tyr Asn Thr Pro Phe Thr
50 55 60
Ser Arg Leu Ser Ile Asn Lys Asp Asn Ser Lys Ser Gln Val Phe Phe
65 70 75 80
Lys Met Asn Ser Leu Gln Ser Asn Asp Thr Ala Ile Tyr Tyr Cys Ala
85 90 95
Arg Ala Leu Thr Tyr Tyr Asp Tyr Glu Phe Ala Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp Lys
210 215 220
Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro
225 230 235 240
Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser
245 250 255
Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp
260 265 270
Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn
275 280 285
Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val
290 295 300
Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu
305 310 315 320
Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys
325 330 335
Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr
340 345 350
Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr
355 360 365
Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu
370 375 380
Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu
385 390 395 400
Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys
405 410 415
Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu
420 425 430
Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly
435 440 445
Lys Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val Gln Leu Gln
450 455 460
Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly Ser Leu Arg Leu Ser
465 470 475 480
Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr Trp Met Ser Trp Val
485 490 495
Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ala Asn Ile Asn Arg
500 505 510
Asp Gly Ser Ala Ser Tyr Tyr Val Asp Ser Val Lys Gly Arg Phe Thr
515 520 525
Ile Ser Arg Asp Asp Ala Lys Asn Ser Leu Tyr Leu Gln Met Asn Ser
530 535 540
Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Asp Arg Gly
545 550 555 560
Val Gly Tyr Phe Asp Leu Trp Gly Arg Gly Thr Leu Val Thr Val Ser
565 570 575
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
580 585 590
Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
595 600 605
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr
610 615 620
Asn Phe Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
625 630 635 640
Met Ile Tyr Asp Val Ser Asp Arg Pro Ser Gly Val Ser Asp Arg Phe
645 650 655
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Ile Ile Ser Gly Leu
660 665 670
Gln Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Gly Ser Ser
675 680 685
Ser Thr His Val Ile Phe Gly Gly Gly Thr Lys Val Thr Val Leu
690 695 700
<210> 119
<211> 119
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 119
Gln Val Gln Leu Lys Gln Ser Gly Pro Gly Leu Val Gln Pro Ser Gln
1 5 10 15
Ser Leu Ser Ile Thr Cys Thr Val Ser Gly Phe Ser Leu Thr Asn Tyr
20 25 30
Gly Val His Trp Val Arg Gln Ser Pro Gly Lys Gly Leu Glu Trp Leu
35 40 45
Gly Val Ile Trp Ser Gly Gly Asn Thr Asp Tyr Asn Thr Pro Phe Thr
50 55 60
Ser Arg Leu Ser Ile Asn Lys Asp Asn Ser Lys Ser Gln Val Phe Phe
65 70 75 80
Lys Met Asn Ser Leu Gln Ser Asn Asp Thr Ala Ile Tyr Tyr Cys Ala
85 90 95
Arg Ala Leu Thr Tyr Tyr Asp Tyr Glu Phe Ala Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser
115
<210> 120
<211> 244
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 120
Gln Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Asn Ile Asn Arg Asp Gly Ser Ala Ser Tyr Tyr Val Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ala Lys Asn Ser Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Asp Arg Gly Val Gly Tyr Phe Asp Leu Trp Gly Arg Gly Thr
100 105 110
Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
115 120 125
Gly Gly Gly Gly Ser Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser
130 135 140
Gly Ser Pro Gly Gln Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser
145 150 155 160
Asp Val Gly Gly Tyr Asn Phe Val Ser Trp Tyr Gln Gln His Pro Gly
165 170 175
Lys Ala Pro Lys Leu Met Ile Tyr Asp Val Ser Asp Arg Pro Ser Gly
180 185 190
Val Ser Asp Arg Phe Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu
195 200 205
Ile Ile Ser Gly Leu Gln Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Ser
210 215 220
Ser Tyr Gly Ser Ser Ser Thr His Val Ile Phe Gly Gly Gly Thr Lys
225 230 235 240
Val Thr Val Leu
<210> 121
<211> 642
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 121
gacatcttgc tgactcagtc tccagtcatc ctgtctgtga gtccaggaga aagagtcagt 60
ttctcctgca gggccagtca gagtattggc acaaacatac actggtatca gcaaagaaca 120
aatggttctc caaggcttct cataaagtat gcttctgagt ctatctctgg gattccttcc 180
aggtttagtg gcagtggatc agggacagat tttactctta gcatcaacag tgtggagtct 240
gaagatattg cagattatta ctgtcaacaa aataataact ggccaaccac gttcggtgct 300
gggaccaagc tggagctgaa acgtacggtg gctgcaccat ctgtcttcat cttcccgcca 360
tctgatgagc agttgaaatc tggaactgcc tctgttgtgt gcctgctgaa taacttctat 420
cccagagagg ccaaagtaca gtggaaggtg gataacgccc tccaatcggg taactcccag 480
gagagtgtca cagagcagga cagcaaggac agcacctaca gcctcagcag caccctgacg 540
ctgagcaaag cagactacga gaaacacaaa gtctacgcct gcgaagtcac ccatcagggc 600
ctgagctcgc ccgtcacaaa gagcttcaac aggggagagt gt 642
<210> 122
<211> 321
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 122
gacatcttgc tgactcagtc tccagtcatc ctgtctgtga gtccaggaga aagagtcagt 60
ttctcctgca gggccagtca gagtattggc acaaacatac actggtatca gcaaagaaca 120
aatggttctc caaggcttct cataaagtat gcttctgagt ctatctctgg gattccttcc 180
aggtttagtg gcagtggatc agggacagat tttactctta gcatcaacag tgtggagtct 240
gaagatattg cagattatta ctgtcaacaa aataataact ggccaaccac gttcggtgct 300
gggaccaagc tggagctgaa a 321
<210> 123
<211> 214
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 123
Asp Ile Leu Leu Thr Gln Ser Pro Val Ile Leu Ser Val Ser Pro Gly
1 5 10 15
Glu Arg Val Ser Phe Ser Cys Arg Ala Ser Gln Ser Ile Gly Thr Asn
20 25 30
Ile His Trp Tyr Gln Gln Arg Thr Asn Gly Ser Pro Arg Leu Leu Ile
35 40 45
Lys Tyr Ala Ser Glu Ser Ile Ser Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Ser Ile Asn Ser Val Glu Ser
65 70 75 80
Glu Asp Ile Ala Asp Tyr Tyr Cys Gln Gln Asn Asn Asn Trp Pro Thr
85 90 95
Thr Phe Gly Ala Gly Thr Lys Leu Glu Leu Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210> 124
<211> 107
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 124
Asp Ile Leu Leu Thr Gln Ser Pro Val Ile Leu Ser Val Ser Pro Gly
1 5 10 15
Glu Arg Val Ser Phe Ser Cys Arg Ala Ser Gln Ser Ile Gly Thr Asn
20 25 30
Ile His Trp Tyr Gln Gln Arg Thr Asn Gly Ser Pro Arg Leu Leu Ile
35 40 45
Lys Tyr Ala Ser Glu Ser Ile Ser Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Ser Ile Asn Ser Val Glu Ser
65 70 75 80
Glu Asp Ile Ala Asp Tyr Tyr Cys Gln Gln Asn Asn Asn Trp Pro Thr
85 90 95
Thr Phe Gly Ala Gly Thr Lys Leu Glu Leu Lys
100 105
<210> 125
<211> 1344
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 125
caggtgcagc tgaagcagtc aggacctggc ctagtgcagc cctcacagag cctgtccatc 60
acctgcacag tctctggttt ctcattaact aactatggtg tacactgggt tcgccagtct 120
ccaggaaagg gtctggagtg gctgggagtg atatggagtg gtggaaacac agactataat 180
acacctttca catccagact gagcatcaac aaggacaatt ccaagagcca agttttcttt 240
aaaatgaaca gtctgcaatc taatgacaca gccatatatt actgtgccag agccctcacc 300
tactatgatt acgagtttgc ttactggggc caagggactc tggtcactgt ctctagcgct 360
agcaccaagg gcccatcggt cttccccctg gcaccctcct ccaagagcac ctctgggggc 420
acagcggccc tgggctgcct ggtcaaggac tacttccccg aaccggtgac ggtgtcgtgg 480
aactcaggcg ccctgaccag cggcgtgcac accttcccgg ctgtcctaca gtcctcagga 540
ctctactccc tcagcagcgt ggtgaccgtg ccctccagca gcttgggcac ccagacctac 600
atctgcaacg tgaatcacaa gcccagcaac accaaggtgg acaagagagt tgagcccaaa 660
tcttgtgaca aaactcacac atgcccaccg tgcccagcac ctgaactcct ggggggaccg 720
tcagtcttcc tcttcccccc aaaacccaag gacaccctca tgatctcccg gacccctgag 780
gtcacatgcg tggtggtgga cgtgagccac gaagaccctg aggtcaagtt caactggtac 840
gtggacggcg tggaggtgca taatgccaag acaaagccgc gggaggagca gtacaacagc 900
acgtaccgtg tggtcagcgt cctcaccgtc ctgcaccagg actggctgaa tggcaaggag 960
tacaagtgca aggtctccaa caaagccctc ccagccccca tcgagaaaac catctccaaa 1020
gccaaagggc agccccgaga accacaggtg tacaccctgc ccccatcccg ggatgagctg 1080
accaagaacc aggtcagcct gacctgcctg gtcaaaggct tctatcccag cgacatcgcc 1140
gtggagtggg agagcaatgg gcagccggag aacaactaca agaccacgcc tcccgtgctg 1200
gactccgacg gctccttctt cctctatagc aagctcaccg tggacaagag caggtggcag 1260
caggggaacg tcttctcatg ctccgtgatg catgaggctc tgcacaacca ctacacgcag 1320
aagagcctct ccctgtctcc gggt 1344
<210> 126
<211> 357
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 126
caggtgcagc tgaagcagtc aggacctggc ctagtgcagc cctcacagag cctgtccatc 60
acctgcacag tctctggttt ctcattaact aactatggtg tacactgggt tcgccagtct 120
ccaggaaagg gtctggagtg gctgggagtg atatggagtg gtggaaacac agactataat 180
acacctttca catccagact gagcatcaac aaggacaatt ccaagagcca agttttcttt 240
aaaatgaaca gtctgcaatc taatgacaca gccatatatt actgtgccag agccctcacc 300
tactatgatt acgagtttgc ttactggggc caagggactc tggtcactgt ctctagc 357
<210> 127
<211> 448
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 127
Gln Val Gln Leu Lys Gln Ser Gly Pro Gly Leu Val Gln Pro Ser Gln
1 5 10 15
Ser Leu Ser Ile Thr Cys Thr Val Ser Gly Phe Ser Leu Thr Asn Tyr
20 25 30
Gly Val His Trp Val Arg Gln Ser Pro Gly Lys Gly Leu Glu Trp Leu
35 40 45
Gly Val Ile Trp Ser Gly Gly Asn Thr Asp Tyr Asn Thr Pro Phe Thr
50 55 60
Ser Arg Leu Ser Ile Asn Lys Asp Asn Ser Lys Ser Gln Val Phe Phe
65 70 75 80
Lys Met Asn Ser Leu Gln Ser Asn Asp Thr Ala Ile Tyr Tyr Cys Ala
85 90 95
Arg Ala Leu Thr Tyr Tyr Asp Tyr Glu Phe Ala Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp Lys
210 215 220
Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro
225 230 235 240
Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser
245 250 255
Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp
260 265 270
Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn
275 280 285
Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val
290 295 300
Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu
305 310 315 320
Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys
325 330 335
Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr
340 345 350
Leu Pro Pro Ser Arg Asp Glu Leu Thr Lys Asn Gln Val Ser Leu Thr
355 360 365
Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu
370 375 380
Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu
385 390 395 400
Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys
405 410 415
Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu
420 425 430
Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly
435 440 445
<210> 128
<211> 119
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 128
Gln Val Gln Leu Lys Gln Ser Gly Pro Gly Leu Val Gln Pro Ser Gln
1 5 10 15
Ser Leu Ser Ile Thr Cys Thr Val Ser Gly Phe Ser Leu Thr Asn Tyr
20 25 30
Gly Val His Trp Val Arg Gln Ser Pro Gly Lys Gly Leu Glu Trp Leu
35 40 45
Gly Val Ile Trp Ser Gly Gly Asn Thr Asp Tyr Asn Thr Pro Phe Thr
50 55 60
Ser Arg Leu Ser Ile Asn Lys Asp Asn Ser Lys Ser Gln Val Phe Phe
65 70 75 80
Lys Met Asn Ser Leu Gln Ser Asn Asp Thr Ala Ile Tyr Tyr Cys Ala
85 90 95
Arg Ala Leu Thr Tyr Tyr Asp Tyr Glu Phe Ala Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser
115
<210> 129
<211> 642
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 129
gacatcttgc tgactcagtc tccagtcatc ctgtctgtga gtccaggaga aagagtcagt 60
ttctcctgca gggccagtca gagtattggc acaaacatac actggtatca gcaaagaaca 120
aatggttctc caaggcttct cataaagtat gcttctgagt ctatctctgg gattccttcc 180
aggtttagtg gcagtggatc agggacagat tttactctta gcatcaacag tgtggagtct 240
gaagatattg cagattatta ctgtcaacaa aataataact ggccaaccac gttcggtgct 300
gggaccaagc tggagctgaa acgtacggtg gctgcaccat ctgtcttcat cttcccgcca 360
tctgatgagc agttgaaatc tggaactgcc tctgttgtgt gcctgctgaa taacttctat 420
cccagagagg ccaaagtaca gtggaaggtg gataacgccc tccaatcggg taactcccag 480
gagagtgtca cagagcagga cagcaaggac agcacctaca gcctcagcag caccctgacg 540
ctgagcaaag cagactacga gaaacacaaa gtctacgcct gcgaagtcac ccatcagggc 600
ctgagctcgc ccgtcacaaa gagcttcaac aggggagagt gt 642
<210> 130
<211> 321
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 130
gacatcttgc tgactcagtc tccagtcatc ctgtctgtga gtccaggaga aagagtcagt 60
ttctcctgca gggccagtca gagtattggc acaaacatac actggtatca gcaaagaaca 120
aatggttctc caaggcttct cataaagtat gcttctgagt ctatctctgg gattccttcc 180
aggtttagtg gcagtggatc agggacagat tttactctta gcatcaacag tgtggagtct 240
gaagatattg cagattatta ctgtcaacaa aataataact ggccaaccac gttcggtgct 300
gggaccaagc tggagctgaa a 321
<210> 131
<211> 214
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 131
Asp Ile Leu Leu Thr Gln Ser Pro Val Ile Leu Ser Val Ser Pro Gly
1 5 10 15
Glu Arg Val Ser Phe Ser Cys Arg Ala Ser Gln Ser Ile Gly Thr Asn
20 25 30
Ile His Trp Tyr Gln Gln Arg Thr Asn Gly Ser Pro Arg Leu Leu Ile
35 40 45
Lys Tyr Ala Ser Glu Ser Ile Ser Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Ser Ile Asn Ser Val Glu Ser
65 70 75 80
Glu Asp Ile Ala Asp Tyr Tyr Cys Gln Gln Asn Asn Asn Trp Pro Thr
85 90 95
Thr Phe Gly Ala Gly Thr Lys Leu Glu Leu Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210> 132
<211> 107
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 132
Asp Ile Leu Leu Thr Gln Ser Pro Val Ile Leu Ser Val Ser Pro Gly
1 5 10 15
Glu Arg Val Ser Phe Ser Cys Arg Ala Ser Gln Ser Ile Gly Thr Asn
20 25 30
Ile His Trp Tyr Gln Gln Arg Thr Asn Gly Ser Pro Arg Leu Leu Ile
35 40 45
Lys Tyr Ala Ser Glu Ser Ile Ser Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Ser Ile Asn Ser Val Glu Ser
65 70 75 80
Glu Asp Ile Ala Asp Tyr Tyr Cys Gln Gln Asn Asn Asn Trp Pro Thr
85 90 95
Thr Phe Gly Ala Gly Thr Lys Leu Glu Leu Lys
100 105
<210> 133
<211> 2106
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 133
caggtgcagc tgaagcagtc aggacctggc ctagtgcagc cctcacagag cctgtccatc 60
acctgcacag tctctggttt ctcattaact aactatggtg tacactgggt tcgccagtct 120
ccaggaaagg gtctggagtg gctgggagtg atatggagtg gtggaaacac agactataat 180
acacctttca catccagact gagcatcaac aaggacaatt ccaagagcca agttttcttt 240
aaaatgaaca gtctgcaatc taatgacaca gccatatatt actgtgccag agccctcacc 300
tactatgatt acgagtttgc ttactggggc caagggactc tggtcactgt ctctagcgct 360
agcaccaagg gcccatcggt cttccccctg gcaccctcct ccaagagcac ctctgggggc 420
acagcggccc tgggctgcct ggtcaaggac tacttccccg aaccggtgac ggtgtcgtgg 480
aactcaggcg ccctgaccag cggcgtgcac accttcccgg ctgtcctaca gtcctcagga 540
ctctactccc tcagcagcgt ggtgaccgtg ccctccagca gcttgggcac ccagacctac 600
atctgcaacg tgaatcacaa gcccagcaac accaaggtgg acaagagagt tgagcccaaa 660
tcttgtgaca aaactcacac atgcccaccg tgcccagcac ctgaactcct ggggggaccg 720
tcagtcttcc tcttcccccc aaaacccaag gacaccctca tgatctcccg gacccctgag 780
gtcacatgcg tggtggtgga cgtgagccac gaagaccctg aggtcaagtt caactggtac 840
gtggacggcg tggaggtgca taatgccaag acaaagccgc gggaggagca gtacaacagc 900
acgtaccgtg tggtcagcgt cctcaccgtc ctgcaccagg actggctgaa tggcaaggag 960
tacaagtgca aggtctccaa caaagccctc ccagccccca tcgagaaaac catctccaaa 1020
gccaaagggc agccccgaga accacaggtg tacaccctgc ccccatcccg ggatgagctg 1080
accaagaacc aggtcagcct gacctgcctg gtcaaaggct tctatcccag cgacatcgcc 1140
gtggagtggg agagcaatgg gcagccggag aacaactaca agaccacgcc tcccgtgctg 1200
gactccgacg gctccttctt cctctatagc aagctcaccg tggacaagag caggtggcag 1260
caggggaacg tcttctcatg ctccgtgatg catgaggctc tgcacaacca ctacacgcag 1320
aagagcctct ccctgtctcc gggtggcggt ggagggtccg gcggtggtgg atcacaggtg 1380
caattgcagg agtcgggggg aggcctggtc aagcctggag ggtccctgag actctcctgt 1440
gcagcctctg gattcacctt tagtagttat tggatgagct gggtccgcca ggctccaggg 1500
aaggggctgg agtgggtggc caacataaac cgcgatggaa gtgcgagtta ctatgtggac 1560
tctgtgaagg gccgattcac catctccaga gacgacgcca agaactcact gtatctgcaa 1620
atgaacagcc tgagagctga ggacacggct gtgtattact gtgcgagaga tcgtggggtg 1680
ggctacttcg atctctgggg ccgtggcacc ctggtcaccg tctcgagcgg tggaggcggt 1740
tcaggcggag gtggttccgg cggtggcggc tcccagtctg ccctgactca gcctgcctcc 1800
gtgtctgggt ctcctggaca gtcgatcacc atctcctgca ctggaaccag cagtgacgtt 1860
ggtggttata actttgtctc ctggtaccaa caacacccag gcaaagcccc caaactcatg 1920
atctatgatg tcagtgatcg gccctcaggg gtgtctgatc gcttctccgg ctccaagtct 1980
ggcaacacgg cctccctgat catctctggc ctccaggctg acgacgaggc tgattattac 2040
tgcagctcat atgggagcag cagcactcat gtgattttcg gcggagggac caaggtgacc 2100
gtccta 2106
<210> 134
<211> 357
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 134
caggtgcagc tgaagcagtc aggacctggc ctagtgcagc cctcacagag cctgtccatc 60
acctgcacag tctctggttt ctcattaact aactatggtg tacactgggt tcgccagtct 120
ccaggaaagg gtctggagtg gctgggagtg atatggagtg gtggaaacac agactataat 180
acacctttca catccagact gagcatcaac aaggacaatt ccaagagcca agttttcttt 240
aaaatgaaca gtctgcaatc taatgacaca gccatatatt actgtgccag agccctcacc 300
tactatgatt acgagtttgc ttactggggc caagggactc tggtcactgt ctctagc 357
<210> 135
<211> 732
<212> DNA
<213> 人工序列
<220>
<223> 合成
<400> 135
caggtgcagc tgcaggagtc ggggggaggc ctggtcaagc ctggagggtc cctgagactc 60
tcctgtgcag cctctggatt cacctttagt agttattgga tgagctgggt ccgccaggct 120
ccagggaagg ggctggagtg ggtggccaac ataaaccgcg atggaagtgc gagttactat 180
gtggactctg tgaagggccg attcaccatc tccagagacg acgccaagaa ctcactgtat 240
ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagatcgt 300
ggggtgggct acttcgatct ctggggccgt ggcaccctgg tcaccgtctc gagcggtgga 360
ggcggttcag gcggaggtgg ttccggcggt ggcggctccc agtctgccct gactcagcct 420
gcctccgtgt ctgggtctcc tggacagtcg atcaccatct cctgcactgg aaccagcagt 480
gacgttggtg gttataactt tgtctcctgg taccaacaac acccaggcaa agcccccaaa 540
ctcatgatct atgatgtcag tgatcggccc tcaggggtgt ctgatcgctt ctccggctcc 600
aagtctggca acacggcctc cctgatcatc tctggcctcc aggctgacga cgaggctgat 660
tattactgca gctcatatgg gagcagcagc actcatgtga ttttcggcgg agggaccaag 720
gtgaccgtcc ta 732
<210> 136
<211> 702
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 136
Gln Val Gln Leu Lys Gln Ser Gly Pro Gly Leu Val Gln Pro Ser Gln
1 5 10 15
Ser Leu Ser Ile Thr Cys Thr Val Ser Gly Phe Ser Leu Thr Asn Tyr
20 25 30
Gly Val His Trp Val Arg Gln Ser Pro Gly Lys Gly Leu Glu Trp Leu
35 40 45
Gly Val Ile Trp Ser Gly Gly Asn Thr Asp Tyr Asn Thr Pro Phe Thr
50 55 60
Ser Arg Leu Ser Ile Asn Lys Asp Asn Ser Lys Ser Gln Val Phe Phe
65 70 75 80
Lys Met Asn Ser Leu Gln Ser Asn Asp Thr Ala Ile Tyr Tyr Cys Ala
85 90 95
Arg Ala Leu Thr Tyr Tyr Asp Tyr Glu Phe Ala Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp Lys
210 215 220
Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro
225 230 235 240
Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser
245 250 255
Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp
260 265 270
Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn
275 280 285
Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val
290 295 300
Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu
305 310 315 320
Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys
325 330 335
Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr
340 345 350
Leu Pro Pro Ser Arg Asp Glu Leu Thr Lys Asn Gln Val Ser Leu Thr
355 360 365
Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu
370 375 380
Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu
385 390 395 400
Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys
405 410 415
Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu
420 425 430
Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly
435 440 445
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val Gln Leu Gln Glu
450 455 460
Ser Gly Gly Gly Leu Val Lys Pro Gly Gly Ser Leu Arg Leu Ser Cys
465 470 475 480
Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr Trp Met Ser Trp Val Arg
485 490 495
Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ala Asn Ile Asn Arg Asp
500 505 510
Gly Ser Ala Ser Tyr Tyr Val Asp Ser Val Lys Gly Arg Phe Thr Ile
515 520 525
Ser Arg Asp Asp Ala Lys Asn Ser Leu Tyr Leu Gln Met Asn Ser Leu
530 535 540
Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Asp Arg Gly Val
545 550 555 560
Gly Tyr Phe Asp Leu Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser
565 570 575
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln
580 585 590
Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln Ser
595 600 605
Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr Asn
610 615 620
Phe Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu Met
625 630 635 640
Ile Tyr Asp Val Ser Asp Arg Pro Ser Gly Val Ser Asp Arg Phe Ser
645 650 655
Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Ile Ile Ser Gly Leu Gln
660 665 670
Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Gly Ser Ser Ser
675 680 685
Thr His Val Ile Phe Gly Gly Gly Thr Lys Val Thr Val Leu
690 695 700
<210> 137
<211> 119
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 137
Gln Val Gln Leu Lys Gln Ser Gly Pro Gly Leu Val Gln Pro Ser Gln
1 5 10 15
Ser Leu Ser Ile Thr Cys Thr Val Ser Gly Phe Ser Leu Thr Asn Tyr
20 25 30
Gly Val His Trp Val Arg Gln Ser Pro Gly Lys Gly Leu Glu Trp Leu
35 40 45
Gly Val Ile Trp Ser Gly Gly Asn Thr Asp Tyr Asn Thr Pro Phe Thr
50 55 60
Ser Arg Leu Ser Ile Asn Lys Asp Asn Ser Lys Ser Gln Val Phe Phe
65 70 75 80
Lys Met Asn Ser Leu Gln Ser Asn Asp Thr Ala Ile Tyr Tyr Cys Ala
85 90 95
Arg Ala Leu Thr Tyr Tyr Asp Tyr Glu Phe Ala Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser
115
<210> 138
<211> 244
<212> PRT
<213> 人工序列
<220>
<223> 合成
<400> 138
Gln Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Asn Ile Asn Arg Asp Gly Ser Ala Ser Tyr Tyr Val Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asp Ala Lys Asn Ser Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Asp Arg Gly Val Gly Tyr Phe Asp Leu Trp Gly Arg Gly Thr
100 105 110
Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
115 120 125
Gly Gly Gly Gly Ser Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser
130 135 140
Gly Ser Pro Gly Gln Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser
145 150 155 160
Asp Val Gly Gly Tyr Asn Phe Val Ser Trp Tyr Gln Gln His Pro Gly
165 170 175
Lys Ala Pro Lys Leu Met Ile Tyr Asp Val Ser Asp Arg Pro Ser Gly
180 185 190
Val Ser Asp Arg Phe Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu
195 200 205
Ile Ile Ser Gly Leu Gln Ala Asp Asp Glu Ala Asp Tyr Tyr Cys Ser
210 215 220
Ser Tyr Gly Ser Ser Ser Thr His Val Ile Phe Gly Gly Gly Thr Lys
225 230 235 240
Val Thr Val Leu

Claims (42)

1.一种双特异性四价抗体，所述双特异性四价抗体包含：
两条IgGl重链；
两条κ轻链；以及
两个单链Fv(scFv)结构域；
其中所述两条IgGl重链和κ轻链形成对EGFR家族的第一成员具有结合特异性的IgG部分；
其中所述两个scFv结构域对EGFR家族的第二成员具有结合特异性，且每个scFv结构域通过具有(gly-gly-gly-gly-ser)n的氨基酸序列的连接体连接到所述IgGl重链中任一个的C-端，以提供IgGl-连接体连接，其中n是至少1的整数；以及
其中每个单链Fv结构域具有N端-重链可变区-接头-轻链可变区-C端或N-端-轻链可变区-接头-重链可变区-C-端的结构顺序，其中所述接头由(gly-gly-gly-gly-ser)m的氨基酸序列组成，其中m是至少3的整数。
2.根据权利要求1所述的双特异性四价抗体，其中n是1至10的整数。
3.根据权利要求1所述的双特异性四价抗体，其中m是3、4、5、或6。
4.根据权利要求1所述的双特异性四价抗体，其中所述IgGl重链中至少一个是人源化或人IgGl重链。
5.根据权利要求1所述的双特异性四价抗体，其中所述两个IgGl重链是人源化或人IgGl重链。
6.根据权利要求1所述的双特异性四价抗体，其中所述κ轻链中至少一个是人源化或人κ轻链。
7.根据权利要求1所述的双特异性四价抗体，其中两条κ轻链均是人源化或人κ轻链。
8.根据权利要求1所述的双特异性四价抗体，其中所述IgG部分具有对HER3的结合特异性并且所述单链Fv结构域同时具有对EGFR的结合特异性。
9.根据权利要求1所述的双特异性四价抗体，其中所述IgG部分具有对EGFR的结合特异性并且所述单链Fv结构域同时具有对HER3的结合特异性。
10.根据权利要求1所述的双特异性四价抗体，其中所述IgGl重链中至少一个的所述C端缺失一个氨基酸残基。
11.根据权利要求10所述的双特异性四价抗体，其中所述氨基酸残基是赖氨酸。
12.根据权利要求1所述的双特异性四价抗体，其中所述IgGl-连接体连接能抵抗蛋白酶活性。
13.根据权利要求1所述的双特异性四价抗体，其中所述IgGl重链中至少一个包含在CH3结构域中的两个突变，其中所述两个突变回复成人CH3结构域中的通用残基。
14.根据权利要求1所述的双特异性四价抗体，其中轻链可变区中至少一个包含含有SEQ ID NO 72的氨基酸序列。
15.根据权利要求1所述的双特异性四价抗体，其中重链可变区中至少一个包含含有SEQ ID NO 77的氨基酸序列。
16.根据权利要求1所述的双特异性四价抗体，其中所述IgGl重链、连接体和单链Fv结构域具有包含SEQ ID NO 76的氨基酸序列。
17.根据权利要求1所述的双特异性四价抗体，其中所述κ轻链中至少一个包含含有SEQID NO 71的氨基酸序列。
18.根据权利要求1所述的双特异性四价抗体，其中所述IgG部分具有对HER3的结合特异性，并且所述单链Fv结构域具有对EGFR的结合特异性；
其中所述IgGl重链、连接体和单链Fv结构域具有SEQ ID NO 76的氨基酸序列，并且所述κ轻链具有SEQ ID NO 71的氨基酸序列。
19.根据权利要求1所述的双特异性四价抗体，其中所述抗体抑制癌细胞生长。
20.一种编码根据权利要求1所述的抗体的分离的核酸。
21.一种表达载体，其包含根据权利要求20所述的分离的核酸。
22.根据权利要求21所述的表达载体，其中所述载体可在细胞中表达。
23.一种宿主细胞，其包含根据权利要求20所述的核酸。
24.一种宿主细胞，其包含根据权利要求23所述的表达载体。
25.根据权利要求24所述的宿主细胞，其中所述宿主细胞是原核细胞或真核细胞。
26.一种产生抗体的方法，其包含培养根据权利要求23-25中任一项所述的宿主细胞，从而产生所述抗体。
27.一种包含根据权利要求1所述的抗体和细胞毒性剂的免疫偶联物。
28.一种包含根据权利要求1所述的双特异性四价抗体和药学上可接受的载剂的药物组合物。
29.根据权利要求28所述的药物组合物，其进一步包含放射性同位素、放射性核素、毒素、治疗剂、化学治疗剂或其组合。
30.一种药物组合物，其包含根据权利要求29所述的免疫偶联物和药学上可接受的载剂。
31.根据权利要求1所述的双特异性四价抗体在制备治疗受试者癌症的药物中的用途。
32.根据权利要求31所述的用途，其中所述癌症包含表达EGFR家族中至少两个成员的细胞。
33.根据权利要求31所述的用途，其中所述癌症包含乳腺癌、结肠直肠癌、胰腺癌、头颈癌、黑素瘤、卵巢癌、前列腺癌、非小细胞肺癌、神经胶质瘤、食管癌、鼻咽癌、肛门癌、直肠癌、胃癌、膀胱癌、子宫颈癌和脑癌。
34.根据权利要31所述的用途，其中所述药物与有效量的治疗剂共施用。
35.根据权利要求34所述的用途，其中所述治疗剂包含抗体、化学治疗剂、酶或其组合。
36.根据权利要求34所述的用途，其中所述治疗剂包含抗雌激素剂、受体酪氨酸抑制剂或其组合。
37.根据权利要求34所述的用途，其中所述治疗剂包含卡培他滨、顺铂、曲妥单抗、氟维司群、他莫昔芬、来曲唑、依西美坦、阿那曲唑、氨鲁米特、睾内酯、伏氯唑、福美司坦、法罗唑、来曲唑、埃罗替尼、拉法替尼、达沙替尼、吉非替尼、伊马替尼、帕唑帕尼、拉帕替尼、苏尼替尼、尼洛替尼、索拉非尼、纳米微粒白蛋白结合型紫杉醇、其衍生物或组合。
38.根据权利要求34所述的用途，其中所述治疗剂包含检查点抑制剂。
39.根据权利要求34所述的用途，其中所述治疗剂包含PDl、PDLl、CTLA4、4-lBB、OX40、GITR、TIM3、LAG3、TIGIT、CD40、CD27、HVEM、BTLA、VISTA、B7H4、其衍生物或组合。
40.根据权利要求31所述的用途，其中所述受试者是人。
41.根据权利要求1所述的抗体在制备抑制受试者的HER3受体的生物活性的药物中的用途。
42.一种包含有效量的根据权利要求1所述的双特异性四价抗体的溶液，其中所述溶液是受试者的血浆。
CN202110471082.8A 2014-12-22 2015-12-19 双特异性四价抗体及其制造和使用方法 Pending CN113512122A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462095348P 2014-12-22 2014-12-22
US62/095,348 2014-12-22
CN201580036408.7A CN106659779B (zh) 2014-12-22 2015-12-19 双特异性四价抗体及其制造和使用方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201580036408.7A Division CN106659779B (zh) 2014-12-22 2015-12-19 双特异性四价抗体及其制造和使用方法

Publications (1)

Publication Number Publication Date
CN113512122A true CN113512122A (zh) 2021-10-19

Family

ID=56151464

Family Applications (11)

Application Number Title Priority Date Filing Date
CN202110471476.3A Pending CN113150165A (zh) 2014-12-22 2015-12-19 双特异性四价抗体及其制造和使用方法
CN202110470818.XA Pending CN113512120A (zh) 2014-12-22 2015-12-19 双特异性四价抗体及其制造和使用方法
CN202110471052.7A Pending CN113512121A (zh) 2014-12-22 2015-12-19 双特异性四价抗体及其制造和使用方法
CN202110471245.2A Pending CN113512123A (zh) 2014-12-22 2015-12-19 双特异性四价抗体及其制造和使用方法
CN202110471082.8A Pending CN113512122A (zh) 2014-12-22 2015-12-19 双特异性四价抗体及其制造和使用方法
CN201580036408.7A Active CN106659779B (zh) 2014-12-22 2015-12-19 双特异性四价抗体及其制造和使用方法
CN201580073430.9A Active CN107206074B (zh) 2014-12-22 2015-12-19 双特异性四价抗体及其制备和使用方法
CN202110471392.XA Pending CN113105553A (zh) 2014-12-22 2015-12-19 双特异性四价抗体及其制造和使用方法
CN202110470781.0A Pending CN113105552A (zh) 2014-12-22 2015-12-19 双特异性四价抗体及其制造和使用方法
CN202311507433.1A Pending CN117467017A (zh) 2014-12-22 2015-12-19 双特异性四价抗体及其制备和使用方法
CN202110470743.5A Pending CN113105551A (zh) 2014-12-22 2015-12-19 双特异性四价抗体及其制造和使用方法

Family Applications Before (4)

Application Number Title Priority Date Filing Date
CN202110471476.3A Pending CN113150165A (zh) 2014-12-22 2015-12-19 双特异性四价抗体及其制造和使用方法
CN202110470818.XA Pending CN113512120A (zh) 2014-12-22 2015-12-19 双特异性四价抗体及其制造和使用方法
CN202110471052.7A Pending CN113512121A (zh) 2014-12-22 2015-12-19 双特异性四价抗体及其制造和使用方法
CN202110471245.2A Pending CN113512123A (zh) 2014-12-22 2015-12-19 双特异性四价抗体及其制造和使用方法

Family Applications After (6)

Application Number Title Priority Date Filing Date
CN201580036408.7A Active CN106659779B (zh) 2014-12-22 2015-12-19 双特异性四价抗体及其制造和使用方法
CN201580073430.9A Active CN107206074B (zh) 2014-12-22 2015-12-19 双特异性四价抗体及其制备和使用方法
CN202110471392.XA Pending CN113105553A (zh) 2014-12-22 2015-12-19 双特异性四价抗体及其制造和使用方法
CN202110470781.0A Pending CN113105552A (zh) 2014-12-22 2015-12-19 双特异性四价抗体及其制造和使用方法
CN202311507433.1A Pending CN117467017A (zh) 2014-12-22 2015-12-19 双特异性四价抗体及其制备和使用方法
CN202110470743.5A Pending CN113105551A (zh) 2014-12-22 2015-12-19 双特异性四价抗体及其制造和使用方法

Country Status (12)

Country Link
US (2) US10717783B2 (zh)
EP (2) EP3237006B1 (zh)
JP (2) JP6947639B2 (zh)
KR (3) KR102590385B1 (zh)
CN (11) CN113150165A (zh)
AU (1) AU2015369831B2 (zh)
CA (2) CA3138083A1 (zh)
ES (1) ES2962675T3 (zh)
IL (3) IL286835B2 (zh)
NZ (1) NZ732628A (zh)
SG (1) SG11201704741PA (zh)
WO (2) WO2016106158A1 (zh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113150165A (zh) * 2014-12-22 2021-07-23 西雅图免疫公司 双特异性四价抗体及其制造和使用方法
CN106632681B (zh) * 2016-10-11 2017-11-14 北京东方百泰生物科技有限公司 抗egfr和抗cd3双特异抗体及其应用
CN108948195B (zh) * 2017-05-23 2022-05-31 胡毅 一种抗egfr/pd-l1双靶向抗体、其制备方法及用途
JP7323513B2 (ja) * 2017-06-25 2023-08-08 システィミューン， インク． 抗４－１ｂｂ抗体とその作製及び使用方法
CA3069238A1 (en) * 2017-11-02 2019-05-09 Systimmune, Inc. Bispecific antibodies and methods of making and using thereof
US11708410B2 (en) 2018-01-15 2023-07-25 Nanjing Legend Biotech Co., Ltd. Antibodies and variants thereof against TIGIT
CN107974461A (zh) * 2018-01-18 2018-05-01 东北农业大学 一种高效表达anti-hEGFR基因的真核表达载体构建方法
CN108220244A (zh) * 2018-01-18 2018-06-29 东北农业大学 一种含重组人表皮生长因子受体抗体基因的cho细胞株、筛选方法及其生产工艺
KR20200143436A (ko) * 2018-04-13 2020-12-23 아피메트 게엠베하 Nk 세포 결합 항체 융합 구조체
US20210115152A1 (en) * 2018-05-16 2021-04-22 Arbele Limited Composition of bispecific antibodies and method of use thereof
JP7193058B2 (ja) 2018-08-08 2022-12-20 イミューンオンコ バイオファーマシューティカルズ （シャンハイ） インコーポレイテッド Ｃｄ４７およびｈｅｒ２を標的とする組換え二機能性タンパク質
CN110850068B (zh) * 2018-08-21 2023-08-15 上海恒润达生生物科技股份有限公司 一种嵌合抗原受体亲和力检测方法
CA3115545A1 (en) * 2018-11-13 2020-05-22 Jn Biosciences Llc Bispecific antibodies for activation of immune cells
MX2022001682A (es) 2019-08-08 2022-05-13 Regeneron Pharma Nuevos formatos de moleculas de union a antigenos.
TW202200618A (zh) * 2020-03-17 2022-01-01 美商西雅圖免疫公司 微型導引和導航控制(miniGNC)類抗體蛋白及其製造和使用方法
CN111548424A (zh) * 2020-06-05 2020-08-18 上海科弈药业科技有限公司 一种靶向egfr与cd47的多功能融合蛋白及其应用
IL301472A (en) * 2020-09-21 2023-05-01 Systimmune Inc Specificity-enhanced bispecific antibody (SEBA)
AU2022333089A1 (en) * 2021-08-25 2024-02-29 Baili-Bio (Chengdu) Pharmaceutical Co., Ltd. Bispecific tetravalent antibody targeting egfr and her3
WO2023044483A2 (en) * 2021-09-20 2023-03-23 Voyager Therapeutics, Inc. Compositions and methods for the treatment of her2 positive cancer
CA3233721A1 (en) * 2021-10-03 2023-04-06 Sa XIAO Methods of treating cancer and the pharmaceutical compositions thereof
CN116120460A (zh) * 2021-11-15 2023-05-16 成都百利多特生物药业有限责任公司 双特异性抗体-喜树碱类药物偶联物及其医药用途
WO2023241480A1 (zh) * 2022-06-13 2023-12-21 三优生物医药(上海)有限公司 抗pd-l1、vegf和egfr三特异性抗体及其应用
CN116063564A (zh) * 2022-10-08 2023-05-05 盛禾(中国)生物制药有限公司 一种纯化融合蛋白的方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100196265A1 (en) * 2006-11-21 2010-08-05 Adams Gregory P Anti-egfr family antibodies, bispecific anti-egfr family antibodies and methods of use thereof
US20110091372A1 (en) * 2009-09-01 2011-04-21 Abbott Laboratories Dual Variable Domain Immunoglobulins and Uses Thereof
CN102356092A (zh) * 2009-03-20 2012-02-15 霍夫曼-拉罗奇有限公司 双特异性抗-her抗体
CN104211814A (zh) * 2013-05-29 2014-12-17 三星电子株式会社 用于消耗靶膜蛋白的组合物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2200753B (en) 1986-12-23 1991-01-23 Brookes & Gatehouse Speed measurement device
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
AU2003210802B2 (en) * 2002-02-05 2009-09-10 Genentech Inc. Protein purification
US7332585B2 (en) * 2002-04-05 2008-02-19 The Regents Of The California University Bispecific single chain Fv antibody molecules and methods of use thereof
UA94213C2 (ru) * 2004-09-17 2011-04-26 Домантис Лимитед Применение полипептида одноцепочечного антитела, который подавляет активность cd40 или cd40l в приготовлении медикамента для лечения аутоиммунного заболевания
WO2007147001A2 (en) * 2006-06-14 2007-12-21 Imclone Systems Incorporated Lyophilized formulations of anti-egfr antibodies
AU2010229705A1 (en) 2009-03-27 2011-10-20 Zymogenetics, Inc. Compositions and methods for using multispecific-binding proteins comprising an antibody-receptor combination
CA2756244A1 (en) * 2009-04-02 2010-10-07 Roche Glycart Ag Multispecific antibodies comprising full length antibodies and single chain fab fragments
MX2011010166A (es) * 2009-04-07 2011-10-11 Roche Glycart Ag Anticuerpos biespecificos anti-erbb-3/anti-c-met.
EP2496598B1 (en) * 2009-11-04 2017-08-02 Affibody AB Her3 binding polypeptides
AU2011307251A1 (en) * 2010-09-30 2013-02-28 Merck Sharp & Dohme Corp. Generation, characterization and uses thereof of anti-HER3 antibodies
CN103384681B (zh) 2010-12-23 2018-05-18 霍夫曼-拉罗奇有限公司 结合剂
TWI622597B (zh) 2011-03-28 2018-05-01 賽諾菲公司 具有交叉結合區定向之雙重可變區類抗體結合蛋白
CN103796678B (zh) 2011-04-20 2018-02-27 健玛保 针对her2的双特异性抗体
US20140170148A1 (en) * 2011-04-20 2014-06-19 Genmab A/S Bispecific antibodies against her2
RS57279B1 (sr) * 2011-04-25 2018-08-31 Daiichi Sankyo Co Ltd Anti-b7-h3 antitelo
CN102250246A (zh) * 2011-06-10 2011-11-23 常州亚当生物技术有限公司 抗VEGF/PDGFRβ双特异性抗体及其应用
CN102250247B (zh) * 2011-06-15 2013-06-19 常州亚当生物技术有限公司 一种抗vegf/ang2双特异性抗体及其应用
JP6441079B2 (ja) * 2011-12-19 2018-12-19 シンイミューン ゲーエムベーハー 二重特異性抗体分子
CN104144949B (zh) 2011-12-22 2016-08-31 财团法人生物技术开发中心 双特异性t细胞活化剂抗体
JP2015514710A (ja) * 2012-03-27 2015-05-21 ジェネンテック， インコーポレイテッド Ｈｅｒ３阻害剤に関する診断及び治療
WO2014012082A2 (en) * 2012-07-13 2014-01-16 Zymeworks Inc. Multivalent heteromultimer scaffold design an constructs
KR20240005211A (ko) * 2012-11-21 2024-01-11 얀센 바이오테크 인코포레이티드 이중특이성 EGFR/c-Met 항체
CN104650113A (zh) * 2012-12-21 2015-05-27 百奥泰生物科技(广州)有限公司 类美登素衍生物及其制备方法和用途
US20160009824A1 (en) 2013-03-15 2016-01-14 Merck Patent Gmbh Tetravalent bispecific antibodies
CN113150165A (zh) 2014-12-22 2021-07-23 西雅图免疫公司 双特异性四价抗体及其制造和使用方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100196265A1 (en) * 2006-11-21 2010-08-05 Adams Gregory P Anti-egfr family antibodies, bispecific anti-egfr family antibodies and methods of use thereof
CN102356092A (zh) * 2009-03-20 2012-02-15 霍夫曼-拉罗奇有限公司 双特异性抗-her抗体
US20110091372A1 (en) * 2009-09-01 2011-04-21 Abbott Laboratories Dual Variable Domain Immunoglobulins and Uses Thereof
CN104211814A (zh) * 2013-05-29 2014-12-17 三星电子株式会社 用于消耗靶膜蛋白的组合物

Also Published As

Publication number Publication date
EP3237006B1 (en) 2023-08-16
ES2962675T3 (es) 2024-03-20
KR20230149328A (ko) 2023-10-26
EP3237005A1 (en) 2017-11-01
CN113105551A (zh) 2021-07-13
KR20230104988A (ko) 2023-07-11
CN113105552A (zh) 2021-07-13
EP3237005A4 (en) 2018-05-23
CN113105553A (zh) 2021-07-13
KR102548827B1 (ko) 2023-06-30
CA2969867A1 (en) 2016-06-30
US20170073418A1 (en) 2017-03-16
IL286835B2 (en) 2024-03-01
CA3138083A1 (en) 2016-06-30
JP2018509175A (ja) 2018-04-05
CN113512120A (zh) 2021-10-19
JP2021119149A (ja) 2021-08-12
WO2016106157A1 (en) 2016-06-30
NZ732628A (en) 2019-01-25
IL305193A (en) 2023-10-01
CA2969867C (en) 2022-01-25
CN107206074B (zh) 2023-12-01
JP6947639B2 (ja) 2021-10-13
CN117467017A (zh) 2024-01-30
CN113150165A (zh) 2021-07-23
CN106659779A (zh) 2017-05-10
US20170369587A1 (en) 2017-12-28
SG11201704741PA (en) 2017-07-28
KR102590385B1 (ko) 2023-10-18
IL286835B1 (en) 2023-11-01
IL252811A0 (en) 2017-08-31
IL286835A (en) 2021-10-31
CN113512123A (zh) 2021-10-19
US10717783B2 (en) 2020-07-21
JP7335290B2 (ja) 2023-08-29
EP3237006A4 (en) 2018-05-30
AU2015369831A1 (en) 2017-06-29
KR20170091162A (ko) 2017-08-08
US10919977B2 (en) 2021-02-16
EP3237006A1 (en) 2017-11-01
WO2016106158A1 (en) 2016-06-30
CN113512121A (zh) 2021-10-19
AU2015369831B2 (en) 2019-07-11
CN106659779B (zh) 2021-05-18
CN107206074A (zh) 2017-09-26
IL252811B (en) 2021-10-31

Similar Documents

Publication Publication Date Title
KR102590385B1 (ko) 이중특이적 4가 항체 및 이의 제조 및 사용방법
CA2950572C (en) Tri-specific binding molecules that specifically bind to multiple cancer antigens and methods of use thereof
CN110869389B (zh) 抗ror1抗体及其制备和使用方法
RU2753902C2 (ru) Комбинированная терапия на основе активирующих т-клетки биспецифических антигенсвязывающих молекул против cd3 и фолатного рецептора 1 (folr1) и антагонистов, связывающихся с осью pd-1
DK2519543T3 (en) HETERODIMER BINDING PROTEINS AND USE THEREOF
CN111566127A (zh) 制导和导航控制蛋白及其制备和使用方法
CN115551894A (zh) 新型抗lilrb4抗体和衍生产物
KR20220016974A (ko) Cd73에 특이적인 결합 분자 및 결합 분자의 용도
KR20220154710A (ko) 소형 유도 및 항법 제어(miniGNC) 항체-유사 단백질 및 이의 제조 및 사용 방법
CN115362175A (zh) 抗acvr1抗体及其用途
AU2021264846A1 (en) TGFβR2 extracellular domain truncated molecule, fusion protein of TGFβR2 extracellular domain truncated molecule and anti-EGFR antibody, and anti-tumor use of fusion protein
CN117460747A (zh) 靶向CD79b、CD20和CD3的三特异性抗体

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20220530

Address after: No. 15318, 95 Street northeast, Redmond, Washington, U. S.

Applicant after: Seattle Immunization Co.

Applicant after: Chengdu bailidote Biological Pharmaceutical Co., Ltd

Address before: No. 15318, 95 Street northeast, Redmond, Washington, U. S.

Applicant before: Seattle Immunization Co.

Applicant before: Sichuan Baili Pharmaceutical Co., Ltd

TA01 Transfer of patent application right